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II. ABSTRACT 
The H3K9me3 is one of the major modifications characteristic of repressed chromatin. Its 
accumulation is linked to silencing of transcription and compaction of chromatin. Among the 
methyltransferases able to catalyze H3K9me3, SETDB1 leads to the earliest lethal phenotype in 
knockout mice embryos. In vitro studies showed that its interactor ATF7IP is capable of 
modulating SETDB1-dependent catalysis of H3K9me3. The implications of this interaction in a 
cellular system still remains an open question. Thus, to understand the modulation of SETDB1 
methyltransferase activity during mouse early development was the main goal of this work. Using 
ChIP-Seq the genome-wide occupancy of both SETDB1 and ATF7IP was identified in FLAG 
knockin mouse embryonic stem cells (mESC). To investigate the epigenetic outcome of this 
interaction, the genome-wide enrichment for different H3K9 marks was characterized in control 
mESC and cells where Atf7ip was deleted by the CRISPR/Cas system. Afterwards, these data 
were coupled with transcriptome profiles to address whether the epigenetic changes implicated 
in transcriptional deregulation. In contrast to Setdb1 knockout mESC, cells lacking ATF7IP survive 
and grow normally. However, several families of endogenous retrovirus (ERV) belonging to 
classes I and II known to be controlled by SETDB1 were bound by both SETDB1 and ATF7IP 
and became derepressed in Atf7ip knockout mESC. This phenotype is further enhanced when 
cells are devoid of DNA methylation. Interestingly, while mutant cells are able to differentiate and 
repress repetitive sequences during differentiation as in control cells, DNA methylation-depleted 
mutant mESC could not properly repress those sequences. Unexpectedly, H3K9me3 levels in 
Atf7ip knockout mESC were reduced neither globally nor site specifically at transposable 
elements targets of SETDB1-ATF7IP complex. On the contrary, H3K9me3 deposition increased 
at those regions and was followed by increase in H3K9me2. To identify other proteins that might 
be involved in SETDB1-ATF7IP silencing mechanism mass spectrometry of FLAG-ATF7IP 
immune-complexes was performed. Then, taking advantage of an exogenous retrotransposon 
repression reporter system, which is impaired in Atf7ip-depleted mESC, ATF7IP partner proteins 
and other known repressors were screened for genetic interaction with Atf7ip. Some factors were 
found to act within the same pathway, while others had synergistic effects and probably belong 
to independent pathways. Lastly, exchanging the expression of the endogenous locus by that of 
different Atf7ip mutants by using a Bxb1-mediated recombination system demonstrated that 
nuclear localization, as well as the conserved Domains 1 and 2, are essential for proper ERV 
repression. Altogether, this work provides a better understanding of the molecular mechanism of 
repression by SETDB1 and its modulation by the co-factor ATF7IP. 
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III. ZUSAMENFASSUNG 
Die Histonmodifikation H3K9me3 ist eine der charakteristischsten für reprimiertes Chromatin. 
Ihre Ansammlung ist mit Stilllegung der Transkription und Verdichtung von Chromatin verbunden. 
Unter den Methyltransferasen, die in der Lage sind H3K9me3 zu katalysieren, führt SETDB1 zu 
dem frühesten letalen Phänotyp bei Knockout-Maus-Embryonen. In-vitro-Studien haben gezeigt, 
dass sein Interaktionspartner ATF7IP die SETDB1-abhängige Katalyse von H3K9me3 
modulieren kann. Die Auswirkungen dieser Interaktion in einem zellulären System stellen nach 
wie vor eine offene Frage dar. Daher war das Hauptziel dieser Arbeit die Modulation der SETDB1-
Methyltransferase-Aktivität während der frühen Mausentwicklung zu verstehen. Mittels ChIP-Seq 
wurden die genomweiten Bindungsorte, sowohl von SETDB1 als auch von ATF7IP, in FLAG-
Knockin-Mausembryonalen Stammzellen (mESC) identifiziert. Um die epigenetischen Folgen 
dieser Interaktion zu untersuchen, wurde die genomweite Anreicherung für verschiedene H3K9-
Modifikationen in Kontroll-mESC und Zellen, in denen Atf7ip durch das CRISPR/Cas-System 
deletiert wurde, charakterisiert. Anschließend wurden diese Daten mit Transkriptomprofilen 
gekoppelt, um zu untersuchen ob die epigenetischen Veränderungen bei der transkriptionellen 
Deregulierung beteiligt sind. Atf7ip-Knockout-mESC überleben und wachsen normal. Jedoch 
wurden mehrere Familien der Endogenen Retroviren (ERV), die zu den Klassen I und II gehören 
und sowohl von SETDB1 als auch von ATF7IP gebunden werden, in Atf7ip-Knockout-mESC 
dereprimiert. Dieser Phänotyp wird weiter verstärkt, wenn die Zellen keine DNA-Methylierung 
aufweisen. Während mutierte Zellen, sowie Kontrollzellen, in der Lage sind zu differenzieren und 
repetitive Sequenzen während der Differenzierung zu unterdrücken, konnten interessanterweise 
die DNA-Methylierungs-reduzierte Mutanten diese Sequenzen nicht richtig unterdrücken. 
Unerwarteter Weise wurden die H3K9me3-Spiegel in Atf7ip-Knockout-mESC weder global noch 
ortspezifisch an Transposons, die Ziele des SETDB1-ATF7IP-Komplexes sind, reduziert. Im 
Gegenteil kam es vielmehr zu einer H3K9me3 Anreicherung an diesen Regionen die von einer 
Zunahme von H3K9me2 gefolgt war. Um andere Proteine zu identifizieren, die an dem SETDB1-
ATF7IP-Silencing-Mechanismus beteiligt sein könnten, wurde Massenspektrometrie von FLAG-
ATF7IP-Immunkomplexen durchgeführt. Anschließend wurden ATF7IP- Interaktionspartner und 
andere bekannte Repressoren unter Verwendung eines exogenen Retrotransposon-
Repressions-Reportersystems, das in Atf7ip-depletierten mESC beeinträchtigt ist, auf eine 
genetische Interaktion mit Atf7ip überprüft. Es wurde festgestellt, dass einige Faktoren auf 
demselben Weg agieren, während andere synergistische Wirkungen haben und wahrscheinlich 
zu unabhängigen Signalwegen gehören. Schließlich zeigte der Austausch der Expression des 
endogenen Locus durch die von verschiedenen Atf7ip-Mutanten unter Verwendung eines Bxb1-
vermittelten Rekombinationssystems, dass sowohl die Kernlokalisierung als auch die 
konservierten Domänen 1 und 2 für eine korrekte TE-Repression essentiell sind. Insgesamt liefert 
diese Arbeit ein besseres Verständnis für den molekularen Mechanismus der Repression durch 
SETDB1 und dessen Modulation durch den Cofaktor ATF7IP.
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1. INTRODUCTION 
1.1. From naked DNA to highly organized chromatin 
Eukaryotic organisms organize the DNA in their nucleus in structures of different orders of 
magnitude to form the chromatin template (Flemming, 1882). The nucleosome is the most basic 
structural unit of the chromatin (Kornberg, 1974), which is constituted of a 147 bp long-DNA 
wrapped around a histone octamer. Two molecules of each of the highly conserved canonical 
histones H2A, H2B, H3 and H4 form the octamer. The arrays of nucleosomes form a more 
compact structure following the recruitment of linker histone H1. Association of this compacted 
array of nucleosomes to the nuclear periphery or other nuclear regions results in a larger domain 
organization, characteristic of interphase and metaphase chromatin. During nuclear division, 
further compaction occurs to form the chromosomes (Luger et al., 1997).  
The histone tails are targets of a myriad of post-translational modifications (PTM), responsible 
for changes in the charges (Dou and Gorovsky, 2000) and packaging to form the higher-order 
chromatin structure (Wei et al., 1999). These modifications of histone residues, together with DNA 
methylation (DNAme) and nucleosome structural components, are subjected to changes in 
response to intrinsic and extrinsic stimuli (Jaenisch and Bird, 2003). In turn, the transcriptional 
activity of the underlying DNA also changes accordingly (Sims et al., 2004). These signatures at 
the genome-wide level constitute the so-called epigenetic states and are responsible for defining 
the global transcriptional program of a cell (Henikoff and Greally, 2016). In this way, multicellular 
organisms can be composed of many distinct cell types differing in which regions of the genome 
are active or repressed, even though they carry the same genetic material (Strahl and Allis, 2000; 
Turner, 2000; Dambacher et al., 2013). Basically, active chromatin exists in a decompacted form, 
prone for transcriptional activity due to higher permissibility to the transcriptional machinery and 
is termed euchromatin. On the other hand, the chromatin in a silent state, which adopts a 
compacted conformation to restrict the underlying information, is termed heterochromatin. 
1.2. Features of the heterochromatic DNA 
The classical definition of the term heterochromatin is based on the cytological observation of 
nuclear structures densely stained due to higher DNA compaction (Heitz, 1928). This repressed 
chromatin state is observed in pericentric regions of chromosomes as well as in telomeres. 
Further molecular and biochemical characterization led to an expansion of the definition. Of note, 
despite the broad conservation, not all the defined characteristics are ubiquitous of 
heterochromatin, especially when considering intermediate states. Probing the heterochromatin 
by nuclease digestion revealed an organization in large arrays regularly spaced and devoid of 
hyper-sensitive sites characteristic of nucleosome-free regions. The underlying DNA sequence is 
mainly represented by repetitive sequences (satellite DNA and transposons), with lower density 
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of genes. Besides, replication occurs during late S phase and a low frequency of meiotic 
recombination is observed (Richards and Elgin, 2002). 
A covalent modification of the DNA in the form of cytosine methylation is the prevalent 
nucleotide modification in eukaryotes and consolidates pericentric heterochromatin (Bachman et 
al., 2001). All sites of modification in the four core histones are hypoacetylated in telomeric regions 
and heterochromatic loci in yeast (Suka et al., 2001). The deposition of distinct non-histone 
proteins like the heterochromatin protein 1 (HP1) is also detected as a major component in 
telomeres and pericentric heterochromatin (James et al., 1989). Another hallmark of 
heterochromatin is the methylation of amino acid residues in the tail of histones H3 and H4. The 
methylation of histone H3 at the lysine 9 (H3K9me) is evolutionarily conserved throughout most 
eukaryotes. The first enzyme described to catalyze this mark was first identified in Drosophila, 
encoded by the suppressor of position-effect variegation gene Su(var)3-9 (Tschiersch et al., 
1994). This protein is part of a large family of histone lysine methyltransferases (HKMT), whose 
catalytic activity is exerted by the SET domain (Jenuwein et al., 1998). Orthologs of this enzyme 
were found from fission yeast (Nakayama et al., 2001) to humans (Aagaard et al., 1999). 
Euchromatic regions can undergo heterochromatinization to form facultative heterochromatin. 
This subtype occurs in a cell type-dependent manner and just a fraction of the cells will display 
such compaction (Mozzetta et al., 2015). It can also be stablished in only one of the homolog 
chromosomes (Richards and Elgin, 2002), as seen for the female X chromosome inactivation in 
mammals (Lyon, 1961). Interestingly, the repressed state is maintained by the daughter cells after 
mitosis. The occurrence of H3K9me in such euchromatic regions is dependent on enzymes other 
than the SU(VAR)3-9, but belonging to the same family (Huisinga et al., 2006). 
1.3. The SUV39 family of histone lysine methyltransferases 
All members of the SUV39 family of methyltransferases are able to methylate their lysine 
substrate to one or more of the three states (mono-, di- or trimethylation) in the presence of the 
cofactor S-adenosyl-L-methyonine (SAM). The SET domain association to two cysteine-rich 
domains (pre-SET and post-SET), essential for the catalytic activity in vitro (Schultz et al., 2002), 
distinguishes this group from other SET domain-containing proteins (Rea et al., 2000). SUV39H1 
was the first of six members to be characterized in mammalian (Mozzetta et al., 2015). SUV39H2 
is a second homolog of the fruit fly Su(var)3-9 with 59% identity to SUV39H1 (O'Carroll et al., 
2000). SETDB1 and SETDB2, whose SET domain is bifurcated by an insertion of a few hundred 
amino acids (Schultz et al., 2002; Falandry et al., 2010), are also part of this group. The last two 
members, G9A and GLP, are not functional alone in vivo (Shinkai and Tachibana, 2011) and 
cannot catalyze trimethylation in this system. Only a few members of the PR-domain containing 
(PRDM) family share the H3K9 methyltransferase (H3K9MT) ability (Pinheiro et al., 2012). 
Interestingly, non-histone substrates were also described for many H3K9MT (Herz et al., 2013). 
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In general, SET containing-HKMT present an additional domain capable of recognizing PTM, 
specially chromatin marks. This property ensures the HKMT act in the right context and suggests 
mechanisms of protein crosstalk for establishment and dispersion of histone marks to build up 
the mature chromatin. SUV39H1/2 target methylated lysine through their chromatin-organization 
modifier domain (chromodomain), which is essential for the specific binding to pericentric 
heterochromatin (Melcher et al., 2000). SETDB1/2 contain a canonical methyl-CpG binding 
domain (MBD), which might selectively bind methylated DNA (Kang, 2015). G9A and GLP ankyrin 
repeats bind H3K9me1/2 marks and are essential for the H3 tail interaction (Collins et al., 2008). 
All SUV39 family members are able to catalyze the three states of H3K9me in vitro (Mozzetta 
et al., 2015), with the exception of SETDB2, which can only trimethylate (Falandry et al., 2010). 
Thus, the redundancy of these enzymes impedes the assignment of specific functions in vivo. 
However, the bulk H3K9me3 is attributed to SUV39H1/2 enzymes (Peters et al., 2003) and their 
activity is essential for spreading this mark at pericentric heterochromatin (Peters et al., 2001). At 
telomeres, these enzymes mark chromatin with both H3K9me2/3 (Garcia-Cao et al., 2004).  
Besides that, SUV39H-dependent H3K9me during S-phase of differentiating cells is linked to 
transcriptional silencing (Ait-Si-Ali et al., 2004). SETDB2 is recruited to heterochromatic regions 
in vivo for trimethylation of centromere-associated repeats (Falandry et al., 2010). G9A and GLP 
are implicated in regulation of pericentric heterochomatin (Dong et al., 2008; Fritsch et al., 2010). 
On the other hand, they bind euchromatic regions as well and act in concert to establish global 
H3K9me1/2 (Tachibana et al., 2005). SETDB1 is also shown to act over both heterochromatin 
(Loyola et al., 2009) and euchromatin (Schultz et al., 2002) and will be further discussed below. 
1.4. The bifurcated SET domain protein SETDB1 
1.4.a. Structural features 
SETDB1 coding sequence was first predicted in an analysis of cDNA clones from a human cell 
line (Nomura et al., 1994). Later on, in a search for SET domain proteins, SETDB1 was found 
containing a conserved motif at its C-terminus. However, its SET domain is peculiarly interrupted 
by an insertion of 347 amino acids in a less conserved region in the middle of two highly conserved 
ones (Harte et al., 1999). In mouse, SETDB1 was first identified in a screening for interaction 
partners of ERG, a transcription factor related to cell growth and differentiation. It was termed 
ERG-associated protein with SET domain (ESET) and revealed an identity of 92 % to the human 
homolog (Yang et al., 2002). The fruit fly homolog, known as Egg or Eggless, also contains an 
insertion in the bifurcated SET domain and shows 63 %, 44 % and 39 % identity to the SET, tudor 
and MBD domains of the mouse version, respectively (Stabell et al., 2006). An homolog is also 
well characterized in C. elegans, where it is called met-2 (Poulin et al., 2005) and shows 19 % 
identity to hSETDB1 overall and a 50 % identity at the SET domain (Andersen and Horvitz, 2007). 
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Although the calculated molecular weight for SETDB1 is 145 kDa, it is resolved on SDS-PAGE 
at approximately 180 kDa due to PTM (Yang et al., 2002). The presence of a second band with 
higher molecular weight is due to ubiquitination of the SET domain, at K867 in humans (Ishimoto 
et al., 2016). SETDB1 contains a MBD (Yang et al., 2002), characteristic of some proteins related 
to silencing of methylated DNA (Bird and Wolffe, 1999). Recombinant hSETDB1 is not able to 
bind methylated DNA by itself and mutations at the MBD did not impair hSETDB1 localization to 
an endogenous locus (Matsumura et al., 2015). In Drosophila, dSETDB1 preferentially binds DNA 
bearing one or multiple methylated CpA motifs in vitro, like Rb gene and the Rt1b retrotransposon 
(Gou et al., 2010). SETDB1 bears also a tudor domain (Yang et al., 2002), which is known to be 
involved in protein-protein interaction (Ponting, 1997). At the N-terminal region a functional SUMO 
interacting motif (SIM) is present (Ivanov et al., 2007; Tanaka and Saitoh, 2010; Cho et al., 2013) 
nearby two nuclear export (NES) and two nuclear localization (NLS) signals (Cho et al., 2013). 
Interestingly, the N-terminus of dSETDB1 is SUMOylated in S2 cells and colocalizes to SUMO in 
oocytes (Koch et al., 2009). SUMOylation has been observed in mammals too (Yeap et al., 2009). 
 
Figure 1.1 | Schematic representation of the domain structure of mouse SETDB1. 
SETDB1 bears two nuclear export signals (NES) and one nuclear localization signal (NLS) at the N-terminal region. 
Between them there is a SUMO interaction motif (SIM). Two tudor domains are involved in protein interaction. At the 
center of the protein there is a putative methyl-DNA binding domain (MBD). The Pre-SET, SET and Post-SET 
domains are involved in the methyltransferase activity. The residues responsible for SAM binding are indicated. 
1.4.b. Expression and localization patterns 
Setdb1 promoter in mice has an Ets (avian erythroblastosis virus oncogene-E twenty-six) 
binding site and its activity is under control of the transcription factor Ets-2 (Lee et al., 2008). The 
full length transcript is expressed in several mouse cell lines and tissues (liver, brain, thymus, 
heart, lung, spleen, testis, ovary, kidney, liver, skeletal muscle). A shorter splicing variant lacking 
the SET domain and MBD is expressed in many immortalized cell lines, though it only occurs in 
brain, testis and ovary (Yang et al., 2002; Blackburn et al., 2003). 
SETDB1, but not G9a or SUV39H1, is detected in vesicle-stage oocytes. After fecundation, at 
pronucleus stage zygotes, SETDB1 accumulates around the satellite DNA-rich nucleolus. It is 
very abundant as small foci in the male pronucleus, which is devoid of H3K9me2/3, differently 
from the female (Cho et al., 2012). During embryogenesis, expression in the zygote only begins 
at blastocyst stage and there is maternal contribution during the preimplantation period (Dodge 
et al., 2004). The maternal stock decreases from 2-cell stage to complete absence in morula, 
although the protein level is normal until 4-cell stage, with a diffuse nuclear pattern. During 8-cell 
and morula stages, the levels stay low only to reappear in the blastula as several foci in both inner 
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cell mass (ICM) and trophectoderm cells (Cho et al., 2011; Cho et al., 2012). In blastocyst 
outgrowths, SETDB1 was present only in Oct4-expressing cells derived from the ICM in several 
foci similarly to Pml (Cho et al., 2012). Expression is ubiquitous from embryonic day E7.5 to E9.5 
(Dodge et al., 2004). In NIH/3T3 murine embryonic fibroblasts (Schultz et al., 2002) and mouse 
embryonic stem cells (mESC), SETDB1 is predominant in euchromatin (Kourmouli et al., 2005). 
In HeLa, HEK293, hepatoblastoma, functional liver FLC4, adenocarcinoma and lipossarcoma 
cells it localizes mainly at the cytoplasm (Tachibana et al., 2015). 
In Drosophila, dSETDB1 transcripts are not detectable in the first three hours of embryonic 
development and no maternal contribution is observed (Stabell et al., 2006; Seum et al., 2007; 
Tzeng et al., 2007). However, it is present at lower levels in larvae and pupae and regularly 
expressed during other developmental stages (Stabell et al., 2006). Besides expression in the 
ovary, females showed slightly higher expression than males in adult tissues (Yoon et al., 2008). 
dSETDB1 localizes to euchromatin, heterochromatic regions and chromocenter, mainly at 
chromosome 4 (Stabell et al., 2006; Seum et al., 2007). Pericentric localization was also observed 
in the germarium (Yoon et al., 2008). 
1.4.c. Histone lysine methyltransferase activity 
When probed for methyltransferase activity, hSETDB1 showed specificity over H3 substrates 
and did not methylate H2A, H2B and H4. This enzymatic activity was attributed to hSETDB1 itself, 
as mutations abolished H3 methylation. PTM are required to properly exert its enzymatic activity, 
as recombinant hSETDB1 (Yang et al., 2002) or dSETDB1 (Stabell et al., 2006) purified from E. 
coli could not methylate core histones. The in vitro activity depends on the pre-SET, SET and 
post-SET domains in human (Schultz et al., 2002) and Drosophila cells (Tzeng et al., 2007), not 
being affected by mutations on MBD or tudor domains. However, complete removal of the MBD 
abrogates the catalytic ability. SET domain ubiquitination requires the MBD and increases 
hSETDB1 methyltransferase activity (Ishimoto et al., 2016). This ubiquitination by UBE2E1/2/3 is 
protected  by multiple motifs in hSETDB1 which interact with ubiquitin (Sun and Fang, 2016). 
The specificity of SETDB1 for the lysine 9 was demonstrated by using mutated recombinant 
histone tails. No additional PTM of the substrate is needed, although demethylation of H3K9 and 
acetylation of different residues inhibits activity (Schultz et al., 2002). H3K27me3 also blocks 
deposition of H3K9me3, but not of H3K9me1/2 (Fei et al., 2015b). Binding of the C-terminus of 
hSETDB1 expressed in insect cells to recombined histone H3 is impaired by H3K4me3 and blocks 
catalysis (Binda et al., 2010). The activity of recombinant hSETDB1 over core histones is lower 
than the native complex isolated from HeLa cells. Free core histones are a preferred substrate, 
compared to mono- or oligonucleosomes (Wang et al., 2003). In contrast, dSETDB1 trimethylates 
preferentially nucleosomal H3 (Gou et al., 2010). All three states of H3K9me are sequentially 
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catalyzed by dSETDB1 purified from SL2 cells (Tzeng et al., 2007). In vivo, dSETDB1 deposits 
H3K9me1/2 at euchromatin, but not at chromocenter or telomeres (Seum et al., 2007). 
Ribosome complexes translating histone H3 in HeLa cells showed H3K9me1/2 deposition 
while H3 is still associated with ribosomes. Purified ribosome complexes showed H3K9me1/2 
methyltransferase activity and H3K9me1 was detected in nascent polypeptides. This activity is 
dependent on hSETDB1 and its association with ribosome subunits RPL5 and RPS3a. hSETDB1 
dissociates from the substrate before the next catalysis event (Rivera et al., 2015). Interestingly, 
presence of SUMOylated hKAP1 stimulates baculovirus-expressed hSETDB1 activity towards 
histone H3 in a dose-dependent-manner (Ivanov et al., 2007). Non-histone proteins can also be 
used as substrate (Binda et al., 2010; Hwang et al., 2014). 
Met-2, the C. elegans homolog, cooperates with another H3K9me, set-25, to keep chromatin 
at the periphery of the nucleus. Met-2 mono- and dimethylates H3K9, while set-25 trimethylates 
it. H3K9me3 is not needed for perinuclear localization of chromatin, but is required for silencing. 
Met-2 is very abundant in the cytoplasm, while set-25 is found in the nucleus at perinuclear foci 
in a H3K9me3-dependent manner (Towbin et al., 2012). In summary, the primary structure of 
SETDB1 and its expression patterns have been well characterized so far, however, not so much 
is known about the quaternary structure and about the mechanisms of SETDB1 HKMT activity, 
especially in an in vivo system. 
1.5. SETDB1 roles in development and differentiation 
1.5.a. Embryonic stages 
Deletion of Setdb1 leads to peri-implantation lethality between 3.5 and 5.5 (Dodge et al., 2004; 
Keniry et al., 2016). Null blastocysts do not show global changes in staining for H3K9me2/3. 
Besides that, no mESC lines can be derived by blastocyst outgrowth, consistent with the impaired 
HKMT-dependent proliferation and mESC death following depletion (Yuan et al., 2009; Lohmann 
et al., 2010). Setdb1-depleted mESC show no changes in H3K9me2 level and mild or no reduction 
of global H3K9me3 level (Matsui et al., 2010; Thompson et al., 2015), although strong H3K9me3 
loss was reported previously (Yeap et al., 2009). Depletion of hSETDB1 also impairs proliferation 
in HeLa and HEK293T cells (Wang et al., 2003). Interestingly, SETDB1, HP1γ, G9a and GLP 
constitute a block for reprogramming and their depletion enhances the reprograming rates, with 
a more pronounced effect for late steps of reprogramming (Sridharan et al., 2013). 
SETDB1 is essential for keeping mESC pluripotent state, the ability to form colonies and 
capacity to differentiate into embryoid bodies (Bilodeau et al., 2009; Yuan et al., 2009; Lohmann 
et al., 2010). It binds developmental genes, which may contain SETDB1-depedent H3K9me3. 
Depletion leads to differentiation mainly into trophectoderm lineage cells, following the repression 
of pluripotency genes and downregulation of differentiation markers (Bilodeau et al., 2009; Yuan 
et al., 2009). When modified by SUMO1 (Yeap et al., 2009), SETDB1 is recruited by the stem 
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cell-specific transcription factor Oct4 to the promoter of the trophectoderm determinant genes and 
induces H3K9me2/3 deposition to repress transcription (Yuan et al., 2009; Lohmann et al., 2010). 
Curiously, most of these genes are also enriched for H3K4me3 and some of them are co-occupied 
by the Polycomb group (PcG) complex subunit Suz12 and H3K27me2/3 (Bilodeau et al., 2009; 
Lohmann et al., 2010), but not by DNAme (Karimi et al., 2011). Interestingly, SETDB1 interacts 
with the PcG member RNF2 in murine erythroleukemia cells (Sanchez et al., 2007). Furthermore, 
SETDB1-depleted two-cell stage embryos upregulates trophectoderm genes and incorporates 
preferentially into the trophectoderm rather than the blastocysts ICM (Yuan et al., 2009; Lohmann 
et al., 2010). SETDB1 also binds a set of germline genes which contains DNAme and loses 
H3K9me3 in knockout mESC to become upregulated in this mutants and in DNMT triple knockout 
(TKO) mESC (Karimi et al., 2011). Intriguingly, several SETDB1 binding sites have no H3K9me3 
10 kb around the peak center, while fewer had H3K9me1/2/3 (Fei et al., 2015b). 
Compared to the male X chromosome in mouse embryonic fibroblasts (MEF), the female 
shows dense regions of H3K9me2/3 and SETDB1 occupancy occurring at low gene density 
areas, while H3K27me3 is enriched at gene-rich areas. Knockout female MEF and embryos 
cannot perform proper X chromosome inactivation (XCI) of an X-linked reporter. H3K9me2/3 and 
H3K27me3 are reduced in all chromosomes and along the X chromosome, which also showed 
small reduction of DNAme at CpG islands. However, only minimal reactivation of endogenous X-
linked genes occurred. To circumvent the redundancy of XCI maintenance, Setdb1 was depleted 
in differentiating mESC and impaired silencing of X-linked and autosomal genes, but not Xist 
expression or coating of the X inactive chromosome. Genes which undergo silencing during 
mESC differentiation were impaired after Setdb1 depletion, whereas genes which maintained 
silenced state throughout differentiation showed no reactivation. Thus, Setdb1 is involved in 
establishment and in early stages of maintenance of silencing (Keniry et al., 2016). 
dSETDB1 depletion leads to low viability and early lethality. The progeny shows developmental 
arrest just before the second larval instar (Stabell et al., 2006) and death at late pupal stage 
(Seum et al., 2007). Mono-, di- and trimethylation of H3K9 are globally reduced in third instar 
larvae (Tzeng et al., 2007; Riddle et al., 2012), HP1α is lost at chromosome 4 and genes are 
derepressed (Riddle et al., 2012). However, A/T motif-rich promoters also bound by HP2 at this 
chromosome keep a localized H3K9me-independent HP1α binding. The spread of HP1α to the 
gene bodies, though, happens in a dSETDB1 methylation-dependent manner and in the presence 
of the painting of fourth protein POF (Figueiredo et al., 2012), recruited by dSETDB1 (Riddle et 
al., 2012). In first instar larvae, upregulated genes in chromosome 4 overlapped extensively in 
dSetdb1, HP1α and dSu(var)3-9 mutants (Lundberg et al., 2013). Pupae fail to recruit HP1 and 
to repress transgenes in the vicinity of chromosome 4 heterochomatic domains (Seum et al., 
2007) or in pericentric heterochromatin (Brower-Toland et al., 2009), indicating its requirement for 
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repression of variegation. Flies reaching adulthood exhibit spread-out wings (Tzeng et al., 2007) 
and shorter life span, which are more pronounced in males (Brower-Toland et al., 2009). 
1.5.b. Germline cells and reproduction 
In mice testis, SETDB1 and H3K9me3 levels increase during development. Setdb1-depleted 
spermatogonial stem cells (SSC) show reduced levels of H3K9me3, lower viability due to 
apoptosis and does not localize properly to the seminiferous tubules to undergo spermatogenesis. 
The testes showed much lower weight and size. In the spermatogonial stem cell line C18-4, the 
promoter of the cytochrome oxidase Cox4i2, which marks the early onset of apoptotic events, 
shows enrichment for SETDB1-dependent H3K9me3 and DNAme. Knockdown of Cox4i2 in 
Setdb1 depleted C18-4 cells partially rescues from apoptosis (An et al., 2014). In male E13.5 
primordial germ cells (PCG), Setdb1 deletion driven by Tnap promoter, leads to partial loss of 
H3K9me3 and H3K27me3 and reduction in the number of germ cells in the gonads. The global 
DNAme level increases at H3K9me3-enriched regions and at gene bodies, though. Impaired 
gametogenesis is observed in post-natal and adult mutant mice (Liu et al., 2014). 
Maternal contribution of SETDB1 is essential for early mouse embryonic development (Eymery 
et al., 2016) and mouse oocytes show strong staining for SETDB1 (Kim et al., 2016). Deletion in 
mouse oocytes, driven by Zp3-Cre, results in embryo degeneration before morula stage due to 
defects in the first mitotic cycle, even if it is wild type for zygotic expression (Eymery et al., 2016; 
Kim et al., 2016). Mutant females show normal folliculogenesis, besides reduced H3K9me2 
(Eymery et al., 2016) and mild decrease in H3K9me3, but not in H3K9me1. However, they are 
infertile and fewer oocytes reach later stages, showing more γ-H2AX foci, characteristic of DNA 
double-strand breaks. The oocyte requires proper Setdb1 expression and activity to resume 
meiosis (Kim et al., 2016), for instance, for meiotic maturation, bipolar spindle formation, stable 
kinetochore attachment to microtubule and chromatid segregation. Dysregulated genes in Setdb1 
knockout oocytes were enriched for cell cycle, cell division and chromosome organization genes 
(Eymery et al., 2016). The meiosis-related gene Cdc14b is repressed by SETDB1-dependent 
H3K9me3 in mESC and shows higher expression in mutant oocytes. Depletion of Cdc14b in 
Setdb1 mutant oocytes ameliorated the meiotic defects (Kim et al., 2016). 
While dSetdb1 is not critical for spermatogenesis and spermiogenesis (Ushijima et al., 2012), 
mutant females are sterile (Seum et al., 2007), with reduced ovary size, early blockage of 
oogenesis and no formation of egg chambers (Clough et al., 2007; Yoon et al., 2008). Germ cells 
and somatic cells show impaired proliferation, strong H3K9me3 reduction and apoptosis (Clough 
et al., 2007). Maintenance of germline stem cells, their differentiation and survival of escort cells 
also depends on dSETDB1 (Wang et al., 2011). In mutant adult flies, total levels of the three H3K9 
methylation states are reduced (Brower-Toland et al., 2009). In C. elegans, the Setdb1 homolog 
(met-2) is involved in multivulval phenotype (Poulin et al., 2005) when deleted in combination with 
other multivulval class A genes, like the homologs of Setd2, HP1 (Andersen and Horvitz, 2007) 
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and MBT (Koester-Eiserfunke and Fischle, 2011). These genes work redundantly to repress the 
vulval cell fate transcription factor lin-3. Mutant embryos show decreased levels of H3K9me3 and 
H3K36me3 (Andersen and Horvitz, 2007), whereas mutant adults have gonadal defects, loss of 
H3K9me2 in germ cells (Bessler et al., 2010) and sterility (Koester-Eiserfunke and Fischle, 2011). 
Co-deletion of the H3K4me2 demethylase spr-5 (Kerr et al., 2014), the Chd homolog let-418 or 
the Zfp lin-13 enhances sterility (McMurchy et al., 2017). Interestingly, while the X chromosome 
is enriched for H3K9me2, in C. briggsae it is covered with H3K9me3 (Larson et al., 2016). Co-
deletion of another H3K9me set-25 leads to complete loss of H3K9me and sterility in adults (Zeller 
et al., 2016). Functions of MET-2 were also shown in terminal differentiation of neurons (Zheng 
et al., 2013), small-RNA-guided H3K9me3 (Mao et al., 2015; Kalinava et al., 2017) and 
mitochondrial stress response (Tian et al., 2016). 
1.5.c. Neuronal development 
Neural progenitor cells (NPC) express SETDB1 at E9.5, but transcription reduces over time 
until it reaches very low levels at E17.5. SETDB1 is required for appropriate expression of 
neuronal and non-neuronal genes, like the gliogenesis regulator Sox9 and the astrocyte marker 
Gfap. Thus, knockout in E11.5 mouse brain impairs neurogenesis and reduces formation of deep 
layer neurons with increase in apoptotic cells and global H3K9me3 reduction at E14.5 and E18.5. 
NPC proliferation is compromised and astrocyte formation enhanced. These mice do not survive 
more than 10 days after birth (Tan et al., 2012). In fly proneural cluster, the phenotype of dSetdb1 
loss is further enhanced by co-deletion of caspase, due to its non-apoptotic functions (Shinoda et 
al., 2016). In mESC, almost all SETDB1 binding sites at neuronal development regulators and 
pluripotent state regulators are devoid of H3K9me marks. Several neuronal-related transcription 
factors bound by SETDB1 are co-occupied by subunits of the PRC2 complex, their interactors 
and H3K27me3. Loss of Setdb1 reduces the levels of EZH2 and H3K27me3 and leads to 
upregulation, while EZH2 knockdown resulted in deposition of H3K9me3. Thus, enhanced 
neuronal differentiation of mESC is observed in the absence of Setdb1 (Fei et al., 2015b). 
Setdb1 deletion in postnatal forebrain neurons is not lethal, though. Adult mutant mice brains 
are smaller, even though no cell death or neuronal loss occurs. The general spatial organization 
of the genome is unchanged as seen by Hi-C chromosome conformation capture. Several long-
range loop contacts are lost in mutant neurons. Many topologically associated domains (TAD) 
were lost at a cluster containing more than 70 genes, most of which encode adhesion molecules 
grouped in three clusters Pcdha/b/g regulating neuronal connectivity. Several regions losing 
H3K9me3, including this cluster, have CTCF motifs, similarly to mESC and B lymphocytes. Many 
CTCF binding regions show increased binding in mutant, especially in regions losing H3K9me3. 
Thus, SETDB1 prevents excess CTCF binding. Most of the new CTCF binding sites close to TAD 
boundary and to H3K9me3-depleted regions show increased insulation, besides the Pcdh cluster. 
There, insulation was completely lost due to structural collapse, with accumulation of histone 
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hyperacetylation and loss of DNAme. In contrast, DNAme levels are normally already very low 
and CTCF levels high at two related enhancer elements. Many of the upregulated genes in mutant 
neurons were located at the Pcdh cluster and acquired histone acetylation with concomitant 
increase in transcription. This cluster does not show similar effects in prenatal deficiency of 
Setdb1. The enhancer elements form shorter-range promoter contacts and are contained in a 
H3K9me3-marked chromatin in normal neurons, inside repressive loops involving multiple KRAB-
ZFP, like ZFP143 (Jiang et al., 2017). 
1.5.d. Hematopoiesis 
Induction of Setdb1 deletion in hematopoietic stem and progenitor cells (HSPC) via tamoxifen-
responsive Rosa:Cre-ERT driver leads to host mice death 3 weeks after transplantation due to 
strong hematopoietic failure. Levels of bone marrow and primitive hematopoietic cells, including 
LSK hematopoietic stem cells (HSC), LSK multipotent progenitor cell (MPC), common myeloid 
progenitors (CMP), granulocyte/macrophage progenitors (GMP), except for erythrocyte 
progenitors, are strikingly lower. Apoptosis increases in LSK HSC and MPC and cell proliferation 
is lower. Global H3K9me3 level and DNAme in mutant GMP were unchanged but several non-
hematopoietic genes lost H3K9me3 and tended to be derepressed. The gluconeogenesis 
enzymes Fbp1/2 were identified as SETDB1 targets which get upregulated in mutant GMP and 
LSK cells greatly reducing ATP levels and impairing metabolic homeostasis (Koide et al., 2016).  
Deletion of Setdb1 in early stages of B-cell development using the Mb1-Cre driver completely 
suppresses late-stage B-cells at bone marrow and spleen, but not in the thymus. Expression of 
the anti-apoptotic Bcl2 rescues pro-B and pre-B cell compartments, but not late stages B-cells. 
Setdb1 deletion upregulates several innate immunity or non-hematopoietic lineage genes (Collins 
et al., 2015; Pasquarella et al., 2016), none of which showing SETDB1 binding. Transplantation 
assays shows cell intrinsic defects and mutant pro-B cells do not differentiate into B cells in vitro. 
Unfolded protein response (UPR) genes are upregulated in mutant pro-B cells. Knockdown of the 
pro-apoptotic gene Bcl2l11, which regulates apoptosis in the UPR context, could rescue the ability 
of mutant pro-B cells to form colonies. UPR gets triggered due to high levels of the MLV envelop 
protein Env detected in mutant pro-B cells. Indeed, ectopic overexpression of the Env protein in 
B cells led to apoptosis and upregulation of UPR pathway (Pasquarella et al., 2016). 
Thymocyte-specific deletion with Lck-Cre driver reduces cellularity in the thymus, lymph nodes 
and spleen, including late-stage thymocytes (Martin et al., 2015; Takikita et al., 2016). Mutant 
thymocytes are more prone to undergo cell death due to TCR agonism. The IgG inhibitory 
receptor gene Fcgr2b, involved in T-cell development, loses SETDB1-dependent H3K9me3 in 
mutants leading to exacerbated signaling through the TCR complex and apoptosis (Martin et al., 
2015). It was also suggested that activation of ERK by phosphorylation is decreased by FcγRIIb 
in mutant thymocytes and this disturbs positive selection (Takikita et al., 2016). 
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Lipid A stimulation after LysM-Cre induction of Setdb1 loss in macrophage further upregulates 
genes compared to wild type. These genes are enriched for interleukin and chemokine pathways, 
for instance IL6, which lost H3K9me3. When used as reporter, the IL6 promoter is suppressed in 
a HKMT-dependent manner and silencing requires its NF-κB binding site. Binding of NF-κB p65 
to the promoter is further increased in mutant macrophages. The knockout mice are more prone 
to endotoxin shock after LPS treatment, due to enhanced response. Thus, Setdb1 is able to 
suppress in vivo inflammatory responses mediated by TLR4 (Hachiya et al., 2016). 
1.5.e. Musculoskeletal system 
At E14.5, when the growth plate is assembled in the mouse forelimb bone, all H3K9MT are 
expressed in proliferating chondrocytes. H3K9me1/2/3 are modestly detected in the more 
differentiated prehypertrophic, hypertrophic chondrocytes and also in trabecular bones at E16.5, 
when osteogenesis can be observed. H3K9 acetylation (H3K9ac) was evident in prehypertrophic 
chondrocytes and is lost over time in hypertrophic chondrocytes. Higher expression of H3K9MT 
is observed in the trabecular bone compared to other bone regions (Ideno et al., 2013). Setdb1 
deletion in mice bone mesenchymal cells driven by Prx1 leads to improper formation of skeleton 
in newborn pups. Femoral growth plates are disorganized and chondrocyte hypertrophy is 
enhanced (Yang et al., 2013). The trabecular network in tibia already shows impairment 7 days 
after birth, with decrease in proliferating osteoblasts and no formation of epiphyseal plates. 
Mesenchymal stem cell differentiation into osteoblasts is compromised. Basically, the osteoblast 
specific transcription factor Runx2 interacts with SETDB1 and HDAC4 to keep proper levels of its 
target gene osteocalcin (Lawson et al., 2013a; Yang et al., 2013). Regarding the articular 
cartilage, one month-old mutant mice accumulates proliferating hypertrophic chondrocytes 
undergoing apoptosis. In three-month old mutant mice, the chondrocytes reach terminal 
differentiation near the articular surface, where type-II collagen and proteoglycan are lost. In 
twelve-month old, degeneration of the articular cartilage is enhanced (Lawson et al., 2013b). In 
Meckel’s cartilage, that supports embryonic formation of mandible, Setdb1 deletion induced by 
Wnt1-Cre reduces craniofacial size. Mutant mice show larger cartilage with mineralization instead 
of losing it. Hypertrophy and cell proliferation is enhanced in chondrocytes. BMP signaling is 
strongly active due to high pSMAD1/5/8 level (Yahiro et al., 2017). 
In adult mouse skeletal muscle satellite cells, Setdb1 expression strongly increases after 
activation from quiescence (Beyer et al., 2016). It is expressed in proliferating mouse skeletal 
myoblast C2C12 cells, increases during early differentiation and drops afterwards (Song et al., 
2015; Beyer et al., 2016). Depletion in proliferating myoblasts impairs proliferation and 
differentiation. Expression of muscle differentiation genes, like MyoD and myogenin are reduced, 
even though SETDB1 neither interacts with MyoD nor binds its promoter (Song et al., 2015). In 
contrast, depletion at the onset of terminal differentiation decreases self-renewal, induces late 
muscle differentiation markers and enhances commitment. Most SETDB1 binding sites have 
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H3K9me3, including many genes upregulated during myoblast differentiation. The homogenous 
distribution of SETDB1 is converted to mainly cytoplasmic during differentiation and the enhancer 
of the myoblast-specific gene Ankrd1 loses SETDB1 binding and H3K9me3 to get upregulated. 
Similarly, ectopic expression of Wnt3a, which is essential for embryonic myogenesis, decreases 
SETDB1 binding and redistributes it preferentially to the cytoplasm in myoblasts, specially of a 
post-translationally modified form. Similar effects were seen in HeLa cells. (Beyer et al., 2016). 
During early stages of adipogenesis in 3T3-L1 preadipocytes, most SETDB1 binding sites are 
intragenic, occur 1 kb downstream from transcription start sites (TSS) and overlap with H3K9me3, 
MBD1 and lineage-specific DNAme. Several of those sites are developmental genes and also 
showed enrichment for H3K4me3 at the proximal promoter. In mESC, these genes are enriched 
for H3K4me3 and H3K27me3 instead. SETDB1 enrichment decreases during preadipocyte 
differentiation and its depletion in 3T3-L1 preadipocytes and lineage-committed mesenchymal 
stem cells leads to differentiation. H3K9me3 deposition by SETDB1 prevents the binding of an 
early adipogenic transcription factor to the adipogenic master regulator Cebpa, the deposition of 
H3K27ac and H3K4me3 at the gene body and keeps Pol II in a paused state. At later stages, the 
adipocytes still keep the DNAme levels on Cebpa gene body. Hence, reduction of SETDB1 
recruitment is due to the decrease in expression during differentiation (Matsumura et al., 2015). 
It is also helped by enhanced recruitment of LSD1, which leads to decrease in H3K9me2 basal 
levels in favor of H3K4me2 followed by H3K4me3 to activate transcription (Musri et al., 2010). 
Lastly, although not directly related to development, hSETDB1 has also a role in DNA damage 
response, where it depends on the DNA damage sensor ATM, HP1 and hCAF-1 to be recruited 
to double strand break sites. Depletion of SETDB1, HP1 or SUV39H1/2 in human immortalized 
fibroblasts leads to homologous recombination defects during G2 phase and reduces sister 
chromatin association, but has no effects on non-homologous end-joining. Even though those 
proteins are not required for resection initiation, they are important for the extension step, for 
repositioning the damage response mediator protein h53BP1 peripherally (Alagoz et al., 2015). 
All in all, SETDB1 is regarded as an important factor for the development of several tissues 
and for the proper differentiation of many specific cell types. Besides that, this protein is required 
to keep the pluripotent state in stem cells. Those facts demonstrate its importance as a 
transcriptional regulator and its essentiality to keep the cell identity. Repression by SETDB1 has 
been described in different contexts, for instance at repetitive genomic regions and also at 
euchromatic genes. The next two chapters cover what is known about this silencing by SETDB1. 
1.6. Silencing of euchromatic genes 
1.6.a. Artificial promoters 
hSETDB1 was linked for the first time to transcriptional repression when its interaction with the 
bromodomain of the KRAB-associated protein hTRIM28 was described. This protein is recruited 
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to chromatin via Krüppel-associated box domain-containing zinc finger transcription factors 
(KRAB-ZFP) to regulate transcriptional repression via chromatin compaction. Targeting a KRAB 
repressor protein to a reporter promoter in NIH/3T3 fibroblasts, hTRIM28 accumulation is 
concomitant to that of hSETDB1 in cells stably silencing the reporter. H3K9me and HP1α 
deposition is also observed (Schultz et al., 2002). This response does not spread to a nearby 
promoter and is strikingly localized to the targeted region, which adopts a compact chromatin 
structure resistant to nuclease treatment (Ayyanathan et al., 2003). Silencing is followed by spatial 
relocalization to condensed chromatin islands. A subpopulation of cells kept a stable mitotically 
heritable repression over several generations. The locus had higher CpG methylation, suggesting 
a role of DNAme on heritable silencing. Similar picture was seen for the endogenous gene 
Col11a2 under the control of a natural KRAB-ZFP. 
Targeting SETDB1 to an artificial promoter in NIH/3T3 fibroblasts strongly represses the 
reporter, independently of the MBD and SET domain. Silencing is impaired by tudor domain 
deletion and inhibition of HDAC activity, as the tudor domain binds the corepressors mSIN3A/B, 
forming a larger complex with the histone deacetylases HDAC1/2 (Yang et al., 2003). In S2 cells, 
dSETDB1 targeting resulted in HKMT-dependent repression and deposition of H3K9m3, with 
concomitant enrichment for DNMT2 and DNAme (Gou et al., 2010). When targeting hTRIM28 to 
an artificial promoter in HEK293 cells, recruitment of RNA polymerase II (Pol-II) is reduced 
together with H3K4me3 enrichment, while H3K9me3, H3K27me3 and H4K20me3 become more 
abundant. The repression is dependent on the presence of hTRIM28, hSETDB1, HP1α and HP1β 
to less extent (Sripathy et al., 2006). SUMOylation of hTRIM28 by SUMO1 and an intact SIM is 
required for hSETDB1 recruitment, but not for HP1α deposition (Ivanov et al., 2007). However, 
targeting HP1α to pericentric heterochromatin results in SETDB1 recruitment and reestablishment 
of H3K9m3 in Suv39h1/2 double-knockout mESC. Targeting of HP1α/β to a synthetic promoter 
amplified in Chinese hamster ovary cells DG44 also results in chromatin compaction and SETDB1 
localization to the targeted HP1 foci, together with H3K9me3. No polycomb group (PcG) proteins 
co-localized to these foci (Verschure et al., 2005). 
hSETDB1 N-terminal region interacts with the PHD-finger like domain of hDNMT3A/B, but not 
with hDNMT1, in transfected monkey kidney cell line (COS-7). Targeting either DNMT3A or 
SETDB1 to an artificial promoter when the other is co-expressed leads to stronger repression. 
H3K9me3 accumulation and low level of H3K9me2 is observed with decrease in H3K9ac, due to 
HDAC1 binding. The methylated promoter of the tumor suppressing gene RASSF1A in MDA-MB-
231 cells shows accumulation of SETDB1, DNMT3A, HDAC1 and H3K9me3 (Li et al., 2006). 
1.6.b. Endogenous genes 
During cell division in HeLa cells, H3 methylation happens before its incorporation into the 
newly synthesized DNA (Sarraf and Stancheva, 2004). While the methyl-CpG binding protein 
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hMBD1 binds hSETDB1 throughout the cell cycle, they interact with the chromatin assembly 
factor hCAF-1 specifically during the synthesis phase (S phase), depending on actual occurrence 
of replication. Silencing maintenance of many hMBD1 targets, like p53BP2, depends on both 
DNAme and H3K9me3 deposition by hMBD1-SETDB1 complex during replication, but not on 
histone deacetylation. Absence of any of those components leads to H3K4me3 accumulation and 
transcription. The SUMOylation of any of the two hMBD1 sites by PIAS1/3 E3 SUMO-ligases 
disengages hSETDB1 from p53BP2 promoter, but not hMBD1, reducing the levels of H3K9me3 
and disturbing repression (Lyst et al., 2006). Methylation of non-nucleosomal H3 by hSETDB1 
was also observed in the context of its association with the hCAF-1-HP1α-TRIM28 complex, 
where it monomethylates core histones rather than mononucleosomes (Loyola et al., 2009). 
Regarding early development, SETDB1 foci in mouse blastocysts co-localize with the 
promyelocytic leukemia nuclear bodies (PML-NB). This association was also observed in MEF, 
NIH/3T3 (Cho et al., 2011), mESC and HEK293T, with the SUMO1-modified version of SETDB1 
(Yeap et al., 2009) and the shorter isorform (Cho et al., 2013). SETDB1 depletion inhibits MEF 
from reconstituting PML-NB after its dismantlement. Both PML and SETDB1 associate on the 
promoter of the PML target Id2 to repress its transcription (Cho et al., 2011). The overall gene 
deregulation in Setdb1 knockout differs from Dnmt TKO mESC. Most of SETDB1 binding sites 
are enriched for H3K9me3 in wild type mESC and lose this mark after SETDB1 knockout, but not 
in DNMT TKO mESC. However, only few such sites occurring at promoters become upregulated, 
with a minority being enriched for H3K9me3 in wild type mESC. Thus, in general, H3K9me3 
deposition by SETDB1 is independent of DNAme (Karimi et al., 2011). Imprinted genes were 
shown to be regulated by SETDB1 in mESC (Yuan et al., 2009) in the context of ZFP57-TRIM28-
SETDB1 complex. This ZFP is recruited by a specific methylated hexanucleotide that occurs in 
one or two copies in all murine and some human imprinted genes. Together with HP1γ, this 
complex binds preferentially the repressed allele and is required for maintaining H3K9me3 and 
DNAme and blocking H3K9ac deposition, while CTCF interacts with the other allele. The ZFP57-
TRIM28 complex associates also with DNMT1, DNMT3A/B and UHRF1 (Quenneville et al., 2011). 
The maternally imprinted gene hSNOG1 is instead bound by ZFP274 in hESC and is repressed 
by hSETDB1-dependent H3K9me3 and DNAme (Cruvinel et al., 2014). At imprinted and germline 
genes, SETDB1-dependent H3K9me3 is required for DNAme maintenance (Leung et al., 2014). 
SETDB1 is also involved in gene regulation in the context of signal transduction pathways. In 
the nuclei of HeLa cells, hSETDB1 also interacts with the human serine/threonine kinase hAkt1, 
a central effector downstream of phosphoinositide 3-kinase (PI3K) required in many signal 
transduction pathways. Phosphorylation of the transcription factor hFKHRL1 by hAkt1 is 
enhanced by the interaction with hSETDB1 and retains hFKHRL1 in the cytoplasm, where it 
cannot promote expression of apoptotic genes, like FasL (Gao et al., 2007). Besides that, 
signaling pathways might induce HKMT-dependent repression, as depletion of the protein kinase 
CaMKII in MCF7 breast cancer cells led to impaired hSETDB1-dependent repression of a reporter 
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gene regulated by the estrogen receptor (Garcia-Bassets et al., 2007). In murine bone marrow-
derived stroma ST2 cell line, Wnt-5a signaling through CaMKII-TAK1-TAB2 activates Nemo-like 
Kinase NLK, which phosphorylates SETDB1 at T976. This modified form associates with the 
chromodomain helicase DNA-binding protein CHD7 to repress the adipogenesis inducing nuclear 
receptor PPAR-γ through deposition of H3K9me2/3 at its binding site on gene promoters, 
consequently promoting osteoblastogenesis rather than adipogenesis (Takada et al., 2007). 
SETDB1 also complexes with the thyroid hormone receptor TRβ1 when it binds the corepressor 
Alien in murine carcinoma P19 cells. After stimulation with T3, this complex binds the negative 
thyroid hormone response element nTRE of the E2F1 and c-myc promoters to repress their 
activity with concomitant deposition of H3K9me3 (Hong et al., 2011). A role in silencing of quickly 
inducible genes during inflammation response was proposed for hSETDB1. The Interferon 
Regulatory Factor IRF5 induces pro-inflammatory cytokines, such as the tumor necrosis factor 
TNF. To prevent TNF expression for longer than needed, IRF5 recruits hTRIM28 and hSETDB1, 
for deposition of low H3K9me3 levels in HEK293 cells and in human GM-CSF differentiated 
macrophages. Even though these low levels are enough for silencing, they are easily removed 
upon a challenge, allowing quick reactivation of transcription (Eames et al., 2012). 
Recruitment of hSETDB1 to 3’ end of zinc finger genes (Zfp) in human immortalized 
myelogenous leukemia K562 cells was also observed. The KRAB zinc finger protein hZFP274 
targets hTRIM28 to these specific genomic regions, which in turn targets hSETDB1 for deposition 
of H3K9me3 (Frietze et al., 2010). hATRX associates with this complex together with the atypical 
co-occupancy of H3K36me3 at such regions. Co-binding of ATRX was also seen in hESC and 
HeLa, but not in mESC and MEF (Valle-Garcia et al., 2016). Interestingly, a repetitive region 
previously known as MMSAT4 is present at the 3’ end of almost all KRAB-Zfp genes and gets 
silenced by the TRIM28-SETDB1 complex (Kauzlaric et al., 2017). 
An interesting interactor of SETDB1 is the methionine adenosyltransferase MAT2, which 
synthesizes SAM, a methyl donor for histone methylation. The cyclooxygenase gene Cox-2, 
important in inflammation, is bound by the transcription factor MafK, which recruits the subunits 
MAT2A/B. MAT2A, in turn, associates with SETDB1 to deposit H3K9me3 and repress 
transcription in MEF (Kera et al., 2013). Furthermore, a function in RNA-mediated silencing was 
described. In human breast cancer T47D cells, ncRNA are transcribed from promoters with 
androgen receptor and are targets of small interfering antigene RNA (agRNA) which recruit the 
hAGO2-hSETDB1 complex. hSETDB1-dependent H3K9me3 and hEZH2-dependent H3K27me3 
are required for this silencing. The complex hSIN3-hHDAC2, but not hTRIM28 or hDNMT3A/B, is 
also recruited to those regions in an hAGO2- and hSETDB1-dependent manner (Cho et al., 2014). 
In Drosophila, dSetdb1 depletion upregulates genes mainly of the chromosome 4 (Brower-
Toland et al., 2009). However, this finding opposes the general downregulation previously 
observed (Tzeng et al., 2007). In S2 cells, dSETDB1 is not expressed and the Rb gene gets 
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transcribed. Ectopic expression of dSETDB1 is enough to repress Rb transcription. dSETDB1 
deposits H3K9me3 at a distal promoter region and triggers DNAme by dDNMT2, which spreads 
to a proximal promoter region with the help of HP1. H3K9me3 deposition at this proximal region 
depends on the MBD of dSETDB1 and the spread DNAme or silencing is not accomplished. This 
mechanism of Rb silencing is observed in the developing eye imaginal disc (Gou et al., 2010). 
Overall, several genes were demonstrated to have their promoters regulated by SETDB1 in a 
methyltransferase dependent manner. The regulation of developmental genes, though, was 
merely based on genome-wide analyses and has not yet been well curated so far. Thus, how 
SETDB1 acts to suppress developmental-related genes, what exactly its roles are in keeping 
proper development and whether this is a direct role of SETDB1 and not some consequence of 
its other functions are still open questions. 
1.7. Repression of transposable elements 
A significant proportion of human and mouse genomes is comprised of transposable elements 
(TE), reaching 46 % and 37.5 %, respectively. These elements are divided in DNA transposons 
and retrotransposons (Wicker et al., 2007), with the last one relying on an RNA intermediate to 
amplify. Retrotransposons constitute 95 % of mouse TE and are classified in non-LTR and LTR 
(long-terminal direct repeats) retrotransposons. The non-LTR order forms the majority of 
retrotransposons (27 % of the mouse genome) and is constituted by autonomous LINE (long-
interspersed) and non-autonomous SINE (short-interspersed nucleotide elements). The LTR 
order comprises around 9.9 % of both human and mouse genomes. While they are almost extinct 
in humans, many members are still active in mice. In mammals, LTR retrotransposons derived 
from vertebrate-specific endogenous retroviruses (ERV) superfamily. According to similarity to 
modern exogenous retroviruses (XRV), ERV are grouped in classes I, II and III, constituting 0.7 %, 
3 % and 5.4 % of the mouse genome. Class I gathers the families MLV, GLN, VL30, MRRS, 
MRVY and MERVC; class II contains the superfamilies MMTV, IAP and MusD/ETn; and class III 
is composed by families MERVL and MaLR (Stocking and Kozak, 2008). Interestingly, ERV are 
differentially regulated during development and can even become expressed. While somatic cells 
rely on the DNAme machinery for silencing these elements, mouse early embryos and embryonic 
stem cells take advantage of histone modification mechanisms to keep them silent during the 
global DNA demethylation during the preimplantation stage (Gifford et al., 2013). 
SETDB1 has an important role in TE silencing during reprogramming of DNAme in early stages 
of development. Transcriptional repression of ERV classes I (MLV, GLN) and II (IAP, MusD, 
ERVK10C) depends on SETDB1 binding and H3K9me3 deposition in mESC (Matsui et al., 2010; 
Karimi et al., 2011; Maksakova et al., 2011; Reichmann et al., 2012; Maksakova et al., 2013), but 
not on DNAme by DNMTs in general (Karimi et al., 2011; Reichmann et al., 2012). Ubiquitination 
of SETDB1 is essential for this regulation (Sun and Fang, 2016). LINE-1 show only mild 
upregulation after SETDB1 depletion. Loss of H3K9me3 at these ERV classes happens after 
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SETDB1 depletion (Matsui et al., 2010; Karimi et al., 2011), but not in Dnmt TKO (Karimi et al., 
2011) or Dnmt3a/b DKO (Leung et al., 2014), and is accompanied by loss of H4K20me3 but not 
H3K9me2. However, depletion of SUV4-20H1/2 enzymes did not lead to reduction of H3K9me3. 
HP1α/β/γ is also partially lost at these ERV elements. TRIM28 binds them in mESC independently 
of SETDB1, even though binding of the latter depends on TRIM28. Knockdown of TRIM28 leads 
to similar phenotype. In MEF, ERV classes I and II are not bound by either SETDB1 or TRIM28 
and only MLV show strong derepression after SETDB1 depletion. Deposition of SETDB1 is 
independent of DNMTs and their product and SETDB1 loss does not affect DNAme levels strongly 
in mESC (Matsui et al., 2010) or in blastocysts (Dodge et al., 2004). On the other hand, SETDB1 
is involved in maintaining residual DNAme at specific H3K9me3-marked subfamilies of ERV class 
II (IAP, MusD and ERVK10C) and they preserve some DNAme in Dnmt DKO mESC. At these 
regions, SETDB1 opposes DNA demethylation activity, as they showed increased Tet1 binding 
and 5hmC levels in Setdb1 KO mESC (Leung et al., 2014). Besides that, only IAPEz subfamily is 
further upregulated when DNMT1 was depleted together with SETDB1. Expression of genes near 
upregulated ERV tended to increase, along with chimeric transcripts (Karimi et al., 2011). 
Loss of Dnmt1 in mESC increases hemimethylated DNA, leading to prolonged UHRF1 binding 
that disrupts SETDB1 and KAP1 binding. H3K9me3 is partially lost and IAPEz transcription 
increases. This picture is reversed later after hemimethylated DNA is reduced. Loss of only Uhrf1 
resulted in the opposite picture, enhancing the repression status. Setdb1/Dnmt1 DKO and 
Setdb1/Uhrf1 DKO in mESC showed synergistic effect in IAPEz upregulation. In trophoblast stem 
cells, UHRF1 blocks SETDB1-dependent repression, as IAPEz expression increases after 
Setdb1 knockout and gets more repressed in Uhrf1 knockout (Sharif et al., 2016). 
SETDB1 also deposits H3K9me3 at all H3.3-containing ERV. While HIRA deposits H3.3 at 
ERV enriched only for H3.3, DAXX and ATRX are responsible for deposition of H3.3 in ERV 
enriched for both H3.3 and H3K9me3. At IAPEz, H3.3 deposition decreases after Trim28 deletion, 
but not after Setdb1 deletion. Deletion of H3.3 reduces binding of both TRIM28 and DAXX to ERV 
sequences and decreases H3K9me3 levels at IAP, ERVK10C, ETn and MusD, leading to 
derepression of the first two subfamilies (Elsasser et al., 2015). However, it did not affect silencing 
of an IAPEz gag reporter, where expression of a H3.3 interaction-deficient DAXX could still rescue 
reporter repression in Daxx knockout mESC (Sadic et al., 2015). 
Expression of the Agouti allele affecting coat color in mice is driven by an IAP retrotransposon. 
Heterozygous Setdb1 or Trim28 mutant mice are haploinsufficient, but survive and are fertile, 
though with lower probability of repressing paternally inherited Agouti allele. H3K9me3 is absent 
in mature sperm and global DNAme level is unchanged in mutant sperm. However, IAPEY 
showed loss of DNAme, which cannot be reversed by maternal contribution during 
preimplantation (Daxinger et al., 2016). In E13.5 primordial germ cells, some ERV elements 
(IAPEz and ERVK10C) are enriched for H3K9me3, DNAme and, differently from mESC, 
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H3K27me3. Setdb1 deletion in those cells, driven by Tnap promoter, results in reduction of 
DNAme at LTR region of IAP which lost H3K9me3. The reactivation of a subset of ERV is sex-
dependent. IAPEz and ETn were more upregulated in male, while ERVK10C was more 
upregulated in female cells. The derepression of some ERV resulted in upregulation of genes at 
their vicinity (Liu et al., 2014). Lack of SETDB1 in oocytes results in further deregulation of ERV 
classes II and III (Eymery et al., 2016) and LINE1 (Kim et al., 2016). At the X chromosome, only 
LTR order of X-linked repeats showed impaired silencing after Setdb1 knockdown in 
differentiating mESC (Keniry et al., 2016). 
In the hematopoietic system, MLV, MMTV and VL30 contain SETDB1-dependent H3K9me3 
and are derepressed in Setdb1-deleted pro-B cells. Upregulation of some MLV elements, with 
mild or no DNAme loss, led to increase expression of their neighboring genes (Collins et al., 2015; 
Pasquarella et al., 2016). However, in Setdb1 knockout GMP, LSK (Koide et al., 2016) and 
thymocytes (Takikita et al., 2016), IAP were also upregulated. ERV expression is directly 
dependent on the cell type, as a MLV element derepressed in Setdb1 knockout pro-B cells stays 
silent in Setdb1 knockout mESC, while the opposite happens to a nearby IAPEz sequence. 
Specific derepression of particular ERV is due to tissue-specific transcription factors, which 
explains why loss of Setdb1, H3K9me3 and DNAme not always lead to transcriptional activation. 
For instance, the derepressed MLV elements in mutant pro-B cells are bound by the B-lineage 
transcription factor PAX5, whose depletion abolishes derepression in mutant pro-B cells (Collins 
et al., 2015). Upregulation of nearby genes also happens after Setdb1 deletion in mouse brain, 
due to derepression of IAP losing H3K9me3 and DNAme (Tan et al., 2012). 
A MLV-based exogenous retrovirus gets quickly silenced in mESC with accumulation of 
H3K9me3, while de novo DNAme is only observed several days after infection. However, 
SETDB1 deletion leads to derepression of the reporter with concomitant DNAme loss, similarly to 
TRIM28 knockdown (Matsui et al., 2010). Similar SETDB1-dependent repression was observed 
in mESC, but not in MEF, for IAP LTR (Rowe et al., 2013) and IAPEz gag reporters (Sadic et al., 
2015); for MSCV, MFG, IAP or MusD LTR in mESC (Maksakova et al., 2011); for MSCV LTR in 
pro-B cells (Collins et al., 2015); and when reporters with CMV or LTR promoters were introduced 
in HeLa cells (Poleshko et al., 2010). Interestingly, silencing of an IAPEz gag reporter becomes 
further impaired when Setdb1 is depleted together with Atrx in mESC, indicating the occurrence 
of genetic interaction (Sadic et al., 2015). Whether an introduced ERV gets DNA methylated or 
not after transduction is dependent on the pattern of KRAB-ZFP expression. Both mESC and 
MEF, but not NIH/3T3 cells or 293T cells, express ZFP809 and can repress the PBS Pro derived 
from MLV. However, expression of this gene in 293T cells was enough for repression and 
deposition of DNAme. Injection of the IAP LTR reporter in fertilized mouse oocytes results in 
repression and DNAme. Even though transduced MEF cannot repress this reporter, it is 
repressed in MEF derived from transduced embryos. The early deposition of DNAme was kept 
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and is essential for the maintenance of the repression, which is impaired by treatment with the 
DNA methyltransferase inhibitor 5-aza (Rowe et al., 2013).  
SETDB1 and the human silencing hub (HUSH) complex proteins are required for H3K9me3 
deposition and repression of the spleen focus-forming virus promoter (SFFV) reporter in haploid 
human cell line KBM7 and in HeLa cells. The HUSH complex is formed in the nucleus by the 
transgene activation suppressor TASOR, the M-phase phosphoprotein MPP8 and periphilin. 
Reporter integrations silenced by the HUSH complex happened in the vicinity of H3K9me3-
enriched regions, as a result of position-effect variegation (PEV), and are dependent on H3K9me3 
binding by MPP8. H3K9me3 deposition at some endogenous loci and repression also depended 
on this complex in HeLa cells (Tchasovnikarova et al., 2015). 
In NIH/3T3 fibroblasts, association of SETDB1 to the HP1α-CAF1 complex establishes non-
nucleosomal H3K9me1 at HP1-associated pericentric heterochromatin during replication (mid S-
phase). This complex is not associated with ATF7IP (Loyola et al., 2009). Besides that, a role for 
SETDB1 at major satellite repeats of pericentric heterochromatin was also described in concert 
with SUV39H1, G9a and GLP as a multimeric complex. This interaction is observed endogenously 
in HeLa, MEF and mESC. The stability and HKMT activity of the complex depends on the 
enzymatic activity and the chromodomains of SUV39H1. These four proteins work cooperatively 
to establish and maintain gene silencing at euchromatic G9a targets too (Fritsch et al., 2010). 
In the wing imaginal disc, spread of DNAme due to dSETDB1-dependent H3K9me3 deposition 
is important for silencing of retrotransposons (Gou et al., 2010). In third instar larvae, however, 
loss of dSetdb1 does not strongly impact pericentric heterochromatin or the centromere-proximal 
region of chromosome 4 (Riddle et al., 2012). In first instar larvae, upregulated transposons 
overlap in dSetdb1, HP1α and dSu(var)3-9 mutants, but loss of dSetdb1 has lower extent effects 
(Lundberg et al., 2013). In C. elegans, binding of SETDB1, HP1, CHD, ZFP and MBT homologs 
is well correlated with H3K9me3 and are associated with telomeres and repetitive elements, which 
can get upregulated in mutants of SETDB1 homolog (Zeller et al., 2016; McMurchy et al., 2017). 
1.8. Consequences of SETDB1 overexpression 
SETDB1 full-length and splicing variant are almost completely retained in the cytoplasm when 
overexpressed in NIH/3T3 fibroblasts, HEK293 cells, MEF and mESC. It reaches the nucleus only 
when the nuclear export protein CRM1 is blocked by leptomycin B (Cho et al., 2013). Inhibition of 
proteasome degradation by MG132 further increases nuclear localization (Tachibana et al., 
2015). Mice with higher SETDB1 transgenic expression in the forebrain showed antidepressive 
phenotype. Increase in pericentric H3K9me3, at major satellite repeats, was observed. Besides 
that, at higher expression levels, SETDB1 targeted and repressed the NMDA receptor subunit 
Grin2b, similarly to what happens in human U87MG glioma cells. Interestingly, the TSS region of 
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Grin2b bound by TRIM28 forms a loop with a region 30 kb away inside the gene, which is bound 
by SETDB1 (Jiang et al., 2010). 
In normal mature neurons, Setdb1 expression is reduced while the MBD protein MECP2, which 
regulates repressive histone modifications, is upregulated. Overexpression of Setdb1 in Mecp2 
neuronal knockout mice worsened the neurological impairment, instead of ameliorating it (Jiang 
et al., 2011). Furthermore, enhanced expression of SETDB1 in mice due to loss of its repressor 
CREB binding protein CBP increases H3K9me3 in striatal neurons. These mice show brain 
atrophy and striatal neuron dysfunction (Lee et al., 2008). In Drosophila, overexpression of 
dSetdb1 is lethal and flies die at pupal stage. It leads to increase in global H3K9me1/2/3 levels, 
enhancing HP1 recruitment on chromosome 4 and on euchromatic arms (Seum et al., 2007). 
Overexpression of Setdb1 can also impair differentiation. When performed in differentiating 
myoblasts, it reduced the expression of differentiation markers, disrupting terminal differentiation 
(Beyer et al., 2016). Overexpression of wild type Setdb1, but not the ubiquitination site mutant, in 
HeLa cells increases H3K9me3 level at the target gene SERPINE1, decreasing expression. This 
suggests that ubiquitination enhances the activity at target loci in the cell (Ishimoto et al., 2016). 
In summary, SETDB1 is involved in the repression of genes and repetitive sequences by 
different mechanisms and in numerous circumstances, especially during differentiation. 
Moreover, SETDB1 HKMT activity must be regulated properly according to each context. Several 
are the proteins which were shown to act in concert with SETDB1. However, only one of those 
interactors is regarded as a regulator of its methyltransferase activity and is known as ATF7IP. 
1.9. The transcriptional cofactor ATF7IP 
1.9.a. Structural features 
ATF7IP was first identified as a murine ATFa-associated modulator (mAM) with 1306 aa and 
predicted molecular weight of 138 kDa, although it migrates as a 180 kDa protein (De Graeve et 
al., 2000). At the same time, it was found as a partner of Sp1, named p621 (Gunther et al., 2000). 
Later on, it was identified in HeLa cells as an interactor of transcriptional repression domain (TRD) 
of hMBD1, termed MCAF, for MBD1-containing chromatin associated factor (Fujita et al., 2003). 
The Drosophila homolog, Windei, has only 14.8 % identity with Atf7ip, however, the identity of the 
fibronectin type III repeat at the C-terminus is 36 %, with a similarity of 56 % (Koch et al., 2009). 
A NLS close to the center of the protein is enough to target a cytoplasmic reporter protein to 
the nucleus. At the N-terminal side, a putative ATP binding site (ABS) is present, which was 
shown to be required for ATP hydrolysis activity of immunoprecipitated material. No canonical 
DNA binding sequence is observed (De Graeve et al., 2000). ATF7IP bears two other conserved 
domains, with identity of 76 % and 98 % between mouse and human homologs, which are 
important for interaction with other proteins. Domain 1 interacts with Sp1 (Fujita et al., 2003; 
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Ichimura et al., 2005; Liu et al., 2009) and SETDB1 (Ichimura et al., 2005). The C-terminal 
Domain 2 interacts with MBD1 and Sp1 (Fujita et al., 2003; Ichimura et al., 2005; Liu et al., 2009). 
Although no covalent modification by SUMOylation is observed, a SIM between Domains 1 
and 2 binds SUMO2/3 strongly and SUMO1 weakly. This binding is abrogated by D968A and 
L969A in humans. (Uchimura et al., 2006; Tanaka and Saitoh, 2010). Structural characterization 
of the SUMO3 binding to hATF7IP indicates a role for electrostatic interactions in the preferential 
association to SUMO3 (Sekiyama et al., 2008). Analysis of the phosphoproteome of hESC during 
differentiation identified five serine phosphorylation sites in hATF7IP (Rigbolt et al., 2011). 
ATF7IP belongs to an evolutionarily conserved protein family and has a paralog in 
mammalians, called ATF7IP2. The gene Atf7ip2 encodes a 681 aa protein with 27 % and 56 % 
similarity to the domains 1 and 2 of ATF7IP, respectively (Ichimura et al., 2005). In Drosophila, 
the C-terminal region of dATF7IP is enough for its nuclear localization. A coiled coil region 
(Domain 1) interacts with the dSETDB1 region N-terminally to its tudor domain (Koch et al., 2009). 
 
Figure 1.2 | Schematic representation of the domain structure of mouse ATF7IP. 
ATF7IP contains a putative ATP binding site (ABS). Two conserved regions called Domains 1 and 2 are involved in 
protein interaction. A nuclear localization signal (NLS) overlaps with the beginning of Domain 1. A functional SUMO 
interaction motif (SIM) is present. Two fibronectin domains compose the C-terminus of the protein. 
1.9.b. Expression and localization 
Atf7ip is ubiquitously transcribed during embryogenesis, at E9.5, E11.5, E14.5 and E16.5. 
E11.5 embryos show stronger signals in the brain, spinal cord and somatic mesoderm. At E14.5 
and E16.5, the nervous system kept strong signals, mainly in the forebrain, but numerous organs 
also showed high expression. Several adult mouse tissues express Atf7ip, for instance the 
epithelium of the stomach, epididymis, ductus deferens, tongue, intestine and uterus and in the 
spleen and some areas of the brain (De Graeve et al., 2000). During differentiation of mESC and 
hESC into embryoid bodies, Atf7ip expression decreases (Luzzani et al., 2011). 
While ATF7IP is highly expressed in HeLa, HEK293T and K562 cells, ATF7IP2 is not 
expressed only in HeLa cells. hATF7IP overexpressed in HeLa cells shows nuclear colocalization 
with hMDB1, hSETDB1 (Ichimura et al., 2005) and SUMO3 incapable of conjugation (Uchimura 
et al., 2006). hATF7IP forms foci in interphase nuclei of HeLa cells, which co-localized hMBD1 
(Fujita et al., 2003). Mutation on the Domain 2 of ATF7IP or on the TRD of MBD1 leads to 
dissociation of the complex and disruption of hSETDB1 localization, indicating that the latter is 
recruited to DNA methylated regions by hMBD1 via hATF7IP. The complex hMBD1-ATF7IP-
SETDB1 also co-localizes with the three HP1 isoforms, which adopted a diffuse distribution when 
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hMBD1 was mutated. This co-localization is observed for the endogenous proteins as well in 
human cervix carcinoma C33A cells and overlap with heterochromatic foci, including with the 
H3K9me3 mark (Ichimura et al., 2005) and SUMO2/3. hATF7IP colocalization with the 
heterochromatic H3K9me3 mark was also observed in HeLa and MCF7 cells (Sasai et al., 2013). 
Interestingly, part of the endogenous hMBD1 is SUMOylated by SUMO1/2/3, what leads to higher 
stability in the association with hATF7IP. Depletion of either SUMO1 or SUMO2/3 leads to 
impaired hATF7IP, H3K9me3 and HP1β/γ co-localization to MBD1 foci (Uchimura et al., 2006). 
dATF7IP is expressed in germ line, somatic follicle and nurse cells during fruit fly oogenesis. 
It partially colocalizes to HP1 foci at the oocyte nucleus and colocalizes exactly to dSETDB1 and 
POF at the fourth chromosome. dATF7IP, HP1 and POF overlap at many euchromatic bands of 
all polytene chromosomes in salivary glands. Deletion of dSETDB1 SET domain does not impair 
proper dATF7IP localization. However, deletion of dATF7IP affects dSETDB1 nuclear localization 
and protein stabilization in germ line cells (Koch et al., 2009). In HeLa cells, hATF7IP is almost 
exclusively nuclear and stabilizes nuclear hSETDB1, protecting against proteasomal degradation, 
while nuclear hSETDB1 also prevents hATF7IP proteasomal degradation (Timms et al., 2016). 
1.9.c. ATF7IP-mediated transcriptional control 
Ectopic expression of Atf7ip when the transcriptional activator complex ATFa-JunD is targeted 
to a reporter promoter leads to ABS-independent repression. However, artificial tethering of 
ATF7IP to a reporter promoter in mouse testis embryonal carcinoma F9 cells also leads to 
repression (De Graeve et al., 2000). Interaction with subunits of the general transcription factors 
TFIIE (α/β subunit) and TFIIH (ERCC2/3 and p34) and of the Poll-II (hRPB3/4/7/8) was observed 
ectopically in Sf9 (De Graeve et al., 2000) and for endogenous proteins in HeLa (Liu et al., 2009). 
Whether hATF7IP exerts transcriptional repression or activation depends on the proteins 
complexing with it. Expression of ATF7IP in HeLa cells induces transcriptional activity of a reporter 
with promoters of SNRPN or p16, known to contain hSp1 binding motif and an associated CpG 
island. Similarly, co-expression of ATF7IP and Sp1 in SL2 cells, which lack Sp1, MBD1 and 
DNAme, enhances transcription. However, when hMBD1 is also co-expressed, transcription is 
repressed instead (Ichimura et al., 2005). Both activation and repression happened in a 
Domain 2-dependent manner (Fujita et al., 2003). Point mutations on the TRD domain at residues 
important for hMBD1 repressive ability abrogates binding to hATF7IP. The promoter of p16 is not 
methylated in the SBC-5 cell line and hATF7IP binds it via hSp1, independently of hMBD1. In the 
lung cancer cell line NCI-H1299, though, this promoter is methylated and can be bound by hMBD1 
followed by hATF7IP, unless the point mutant hMBD1 is expressed instead. Interestingly, hMBD1 
and hSp1 compete with each other for the binding to ATF7IP (Fujita et al., 2003). 
hATF7IP is involved in autoregulation of the Epstein-Barr virus EBV transcription factor Rta, 
encoded by BRFL1, leading to activation of lytic cycle. Basically, Rta associates with Sp1 via 
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ATF7IP and is recruited to the Sp1 motif in the BRFL1 promoter in P3HR1 lymphoma cells (Chang 
et al., 2005). Besides that, the Domain 1 of hATF7IP, Rta and the BZLF1-encoded transcription 
factor Zta form a complex at Zta response elements of EBV lytic genes, acting synergistically to 
increase their expression (Chang et al., 2010). hATF7IP regulates BZLF1 promoter as well, by 
mediating the interaction between Rta and hATF2 after lytic induction. This complex also binds 
the promoter of BMRF2, a gene important for the viral infectivity (Lin et al., 2014). 
The telomerase-associated genes TERT and TERC, transactivated by hSp1, show binding of 
both hATF7IP and hSp1 at their promoter regions. hATF7IP binding to the TERT promoter 
depends on hSp1, but the opposite is not true. Both proteins are required for proliferation, 
telomerase activity, proper expression of TERT and TERC and promoter occupancy by phospho-
Pol-II and hERCC3. Some CpG sites between the Sp1-binding motifs in TERT promoter get 
methylated after depletion of either hATF7IP or hSp1, while hCTCF binding sites lost CpG 
methylation, even though it did not impact hCTCF binding. hMBD1, but not hSETDB1, is enriched 
in the TERT promoter and is independent of hATF7IP (Liu et al., 2009). hATF7IP is essential for 
stimulating growth rather than cellular senescence also by keeping expression of cell cycle, core 
histones and linker histone H1 genes and inhibiting Rb protein dephosphorylation. In human fetal 
lung IMR90 myofibroblasts, hATF7IP forms several foci colocalized to PML-NB, but not with 
H3K9me3. Depletion of this protein did not disassemble the PML-NB. However, proliferation was 
impaired and premature senescence triggered. Induction of senescence enhances has a similar 
effect, as hATF7IP accumulates to PML-NB in a SIM-dependent manner probably due to 
SUMO2/3 binding and this sequestration leads to cellular senescence (Sasai et al., 2013). 
ATF7IP complexes with MBD1 and SETDB1 also to regulate the expression of X-linked genes 
for XCI in concert with DNAme. Knockdown of Atf7ip, Mbd1 or Setdb1 (but not other H3K9MT) in 
female MEF leads to weak activation of an X inactive-linked reporter, similarly to treatment with 
low levels of azacitidin, which removes DNAme. However, a combination of knockdown and 
azacitidin treatment or co-depletion with Dnmt1 enhances reactivation. ATF7IP does not bind the 
X inactive during initiation of the process after induction of Xist expression in mESC. Enrichment 
was still not observed after retinoic acid differentiation (Minkovsky et al., 2014). Similar to what 
was shown for SETDB1 (Chapter 1.5.a. Embryonic stages), ATF7IP does not regulate Xist 
expression or the coating of the inactive chromosome by Xist RNA, even though concomitant 
depletion of Atf7ip and Xist also showed synergistic effects (Minkovsky et al., 2014). ATF7IP and 
SETDB1 functions in XCI may be involved with the chromodomain-containing transcriptional 
corepressor Cdyl, which binds H3K9me2 in the X inactive chromosome and interacts with 
ATF7IP1/2, SETDB1 and G9a during mESC differentiation (Escamilla-Del-Arenal et al., 2013). 
The hATF7IP-MBD1 complex is also shown to promote tissue-specific antigen encoding 
genes. These genes are targets of the transcriptional regulator Aire, specific of specialized 
medullary thymic epithelial cells (mTEC). In these cells, Aire interacts with Domain 2 of hATF7IP 
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and with hMBD1, which act to recruit Aire to its targets, leading to transcriptional activation 
(Waterfield et al., 2014). An unrelated possible role of hATF7IP, which has been so far 
overlooked, is the involvement in repressing homologous gene targeting (Delacote et al., 2011). 
1.10. Regulation of SETDB1 catalytic activity by ATF7IP 
Co-fractionation of HeLa protein extracts monitoring HMTase activity and SETDB1 led to the 
identification of hATF7IP. When reconstituted from Sf9 cells, the mouse SETDB1-ATF7IP 
complex showed higher activity than SETDB1 alone. Besides, the activity of the complex was 
similar to equal amounts of HeLa cells native complex (Wang et al., 2003). This happens due to 
an increase in the turnover rate of the reaction. The same did not occur after reconstitution with 
the human homologs, where the complex rather showed lower activity (Basavapathruni et al., 
2016). Unexpectedly, when the mouse proteins are combined after being individually purified from 
Sf9 cells, the methyltransferase activity is inhibited instead (Wang et al., 2003). Similar 
phenomenon was seen between HDAC and its modulator MTA2 (Zhang et al., 1999). 
ATF7IP does not change substrate specificity, as mutations in other residues does not affect 
activity of either recombinant SETDB1 or the reconstituted complex (Wang et al., 2003). hATF7IP 
also did not change the activity of hSETDB1 over a large peptide panel of histones H3 and H4. 
Besides that, hATF7IP does not alter hSETDB1 affinity to substrate or SAM (Basavapathruni et 
al., 2016). The reconstituted complex has much higher efficiency in trimethylation in comparison 
to SETDB1 alone, while mono- and dimethylation are similar (Wang et al., 2003). In contrast, for 
the human reconstituted complex the enzyme turnover rate is rather lower for all substrates, 
indicating lower catalytic efficiency when compared to hSETDB1 alone. Interestingly, mono and 
dimethylation promptly accumulate over time, while H3K9me3 is much slower, independently of 
hATF7IP presence. Catalysis by hSETDB1 is distributive, meaning that the substrate is released 
right after catalysis (Basavapathruni et al., 2016). 
Depletion of SETDB1 in HEK293T and HeLa cells leads to mild reduction of global H3K9me2/3 
levels. On the other hand, ATF7IP depletion decrease H3K9me3 and increases H3K9me2. 
Transcription of an in vitro assembled-chromatin, but not of naked DNA, is strongly repressed by 
hSETDB1 in a SAM-dependent manner, but is further repressed by hSETDB1-ATF7IP complex. 
Oligonucleosomes were marked with H3K9me2 by hSETDB1 alone, while in the presence of 
hATF7IP there was enrichment for H3K9me3 instead. The methylation is restricted to the 
promoter region and depends on the activator, which may open up chromatin (Wang et al., 2003). 
In the case of the SNRPN promoter introduced in SL2 cells, where hATF7IP cooperates with 
hMBD1 to enhance silencing when ectopically expressed (Chapter 1.9.c ATF7IP-mediated 
transcriptional control), hSETDB1 further enhances repression. The same does not happen when 
hATF7IP2 is in the place of hATF7IP. In HeLa cells, ATF7IP depletion impaired MBD1 repression 
of this promoter and was only partially restored by ATF7IP2 expression. Similarly, the methylated 
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promoter of p53BP2 (Chapter 1.6.b. Endogenous genes) is bound by the hMBD1-SETDB1-
ATF7IP complex (Ichimura et al., 2005). 
The RNA-binding protein and transcription co-factor heterogeneous nuclear ribonucleoprotein 
hnRNPK interacts with TRIM28 in mESC. It is required for SUMOylation of TRIM28 by the SUMO 
E2 conjugating enzyme Ubc9 and concomitant recruitment of SETDB1 and ATF7IP. Knockdown 
of Setdb1 or Atf7ip in mESC leads to derepression of proviral reporters MSCV-PBS and IAP LTR-
PBS with loss of H3K9me3 (Thompson et al., 2015) and derepression of a MMLV reporter (Yang 
et al., 2015). Depletion of either of those proteins mildly derepresses ERV classes I and II 
(Thompson et al., 2015; Yang et al., 2015), with partial loss of H3K9me3. Depletion of Hnrnpk 
also impairs repression of these proviral reporters and ERV classes I and II, which are also bound 
by hnRNPK. While Dnmt TKO mESC show just mild upregulation of IAP, depletion of Setdb1, 
Hnrnpk or Atf7ip leads to further deregulation of ERV. Several SETDB1 target genes, including 
some germline genes bound by hnRNPK, get upregulated or even lose H3K9me3 after depletion 
of either Setdb1 or Hnrnpk in mESC. Interestingly, depletion of Atf7ip increases SETDB1 
occupancy at ERV (Thompson et al., 2015). 
ERV deregulation shows strong correlation between Setdb1, Atf7ip or Trim28 knockdown 
mESC. Sumo2 knockdown reduces TRIM28 binding, including at the exogenous proviral reporter. 
Besides that, ERV regulated by the ZFP809-TRIM28-SETDB1 machinery overlap with the ones 
regulated by the histone chaperone SUMO2, but not by CHAF1A. However, CHAF1A interacts 
with SETDB1, KDM1a and HDAC2 to also regulate proviruses independently, by removing 
H3K4me3 and H3ac and providing a multi-layered silencing mechanism (Yang et al., 2015). 
hATF7IP is also involved in silencing of a HUSH complex-repressed reporter in HeLa cells. 
The HUSH complex was described in a previous section (Chapter 1.7. Repression of 
transposable elements) and most of the loci which lose H3K9me3 after depletion of this complex 
also lose this mark both in ATF7IP and in SETDB1 knockouts. Striking loss was observed at the 
body of zinc finger protein genes. Furthermore, transcriptome changes were also very similar in 
both knockouts, indicating the interdependency between those proteins (Timms et al., 2016). 
In 3T3-L1 preadipocytes, SETDB1 binds the DNA methylated gene body of Cebpa, as 
mentioned before (Chapter 1.5.e. Musculoskeletal system). This region is also bound by MBD1 
and ATF7IP. Depletion of either protein leads to Cebpa increased expression, reduced SETDB1 
binding and loss of H3K9me3. Thus, MBD1 recruits ATF7IP and SETDB1 to methylated DNA 
targeted via its MBD (Matsumura et al., 2015). 
In Drosophila, deletion of dAtf7ip leads to death at pupal stage. There were few escapers, 
which were very weak and died few days after becoming adults. The ovaries did not develop to 
bud off egg chambers from the germarium in mutant females. dAtf7ip is necessary for survival of 
germ line cells and for keeping H3K9me3 levels, similarly to dSetdb1 loss (Koch et al., 2009). 
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Considering all that, the influence of ATF7IP on SETDB1 methyltransferase activity is directly 
supported only by in vitro experiments, even though the results were contrasting between the 
human and the mouse version of these proteins. In a cellular system, ATF7IP function as a 
cofactor is only supported by indirect observations, where loss of either protein leads to loci 
specific H3K9me3 reduction. However, studies addressing the actual mechanisms are lacking. 
1.11. SETDB1 and ATF7IP in cancer and other diseases 
The importance of Setdb1 in neuronal development could already indicate possible roles in 
neuropathology. Indeed, higher levels of hSETDB1 expression and H3K9me3 accumulation is 
observed in neurons of Huntington’s disease (HD) patients. Pharmacological treatment of HD 
mouse model to reduce Setdb1 expression ameliorates the situation (Ryu et al., 2006). SNP 
located in ATF7IP locus and in its vicinity exhibited association with age of onset of Huntington’s 
disease (Valcarcel-Ocete et al., 2015) and major depressive disease (Song et al., 2013). 
Schizophrenia patients also showed higher SETDB1 expression and H3K9me2 levels (Chase et 
al., 2013). Mutations in SETDB1 locus (Cukier et al., 2012) or copy number variation due to 
deletion (Xu et al., 2016) might be involved in genetic causes of autism. Interestingly, nicotine 
treatment in neuronal cell lowered H3K9me2 levels and HKMT expression, including Setdb1 
(Chase and Sharma, 2013). In the case of HIV, hSETDB1 methylates the viral transactivator Tat 
and represses the HIV-1 promoter (Van Duyne et al., 2008). 
The involvement of SETDB1 in neoplasia was already predicted earlier due to the fact that this 
locus shows a great number of recurrent translocations (Harte et al., 1999). SETDB1 was found 
recurrently upregulated in non-small cell lung cancer cell lines  (Watanabe et al., 2008; Lafuente-
Sanchis et al., 2015) and amplified in patient tissues, where it was associated with advanced 
pathological stages (Inoue et al., 2015). Depletion of SETDB1 impaired proliferation and 
anchorage-independent growth of these cell lines, through inhibition of WNT signaling (Sun et al., 
2015). Similar results were observed for other types of human lung cancer cell lines and patients 
(Rodriguez-Paredes et al., 2014). However, reduced SETDB1 expression was also observed as 
an enhancer of metastatic ability, due to derepression of actin polymerization (Wu et al., 2014). 
Some compounds were shown to decrease hSETDB1 levels in lung cancer cells (Lee and Kim, 
2013; Noh et al., 2014), also without affecting other HKMT (Na et al., 2016).   
In human hepatocellular carcinoma patient tissues, amplification of SETDB1 and progressive 
higher levels of expression were observed, what correlated with lower survival (Wong et al., 
2016). This also occurred in liver cancer cell lines, where SETDB1 dimethylates mutant p53 and 
protects it against degradation, regulating cancer cell growth (Fei et al., 2015a). SETDB1 was 
also identified as a melanoma susceptibility locus (Macgregor et al., 2011), which is recurrently 
amplified in melanoma samples (Ceol et al., 2011) and is correlated with higher proliferation rate 
(Kostaki et al., 2014). A role of SETDB1 is also observed in tissues and/or cell lines of human 
glioma (Spyropoulou et al., 2014), prostatic cancer (Sun et al., 2014), breast cancer (Zhang et al., 
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2014; Regina et al., 2016) and colon carcinoma (Olcina et al., 2016), malignant pleural 
mesothelioma (Kang et al., 2016). Interestingly, hSETDB1 represses MLV in some carcinoma 
cells, with deposition of H3K9me3 at the LTR region (Wang and Goff, 2017). Due to its 
involvement in several diseases SETDB1 has been considered a promising therapeutic target, 
with some potential inhibitors already under study (Karanth et al., 2017). 
Regarding ATF7IP, it was found strongly expressed in stomach, lung and breast cancerous 
tissues. Besides that, telomere-positive cancer cells showed high expression of ATF7IP and Sp1 
(Liu et al., 2009). SNP in ATF7IP locus or on its vicinity showed association with a predictor for 
risk of prostate cancer (Jin et al., 2013), testicular germ cell tumor susceptibility (Turnbull et al., 
2010; Kanetsky et al., 2011; Karlsson et al., 2013) and its aggressiveness (Lessel et al., 2012). 
Besides that, long-term culture of small cell ovarian carcinoma cells shows deletion of the region 
containing ATF7IP (Otte et al., 2012). Interestingly, in B-progenitor acute lymphoblastic leukemia, 
a translocation led to an in-frame fusion protein between ATF7IP and PDGFRB (Kobayashi et al., 
2014) causing interleukin-independent proliferation (Ishibashi et al., 2016).  
1.12. Concluding remarks and open questions 
In summary, SETDB1 makes use of the methyltransferase ability from its SET domain to 
catalyze the H3K9me marks, especially the trimethylation, with the purpose of repressing 
retrotransposon activity and gene transcription (Kang, 2015). Even though ERV repression has 
been well characterized (Chapter 1.7 Repression of transposable elements), studies proving 
SETDB1 direct involvement in regulation of gene promoters are still lacking (Chapter 1.6 Silencing 
of euchromatic genes). For instance, this protein was linked to the regulation of developmental 
genes in mESC by inferences from genome-wide profiles, with no further curation of the data or 
at least not to a great extent. Regardless of that, SETDB1 acts in multiple contexts and for each 
of these specific tasks SETDB1 interacts with distinct set of proteins to become involved in 
different mechanisms of silencing. Some controversial studies suggested that ATF7IP is capable 
of functioning as a cofactor for SETDB1 catalytic activity, either to enhance the process in mouse 
(Wang et al., 2003) or to slow it down in humans (Basavapathruni et al., 2016). A drawback of 
those studies is that most of the observations come from in vitro systems and may not properly 
represent what happens in vivo. Either way, the fact that ATF7IP works as a cofactor suggests 
that the interaction of both proteins may happen in the majority of the contexts. Thus, several 
mechanisms of action for SETDB1 were revealed so far and happen in the most various contexts 
(Figure 1.3). However, the involvement of ATF7IP in most of these cases is not yet known. 
Considering all that, further studies characterizing the cooperation between SETDB1 and ATF7IP 
are required to elucidate the contexts in which they occur and the mechanisms by which they act. 
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Figure 1.3 | Models for SETDB1 mechanism of action, its roles in different contexts and open questions. 
(A) Pattern of Setdb1 expression during early embryonic development. How does Atf7ip expression behave at these 
stages? (B) In the presence of mATF7IP, mSETDB1 shows higher catalytic activity towards H3K9me3 deposition in 
vitro, whereas, hSETDB1 activity is hindered in the presence of hATF7IP. Are these observations similar in a cellular 
system and in vivo? (C) In general, for TE silencing SUMOylated TRIM28 is targeted to ERV classes I and II by 
KRAB-ZFP and recruits SETDB1, which deposits H3K9me3 to block the binding of lineage specific transcription 
factors. ATF7IP is required for establishment of H3K9me3 and proper silencing of some of those ERV. (D) During 
cell division, CAF1-MBD1 complex recruits SETDB1 to the replication fork, where it methylates H3 before its 
incorporation onto DNA for the maintenance of repression. This process may not be linked to ATF7IP, as it is not 
part of the complex. (E) The maintenance of the PML-NB structure and the silencing of PML targets depend on 
SETDB1 and its methyltransferase activity. ATF7IP is not required as a structural component of PML-NB, but its 
sequestration to this complex due to SUMO binding induces senescence. (F) SETDB1 involvement in RNA-mediated 
silencing is also described. Essentially, agRNA-bound AGO2 binds ncRNA transcribed from promoters with the 
androgen receptor and recruits SETDB1 to tether SIN3A-HDAC1/2 complex to the neighbouring chromatin for 
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silencing. (G) KRAB-ZFP-dependent TRIM28 targeting is responsible for recruiting DNMTs to keep the levels of 
DNAme at imprinted and germline genes and for recruiting SETDB1-dependent H3K9me3. (H) Oct4 targets 
SUMOylated SETDB1 to trophoblast lineage-specific genes to restrict potential and keep pluripotent state. (I) 
SETDB1 recruits PRC2 for deposition of H3K27me3 at neuronal genes to hinder differentiation. The H3K27me3 
mark inhibits SETDB1 activity. (J) SETDB1 is recruited by TRIM28 to KRAB-ZFP target sites to prevent excessive 
CTCF binding and regulate large topological chromatin domains which are neuron-specific. (K) Master regulators of 
adipogenesis have lineage-specific DNAme downstream of their promoter in progenitor cells and the active 
H3K4me3 mark upstream. MBD1 binds this mark and recruits ATF7IP, which, in turn, recruits SETDB1 to keep a 
poised bivalent state. H3K9me3 deposition prevents binding of an early adipogenesis transcription factor. (L) MBD1-
SETDB1-ATF7IP complex act in concert with DNMT1 to perform XCI. However, the exact mechanism is not yet 
known. Regulation of several other developmental genes by SETDB1 has been suggested, however, it was not yet 
deeply investigated. Whether ATF7IP takes part in SETDB1 regulation of developmental genes is also unclear. 
2. OBJECTIVES 
The main goal of this work was to further characterize the function of ATF7IP as a cofactor of 
SETDB1 and how their interaction influences the methyltransferase activity of the latter in a 
cellular context representing the early developmental stage in mouse. The motivation to study the 
mechanisms of SETDB1-dependent repression were the indications of its role in regulating 
development. Besides that, its relationship with cancer and disease turns it into an attractive topic 
to gather knowledge which may increase opportunities for the development of future therapeutic 
strategies. The choice of the early development was due to the implications of this protein in 
maintenance of pluripotency and fate decisions. As mouse embryonic stem cells closely resemble 
this developmental stage, they were adopted as model system. To make this general goal feasible 
to address, the approach was to subset it in three more specific aims as follows: 
- Characterize the roles of ATF7IP in embryonic stem cells and contrast it with what has been 
described for SETDB1. For that, the idea was to study the phenotype rising from the deletion of 
the gene coding for this protein by investigating the genome-wide transcriptional changes and the 
impact of its loss on differentiation. To compare it with the phenotype of SETDB1 depletion, 
publicly available datasets were reanalyzed. 
- Determine the functional targets of the complex formed by SETDB1 and ATF7IP in embryonic 
stem cells. Functional targets were defined as genomic elements which are physically bound by 
this complex and have their epigenetic landscape primarily regulated by the activity of this 
complex to induce transcriptional repression. To this end, it was crucial to discover the genome-
wide occupancy of both proteins as well as to figure out the consequences of ATF7IP loss to the 
genome-wide enrichment of different repressive and active histone 3 lysine 9 modifications. 
- Identify the context where the SETDB1-ATF7IP complex exerts epigenetic and transcriptional 
regulation to get some hints in the mechanisms of action. In order to achieve that, the plan was 
to assess for the occurrence of genetic interaction between Atf7ip and other genes which may be 
acting in concert by using a silencing reporter assay. The genes analyzed would be based on the 
identification of putative protein partners of ATF7IP and other proteins involved in 
heterochromatin formation.  
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3. RESULTS 
3.1. Generation of Atf7ip knockout mESC 
The aim to understand the implications of ATF7IP on SETDB1 methyltranferase activity during 
early stages of embryonic development was first approached by reverse genetics. The Atf7ip 
locus was targeted for knockout by the CRISPR/Cas system, using a pair of sgRNA (Figure 3.1A). 
This system induces DNA double strand breaks that are later on repaired often by the non-
homologous end-joining (NHEJ) repair machinery (Popp and Maquat, 2016) and leads to nucleic 
acid insertions or deletions at the damaged site. If the open reading frame changes, a premature 
stop codon rises from the frameshift mutated transcript to generate a truncated version of the 
protein. However, this type of mutation signals to the nonsense-mediated mRNA decay pathway 
to degrade these transcripts before they have the chance to be translated. In independent 
experiments, three Atf7ip KO mESC lines were generated, together with their respective control 
lines (Figure 3.1B). Isogenic population containing the same type of mutation were obtained by 
picking single clones and expanding them. 
Mutants were primarily screened by PCR using a pair of primers flanking the target site (Figure 
3.1C). A second step for the screening was to verify the absence of protein (Figure 3.1C).  The 
identification of ATF7IP by western blot showed an interesting pattern of several bands with higher 
molecular weight than the predicted one. To make sure that those were not unspecific signals 
and to validate the commercial antibody (Ab) used, Atf7ip was depleted in mESC by two different 
short hairpin RNA (shRNA) separately. The shRNA expression vectors were packaged inside 
lentiviral particles used for delivery by transduction. In this way, cells integrated the shRNA-
expressing construct and were permanently expressing it to keep a constant knockdown. Nuclear 
protein extracts probed with this Ab in western blot showed reduction of the signal of all the bands 
detected, proving its specificity (Figure 3.1D). Three control and three knockout clones showing 
complete loss of the ATF7IP were obtained (Figure 3.1E). The sequence of the locus in the 
mutants was verified by Sanger sequencing. For the first knockout cell line, several PCR products 
were cloned individually and sequenced to cover the sequence of both alleles (Figure 3.1F). 
Indeed, a nonsense mutation was produced, leading to loss of ATF7IP expression. 
Figure 3.1 | Generation of Atf7ip knockout mESC. 
(A) Region of the exon 2 of Atf7ip targeted by the sgRNA pair (purple). The PAM sequence recognized by the Cas9 
is indicated (blue), along with the sites where double strand breaks are generated (blue arrows). (B) Experimental 
design for knocking out Atf7ip in mESC. Three control clones and three mutant ones were obtained. (C) UV-exposed 
agarose gel where the genotyping PCR products were separated to identify control and knockout clones. The first 
lane is the DNA ladder and is followed by a control sample and 14 knockout candidates. Below it is the digital image 
of the membranes used for blotting the nuclear extracts of the candidates after separation by SDS-PAGE. The 
membranes were probed with Ab against different ATF7IP and SUZ12 was used as loading control. Not all clones 
showed deletion of the target region even though the protein was absent. (D) Similar to the lower panel in C, but for 
the 6 selected clones alone. (E) Sanger sequencing of the cloned PCR products spanning the Atf7ip target site of 
the first mutant clone (ko25-1). Each clone represents one separate PCR product. The newly introduced premature 
termination codon is indicated in pink (F) Digital image of the membranes used for blotting the SDS-PAGE-separated 
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nuclear extracts of Atf7ip-depleted mESC after shRNA transduction. The membranes were probed with Ab against 
ATF7IP and exposed shortly and for a longer time. SUZ12 was used as loading control. 
 
3.2. Loss of ATF7IP does not lead to changes in global H3K9me levels 
Although loss of Setdb1 leads to a severe phenotype, which is lethal for mESC (Chapter 
1.5.a Embryonic stages), deletion of Atf7ip was not enough to lead to cell death in this system. 
Growth curves carried out by the laboratory technician Alexander Nuber, whose work supported 
this project, showed that these mutant cell lines behave similarly to control mESC in terms of 
growth (Nuber, Diploma thesis, 2017). Furthermore, cell cycle analysis via BrdU incorporation in 
newly synthesized DNA combined with staining of total DNA by propidium iodide, revealed no 
differences compared to control cells regarding progression through the distinct cell cycle phases. 
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In several cell types ATF7IP displays nuclear localization (Chapter 1.9.b Expression and 
localization), what is consistent with an interplay with SETDB1, a protein also present in the 
nucleus (Chapter 1.4.b Expression and localization patterns). Analysis of protein extracts from 
nuclear and cytoplasmic fractions indicated that the majority of ATF7IP peptides are retained in 
the nucleus of mESC (Figure 3.2), even though a portion still remains in the cytoplasm. 
Intriguingly, it seems that the post-translationally modified versions of this protein localize 
preferentially to the nuclear fraction. Whether one requires the other for the proper nuclear 
localization in mESC is still unclear. However, this is an unlikely situation as lack of nuclear 
SETDB1 would lead to cell death and contradicts the fact that the cells survive Atf7ip deletion. 
 
Figure 3.2 | Loss of ATF7IP does not lead to changes in global H3K9me levels. 
(A) Digitalization of the membranes used for blotting the protein extracts of nuclear and cytoplasmic fractions of wild 
type and Atf7ip ko mESC after being resolved in SDS-PAGE. Samples were loaded in 4-fold dilutions as indicated 
on top. Membranes were probed with Ab against ATF7IP. Anti-SUZ12 and anti-α-TUBULIN Ab were used as loading 
control for nuclear and cytoplasmic extracts, respectively. (B) Digital image of the membrane used for blotting the 
acid extracts of nuclear histones from wild type and Atf7ip ko mESC after SDS-PAGE separation. Membranes were 
probed with Ab specifically recognizing H3K9 epitopes containing each of the modifications. H3 was used as loading 
control. Samples were loaded in 5-fold dilutions as indicated. 
As SETDB1 methyltransferase activity was shown to be influenced by ATF7IP in vitro (Chapter 
1.10 Regulation of SETDB1 catalytic activity by ATF7IP) the first step towards understanding the 
impact of the latter on the enzymatic activity of the former was to characterize the total levels of 
the different H3K9 marks. Histones were purified from wild type and Atf7ip knockout mESC by 
acid extraction. The levels of histone H3 and of the three methylation states of its lysine 9 were 
Results  33 
 
quantified by Western blot using antibodies with high specificity for those marks and which did 
not exhibit cross reactivity to other marks (Hayashi-Takanaka et al., 2011). The total amount of 
histone H3 was unchanged between both samples. The same was true for the three H3K9me 
marks, indicating that if there is any alteration of SETDB1 activity due ATF7IP loss it does not 
largely affect global deposition of those modifications. This is consistent with the fact of SETDB1 
not being regarded as responsible for the bulk H3K9me3 (Chapter 1.5.a Embryonic stages). 
3.3. Transposable elements lose repression following ATF7IP deletion 
In mESC the maintenance of repressed stated at ERV classes I and II is strictly dependent on 
SETDB1 enzymatic activity (Chapter 1.7 Repression of transposable elements). ATF7IP was 
found between the proteins which might assist SETDB1 in this task, as depletion by knockdown 
also led to upregulation of similar TE families (Chapter 1.10 Regulation of SETDB1 catalytic 
activity by ATF7IP). To test whether stable Atf7ip knockout cell lines lose proper control of 
transcriptional repression at those regions, TE transcript levels were quantified by reverse 
transcription quantitative PCR (RT-qPCR). Primers were designed based on consensus 
sequences for each ERV family, in order to amplify the majority of its elements. In consonance 
with previous findings, stable Atf7ip knockout cell lines showed impaired silencing of ERV class 
II, specially of MusD elements (Figure 3.3A). However, class I ERV did not become derepressed. 
Class III family MERVL did not show impairment as expected, considering that SETDB1 has no 
activity towards those elements. 
 To make sure mutant mESC did not lose the characteristic pluripotent state the expression 
levels of embryonic stem cell marker genes were assessed. The mutants showed comparable 
levels of three marker genes tested, except for one of them which exhibited rather higher 
transcriptional levels (Figure 3.3B). Besides that, the colonies display a round-shaped 
morphology, typical of this cell type (data not shown). Thus, the pluripotent state seems unaltered 
 
Figure 3.3 | Transposable elements lose repression following ATF7IP deletion. 
(A) Expression levels of different TE families, members of ERV classes I (MLV and VL30), II (IAP, MusD and 
ERVK10C) and III (MERVL), in Atf7ip knockout mESC lines relative to control samples. For each replicate, 
expression was normalized by that of Gapdh and Hprt. The red dotted line indicates the level correspondent to no 
changes. (B) Similar to A, but for Atf7ip and a set of marker genes for embryonic stem cell pluripotent state. 
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in mESC lacking ATF7IP, differently from what is seen for SETB1 loss, where mESC that survive 
shortly the depletion tend to differentiate (Chapter 1.5.a Embryonic stages). Reduction of Atf7ip 
transcripts was also confirmed and is probably due to activity of the mRNA decay pathway. 
3.4. Silencing kinetics of an exogenous IAPEz reporter is impaired by ATF7IP deletion 
An internal fragment of the gag region from the IAPEz clade of TE containing around 160 bp 
is the minimal fragment required for recruitment of H3K9me3-dependent silencing through the 
TRIM28-SETDB1 pathway (Sadic et al., 2015). To understand the implications of ATF7IP on the 
silencing mechanism which acts upon this sequence, a reporter assay for exogenous TE silencing 
was carried out as previously described. Basically, this assay consists in delivering two reporter 
sequences by lentiviral transduction. The vector containing the enhanced green fluorescent 
protein (EGFP) controls for the virus titer (control), indicating the total amount of cells that are 
infected in the experiment. The second one is similar to the first, but the internal gag fragment is 
placed nearby the promoter (test) and is used for measuring the amount of cells able to use this 
fragment as a signal to repress transcription (Figure 3.4A). Each of these reporters are introduced 
in parallel in two batches of cells. Finally, the amount of EGFP-positive (EGFP+) cells in the test 
batch is measured by flow cytometry and is compared to the total EGFP+ cells captured in the 
control batch, giving the percentage of cells infected with the test reporter which remains EGFP+ 
(Figure 3.4F - second transduction step). 
First of all, the results should be normalized by the total quantity of infective particles from each 
reporter. For that, the viral titer of both control and test viruses were measured (Figure 3.4B) in 
HeLa cells, where neither the control nor the test reporter sequences can be repressed. After 
that, two standardization procedures were carried out. In the first one, different viral titers were 
used to infect mESC to find out the minimum titer that leads to robust results (Figure 3.4C). In the 
second, a curve for the efficiency of infection of different starting amount of cells was obtained to 
identify the minimum cell number that needs to be seeded for getting replicable results (Figure 
3.4D). To test the requirement of ATF7IP for the silencing of this gag sequence, knockout mESC 
lines were submitted to this reporter assay. While the control cells are able to rapidly silence the 
newly integrated gag reporter after lentiviral transduction, the mutant cells failed to do so and 
displayed a much slower kinetics of repression (Figure 3.4E). 
To preclude the interference of possible variability between infection rates from control and 
knockout cell lines, the reporter assay was carried out on cells where Atf7ip was freshly knocked 
out. For that purpose, sgRNA targeting different portions of the Atf7ip locus were expressed 
separately in a mESC line constitutively expressing the Cas9 (Figure 3.4F). After that, those cells 
were used in the IAPEz-gag fragment reporter assay (Figure 3.4G). Several of the sgRNA led to 
impairment of silencing to levels similar to the one seen for the positive control Daxx, which was 
previously linked to this repression (Sadic et al., 2015). As the ATF7IP paralog ATF7IP2 was able 
to partially rescue MBD1-dependent repression (Chapter 1.10 Regulation of SETDB1 catalytic 
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activity by ATF7IP), its relevance for the gag fragment silencing was also addressed. However, 
no alteration of the repression was observed using sgRNA targeting different regions of this gene. 
Thus, ATF7IP, but not ATF7IP2, is involved in the SETDB1-dependent repression of exogenous 
TE coming from the IAPEz subfamily. 
 
Figure 3.4 | Silencing kinetics of an exogenous IAPEz reporter is impaired by ATF7IP deletion. 
(A) Diagram illustrating the control and test constructs for the IAPEz-gag fragment reporter assay, measured by 
EGFP expression driven by a promoter with strong activity in mESC. (B) Titration in HeLa cells of the viruses carrying 
either the control or the test construct. During viral production, two harvests were performed: one at 30 h and another 
at 60 h after co-transfection of HEK293T cells with packaging vectors and the reporter constructs. (C) Effect of the 
amount of viruses used for mESC transduction on the replicability of the experiment. (D) Effect of the amount of 
starting cell number on the robustness of the results. (E) Relative percentage of remaining EGFP+ cells after the gag 
fragment reporter assay in wild type and Atf7ip KO cells. (F) Experimental design for acutely knocking out Atf7ip in 
mESC. Cells constitutively expressing Cas9 were transduced with lentiviruses carrying a sgRNA expression 
construct. After antibiotics selection, and culture expansion, cells were divided in two batches to be transduced 
separately with the control and test reporter sequences. (G) Relative percentage of remaining EGFP+ cells after the 
gag fragment reporter assay in Cas9+ mESC transduced with sgRNA targeting different portions of either Atf7ip or 
Atf7ip2. An empty vector and a vector expressing a sgRNA targeting a non-related sequence were used as negative 
controls. A sgRNA targeting Daxx was used as positive control. 
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3.5. ATF7IP is not essential for in vitro differentiation in mESC 
As the pluripotent state was kept in mESC lines not expressing ATF7IP, the ability to 
differentiate into the three germ layers was assessed. It could be the case that this protein is 
dispensable for the steady state of mESC, despite being required for the dynamic changes which 
take place during differentiation. To test that, mutant and control cells were triggered to form 
embryoid bodies (EB) by removing the leukemia inhibitor factor (LIF) from the medium and 
proceeding with the hanging drop method. With that, cells are stimulated to differentiate towards 
cell lineages from any of the three germ layers. Transcript levels were measured by RT-qPCR at 
the initial time point before differentiation was triggered and at days 5 and 10 after differentiation. 
Similarly to what was observed in control mESC, Atf7ip ko cells displayed gradual decrease of 
the pluripotency marker genes over time of EB formation (Figure 3.5A). Even though the process 
was slower than in the control samples, expression in mutants reached levels comparable to 
control at day 10. Regarding mesoderm-related genes, their expression in mutants also followed 
the same trend seen in the reference samples (Figure 3.5B). Of note, the gene Nodal is already 
expressed in the pluripotent state, because of its involvement in early embryonic development. 
Finally, the late differentiation genes implicated in either endoderm or ectoderm development 
showed no changes between knockout and control cells (Figure 3.5C). Hence, the dynamic 
changes of stage-specific gene expression are independent of the expression of Atf7ip. 
Not only transcription of genes but also of TE is targeted for differential regulation during 
development (Chapter 1.7 Repression of transposable elements). Their activity is directly 
involved in controlling tissue-specific regulatory networks, as they may act as transcriptional 
enhancers (Xie et al., 2013; Garcia-Perez et al., 2016). To verify whether loss of ATF7IP would 
impair the regulation of specific ERV families, the changes in their transcription was followed 
along the EB differentiation. In normal situation, members of all three ERV classes remain not 
altered during the onset of differentiation (Figure 3.5D). This picture changes at later stages, when 
their expression gets enhanced, with some of them showing stronger activation like the IAP 
elements. On the other hand, mutant mESC exhibit the opposite behavior, as ERV which are 
initially upregulated during mESC stage tend to get repressed, while the transcription of the others 
is reactivated to a lower extent or does not show any alteration. This indicates that TE repression 
becomes independent of ATF7IP at later stages of differentiation. Besides that, the alteration of 
the epigenetic landscape at those regions might signal for their repression in differentiated cells 
by the respective mechanism governing at that stage. 
Interestingly, Atf7ip expression is gradually stimulated upon differentiation (Figure 3.5E), 
indicating some importance during differentiation, even though mutant cells are capable of 
forming late stages EB. Indeed, presence of ATF7IP is correlated with the maintenance of proper 
levels of expression at least at the imprinted gene H19, as Atf7ip ko mESC showed stronger 
activation of transcription at this locus during differentiation into EB (Figure 3.5F). 
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Figure 3.5 | ATF7IP is not essential for in vitro differentiation in mESC. 
(A) Expression levels of different marker genes for pluripotency during the time course of differentiation into EB, in 
Atf7ip knockout mESC lines and control samples relative to the latter at day 0, before differentiation was triggered. 
For each replicate, expression was normalized by that of Gapdh and Hprt. The red dotted line indicates the level 
correspondent to no changes. (B) Same as in A, but the expression of genes marker for the mesoderm state were 
analyzed and normalized to control samples at day 5, when cells reach this state. (C) Same as in A, but for endoderm 
marker genes and an ectoderm marker (Reep6) normalized to control samples at day 10, when cells reach later 
stages of differentiation. (D) Same as in A, but for distinct ERV from classes I (MLV and VL30), II (IAP, MusD and 
ERVK10C) and III (MERVL). (E) Same as in A, but levels of Atf7ip expression were analyzed instead. (F) Same as 
in A, but for the imprinted gene H19. Note that the scales are different between each of the days of differentiation, 
as the levels of expression become much higher than the previous time point. 
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3.6. Developmental genes are misregulated in Atf7ip-depleted mESC 
The derepression of some ERV families following Atf7ip depletion in mESC as measured by 
RT-qPCR (Chapter 3.3 Transposable elements lose repression following ATF7IP deletion) 
indicated the possibility of global changes in gene expression. To unravel the genome-wide 
changes in transcription, rRNA-depleted total RNA isolated from 3 biological replicates of control 
and Atf7ip KO mESC were quantified by RNA high-throughput sequencing (RNA-Seq). From the 
228 significantly misregulated genes around half showed increased expression in mutants (Figure 
3.6A). Comparison to published RNA-Seq datasets for Setdb1 KO mESC and its respective 
control cell line (Karimi et al., 2011) indicated a more severe phenotype when SETDB1 is lost 
(Figure 3.6B), consistent with the fact that these cells do no survive long (Chapter 
1.5.a Embryonic stages). However, several of the genes showing expression changes in Atf7ip 
KO cells overlapped with those misregulated after SETDB1 loss (Figure 3.6C). The up- and 
downregulated gene sets in both Atf7ip- and Setdb1-depleted cells were enriched for biological 
process gene ontology (GO) terms related to development and differentiation, especially within 
the downregulated ones (Figure 3.6D). Hence, development-related genes may be regulated by 
a joint effort of both proteins. Unexpectedly, these results indicate that the presence of the 
complex SETDB1-ATF7IP might be involved in hindering further repression of those genes, as 
they undergo downregulation when either protein is depleted in mESC. 
 
Figure 3.6 | Developmental genes are misregulated in Atf7ip-depleted mESC. 
(A) Correlation of the expression levels (given by RPKM) of all protein-coding UCSC genes between Atf7ip KO mESC 
and control cells. Average of three biological replicates is plotted. Up- and down-regulated genes with more than 
two-fold changes are highlighted. (B) As in A, but for Setdb1 KO mESC versus its control cell line. The raw data was 
previously published (Karimi et al., 2011) and only one replicate was available. (C) Scaled Venn diagram representing 
the overlap of upregulated (in the left) and downregulated genes (in the right) across Atf7ip and Setdb1 knockout 
mESC. (D) GO term enrichment analysis for biological processes of up- and downregulated genes (upper and lower 
panels respectively) in either Atf7ip or Setdb1 mutant cells. Shown is the probability based on the p-value. The 
number on top of each bar indicates the amount of genes fitting the specific GO term for each mutant. 




3.7. TE families derepressed overlap in mESC lacking ATF7IP or SETDB1 
The global transcription profiles of Atf7ip KO mESC were generated using paired-end reads, 
which results in a better mappability of the reads to the reference genome as it increases the 
number of uniquely assigned reads (Corley et al., 2017). With these data in hand, the differential 
expression of all annotated repeats defined in the University of California Santa Cruz (UCSC) 
genome browser were assessed. Several TE families exhibited expression in Atf7ip-deleted cells 
higher than 2-fold over the control samples (Figure 3.7A). Similarly to what was seen for 
transcription at coding genes (Chapter 3.6 Developmental genes are misregulated in Atf7ip-
depleted mESC), the misregulation of repetitive regions in Setdb1 mutant cells was stronger, with 
five times as many families being derepressed (Figure 3.7B). Nonetheless, the majority of the 
upregulated families following Atf7ip deletion overlaps with the misregulated ones in Setdb1-
deleted mESC (Figure 3.7C). Consistent with the RT-qPCR data (Chapter 3.3 Transposable 
elements lose repression following ATF7IP deletion), the classes of TE identified as derepressed 
in Atf7ip or Setdb1 mutants or in both at the same time are mainly ERV from classes I and II 
(Figure 3.7D). 
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Figure 3.7 | TE families derepressed overlap in mESC lacking ATF7IP or SETDB1. 
(A) Correlation of the expression levels (given by RPKM) of all families of TE as defined by the UCSC database 
between Atf7ip KO mESC and control cells. Average of three biological replicates is plotted. Up- and down-regulated 
families with expression higher or lower than two-fold over the control are highlighted. (B) As in A, but for Setdb1 KO 
mESC versus its control cell line. The raw data was previously published (Karimi et al., 2011) and only one replicate 
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was available. (C) Scaled Venn diagram representing the overlap of derepressed TE families across Atf7ip and 
Setdb1 knockout mESC. (D) Percentage of families of different TE classes which become upregulated in either Atf7ip 
or Setdb1 mutants. The total number of families composing each of the classes depicted are shown on the top of 
their respective bar. (E) Correlation of the expression levels (given by RPKM) of all individual elements belonging to 
the indicated TE subfamilies as annotated in the UCSC database between Atf7ip KO and control mESC. Average 
expression of the three biological replicates is plotted. Dashed lines are drawn at the threshold of two-fold (upper) or 
half-fold (lower) expression. (F) As in E, but for Setdb1 KO mESC versus its control cell line using the sole replicates 
available in the published raw data (Karimi et al., 2011). (G) Percentage of individual elements which are upregulated 
in either Atf7ip or Setdb1 KO cells. The total amount of loci forming each of the subfamilies depicted are shown on 
the top of their respective bar. 
The reads were then mapped to individual elements composing each of the subfamilies MLV, 
VL30, ETn, IAPEz, MERVL and LINE-L1 (Figure 3.7E). While in SETDB1-depleted cells most 
IAPEz and ETn elements were derepressed (Figure 3.7F), in ATF7IP-depleted cells they were 
only in part upregulated (Figure 3.7E). On the other hand, individual MLV which also undergo 
strong reactivation in Setdb1 mutants, did not show any increase in expression in Atf7ip mutants. 
This can be easily noticed when a distribution of derepressed TE are plotted according to the 
subfamilies they belong (Figure 3.7G). Interestingly, when looking at individual repeat loci, some 
LINE-L1 and MERVL elements also showed upregulation in both mutant types. Whether this is a 
direct effect of The SETDB1-ATF7IP complex requires the investigation of their binding sites, 
which is going to be discussed later, even though SETDB1 activity on those sites was not 
appreciated in previous works (Chapter 1.7 Repression of transposable elements). 
3.8. mESC partially adapt to the loss of ATF7IP 
The mild changes in the transcriptome of Atf7ip KO mESC in comparison to control cells can 
also be observed by principal component analysis (PCA). The first component, based on 
differences which cover 50 % of the variance between all the samples, distinguishes well the 
mutant cell lines from the control group (Figure 3.8A). On the other hand, the second component, 
which represents 30 % of the variance, is not consistent in grouping the mutant genotype away 
from the control. A reason for this might be that the several passages required for isolation and 
expansion of clones originating from single colonies gives enough time for the cells to adapt to 
the knockout condition. 
To test the hypothesis of adaptation to the knockout condition in Atf7ip mutants, transcription 
levels were measured by RT-qPCR in wild type mESC few days after deletion of the gene. This 
constitutes an acute knockout situation, where one can capture the very early responses. 
Expression of different subfamilies of ERV classes I, II and III were analyzed at days 0, 2 and 4 
after knockout induction (Figure 3.8B). Knockout of Dnmt1 was performed as a positive control, 
as it was shown previously that its deletion in mESC leads to upregulation of TE early after 
induction of knockout, while they become repressed again at later time points (Sharif et al., 2016). 
Consistently, similar derepression was observed in the present experiment. 
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Figure 3.8 | mESC partially adapt to the loss of ATF7IP. 
(A) PCA projection of control and Atf7ip knockout stable cell lines. Each dot represents the dataset originating from 
one sample. (B) Expression levels of different TE subfamilies during the time course of acute knockout induction via 
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CRISPR/Cas9, relative to non-transfected samples at day 0. Dnmt1 was used as a positive control for reactivation 
of TE. For each replicate, expression was normalized by that of Gapdh and Hprt. The red dotted line marks the level 
where no changes are observed. (C) Same as in B, but for the expression of the genes targeted by sgRNA in the 
experiment in B. Expression of Oct4 was verified as a means to assess whether the cells still kept the pluripotent 
state. (D) Re-plotting of the data shown in B for the sgControl and the sgAtf7ip with higher efficiency and for the data 
presented in (Figure 3.3), to compare side by side the differences between TE derepression in stable knockout cell 
lines and acutely deleted pool of cells. (E) Correlation of the expression levels (given by RPKM) of all protein-coding 
UCSC genes between mESC expressing shRNA to knockdown Atf7ip and cells expressing a control shRNA. Up- 
and down-regulated genes with more than two-fold changes are highlighted. The raw data was previously published 
(Yang et al., 2015) and only one replicate was available. (F) Same as in E, but for TE families. (G) Scaled Venn 
diagram depicting the overlap of derepressed TE families across Atf7ip knockdown and Setdb1 knockout mESC. 
Acute deletion of Atf7ip also led to upregulation of some TE subfamilies, namely MusD and 
ERVK10C, even though IAP elements did not show increased expression as seen for Dnmt1 KO. 
Expression of the genes targeted for deletion were also verified and displayed reduction over time 
in the respective knockouts (Figure 3.8C). Levels of Oct4 transcripts remained similar during the 
course of the experiment, indicating that cells were not affected by loss of pluripotency. Of note, 
deletion of Dnmt1 led to gradual increase in Atf7ip expression levels over time (Figure 3.8D). 
The impact in the whole transcriptome of an acute depletion of ATF7IP was investigated using 
readily available data previously published, where knockdown was achieved by shRNA 
expression (Yang et al., 2015). As expected, many more genes were dysregulalted (Figure 3.8E) 
when compared to the knockout cell lines (Figure 3.6A). Similar effect was observed for the 
number of derepressed TE families (Figure 3.8F), which was also higher than the amount of 
derepression in stable knockout cell lines (Figure 3.7A). When contrasted with the families 
upregulated in SETDB1 knockout mESC, a larger overlap was observed (Figure 3.8G). Thus, 
cells are able to cope with Atf7ip deletion in the long term and manage to partially contain the 
reactivation of several TE and genes. To achieve this adaptation, they probably take advantage 
of other silencing mechanisms which act in parallel, though independently of the pathway 
involving ATF7IP. 
3.9. Loss of DNA methylation further enhances Atf7ip knockout phenotype 
The DNAme pathway is known to act as a second layer of silencing over some TE families in 
mESC, specially of IAPEz, which display enhanced derepression when deletion of Setdb1 is 
combined with that of Dnmt1 (Chapter 1.7 Repression of transposable elements). Treatment of 
mESC with the two inhibitors (2i) of MEK and GSK3β maintains cells in a naive ground state by 
reducing global DNAme (Sim et al., 2017). Addition of vitamin C (vitC) to the growth medium 
promotes Tet activity of DNA demethylation enhancing loss of DNAme and inducing a blastocyst-
like state with effects beyond those obtained with 2i (Blaschke et al., 2013). TE repression is 
ensured by SETDB1-dependent H3K9me3 and PcG-mediated H3K27me3 deposition after the 
intense loss of DNAme (Walter et al., 2016). To investigate the roles of SETDB1-ATF7IP complex 
while precluding the influence of silencing by DNAme, control and Atf7ip mutant mESC were 
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transferred to 2i medium complemented with vitC (2i+vitC) for induction of global DNAme 
reduction. Transcript levels were quantified by RT-qPCR at early and late time points. 
After 14 days of culture in 2i+vitC Oct4 expression showed some decrease in expression, while 
Nanog became upregulated (Figure 3.9A). Interestingly, expression changes for Oct4 and Rex2 
over the course of the experiment were similar between control and mutant samples. However, 
Nanog transcriptional levels at the last time point, which were higher in control cells, exhibited an 
opposite behavior in cells lacking ATF7IP. As expected, some of the TE groups underwent 
activation during early time points, though they got repressed at the latest point, with the exception 
of MusD, which could not be reach down to the initial levels (Figure 3.9B). Besides MLV, all the 
TE families tested suffered enhanced derepression in the mutant when compared to the kinetics 
in the control samples. Contrasting to the reduction of expression at the latest time point in the 
control cells to levels similar to the initial ones, all TE reached the end of the experiment with 
transcriptional levels higher than the initial ones in the mutants. MusD elements were again the 
exception and showed opposite effects, with expression at the latest time point lower than the 
one measured before transferring the cells to 2i+vitC. 
 
Figure 3.9 | Loss of DNA methylation further enhances Atf7ip knockout phenotype. 
(A) Expression levels relative to control day 0 of different pluripotency marker genes during the time course after 
transferring Atf7ip knockout mESC lines and control samples to medium containing 2i complemented with vitamin C. 
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For each replicate, expression was normalized by the geometric mean of Gapdh and Hprt. The red dotted line 
indicates the level correspondent to no changes. (B) Same as in A, but for distinct ERV from classes I (MLV and 
VL30), II (IAP, MusD and ERVK10C) and III (MERVL). (C) Same as in A, but levels of expression of the imprinted 
gene H19 were analyzed instead. (D) Same as in A, but for Atf7ip. 
Regarding the imprinted gene H19, the long exposure to 2i+vitC medium led to strong and 
stable derepression of this gene, but only in the Atf7ip mutant mESC (Figure 3.9C). Of note, Atf7ip 
expression increases during the beginning of DNAme loss, probably as a positive feedback of a 
synergic pathway with the aim to counter the effects of DNA demethylation and prevent 
transcriptional derepression (Figure 3.9D). This result is consistent with the one observed right 
after deletion of Dntm1 in mESC (Chapter 3.8 mESC partially adapt to the loss of ATF7IP), where 
Atf7ip exhibited similar upregulation. 
3.10. mESC are more prone to differentiate when lacking both ATF7IP and DNA methylation 
As the DNAme mechanisms somehow lessen the effects of Atf7ip deletion in mESC over time, 
the impact in differentiation of ATF7IP deletion coupled to global loss of DNAme was investigated. 
For that, cells grown for several passages in 2i+vitC were used in EB formation assay. 
Transcription levels were measured by RT-qPCR at days 0, 5 and 10 after induction of 
differentiation. When compared to differentiation of primed cells grown in medium containing only 
LIF (Chapter 3.5 ATF7IP is not essential for in vitro differentiation in mESC), control cells with 
depleted DNAme took longer to partially lose pluripotency as measured by the expression of a 
few marker genes, even though Oct4 expression did not reduce (Figure 3.10A). However, genes 
involved in mesoderm formation were already expressed at levels similar to the ones seen at day 
5, when they were supposed to have the peak of transcription (Figure 3.10B). Besides that, these 
genes did not undergo differential regulation of expression over time during differentiation. Similar 
trend was observed for the endoderm gene CD55 and the ectoderm marker Reep6, which were 
already expressed in stem cell stage (Figure 3.10C). On the other hand, the other two endoderm-
related genes tested became upregulated only in the last time point analyzed, similar to what 
happens to the primed cells in LIF. 
In the case of the Atf7ip KO cells, depletion of DNAme seemed to facilitate the differentiation 
into EB. In the first 5 days, transcription of pluripotency genes was already strongly downregulated 
(Figure 3.10A). Marker genes for endoderm, but not for ectoderm, were induced very early and 
at high levels (Figure 3.10C), even when compared to what is seen for control and mutant cells 
with normal DNAme levels in LIF medium (Figure 3.5C). Also unexpected was the reduction of 
their expression at later stage of EB differentiation, which was concomitant with the increase in 
transcription of some of the mesoderm genes later than normal (Figure 3.10B). 
In control cells, which presented reactivation of TE at day 10 of EB formation when coming 
from medium with LIF only (Figure 3.5D), depletion of DNAme led to an anticipation of this 
reactivation to day 5 (Figure 3.10D). In contrast to what happens with Atf7ip KO cells in the primed 
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state, where TE expression is either reduced or unchanged, mutant cells in 2i+vitC-induced naïve 
state lacking proper DNAme lost repressive control over these regions and most of the ERV 
families tested became upregulated already in the first 5 days of differentiation. The only 
exception were the MusD elements, which rather showed some decrease in transcription. 
 
Figure 3.10 | mESC are more prone to differentiate when lacking both ATF7IP and DNA methylation.  
(A) Expression levels of different genes involved in pluripotency during the time course of differentiation into EB in 
Atf7ip knockout mESC lines and control samples grown for several passages in medium containing 2i and vitamin C 
to reduce global DNAme levels. The values shown are relative to the control cells at day 0, before triggering 
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differentiation. In each replicate, expression was normalized to Gapdh and Hprt. The red dotted line indicates the 
level correspondent to no changes. (B) Same as in A, but the transcription of genes marker for the mesoderm state 
were assessed and normalized to control samples at day 5, when cells reach this state. (C) Same as in A, but for 
endoderm-related genes and an ectoderm marker (Reep6) normalized to control samples at day 10, when cells reach 
later stages of differentiation. (D) Same as in A, but for distinct ERV from classes I (MLV and VL30), II (IAP, MusD 
and ERVK10C) and III (MERVL). (E) Same as in A, but transcriptional levels of Atf7ip were analyzed. (F) Same as 
in A, but for the imprinted gene H19. Note the different scales between both plots, as the upregulation is much 
stronger in mutant samples. 
Regarding Atf7ip expression, instead of gradually increasing over time it showed strong 
downregulation at day 5, while an opposite trend was observed in the knockout mutants (Figure 
3.10E). The imprinted gene H19 became upregulated, although not as strong as in the primed 
control cells containing DNAme (Figure 3.10F). Even though primed Atf7ip KO mESC showed 
gradual increase in expression of this gene achieving very high levels at day 10, removal of 
DNAme prior to induction of differentiation in EB enhanced this effect and led to an extremely 
strong upregulation already at day 5 Altogether, these results indicate that there is a crosstalk 
between DNAme and SETDB1-ATF7IP complex in regulating genes and TE expression changes 
during differentiation. Furthermore, ATF7IP seems to be required for proper transcriptional 
regulation in the context of development when DNAme is depleted in mESC, suggesting an 
important role for the SETDB1-ATF7IP complex during very early stages of embryonic 
development (pre-implantation embryo) marked by global erasure of DNAme (Atlasi and 
Stunnenberg, 2017). 
3.11. ATF7IP is involved in SETDB1-dependent TE repression in primary MEF 
The fact that SETDB1 knockout embryos do not survive and die very early during the pre-
implantation period indicates its fundamental roles in embryonic development (Chapter 
1.5.a Embryonic stages). As an important interactor and cofactor of SETDB1 catalytic activity, 
ATF7IP might also play a role during these early developmental stages as it is indicated by the 
impairment in transcription regulation in the absence of ATF7IP and DNAme (Chapter 3.10 mESC 
are more prone to differentiate when lacking both ATF7IP and DNA methylation). Some of the 
results obtained by the laboratory technician Alexander Nuber support the idea that ATF7IP 
functions with SETDB1 during early embryonic development. In summary, he showed that in 
crosses between heterozygous Atf7ip knockout adults, no homozygous mutants puppets were 
born. Furthermore, homozygous mutants could only be observed until blastocyst stage and they 
already did not reach Mendelian rate (Nuber, Diploma thesis, 2017) indicating a phenotype as 
early as in Setdb1 KO embryos. Interestingly, these mutants failed to properly form the ICM. 
All those observations suggest a role for the complex SETDB1-ATF7IP in the pluripotent stem 
cells forming the embryo. To investigate the possibility of this complex acting at the layer of cells 
giving support for the formation of the embryo proper, primary mouse embryonic fibroblasts 
(pMEF) isolated from homozygous embryos conditional knockout (cKO) for either Atf7ip 
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(Atf7ip p/p) or Setdb1 (Setdb1 p/p) were experimented. In these cells lines, the flox allele (p) can 
be efficiently deleted by transducing the cells with viruses carrying a cassette for Cre recombinase 
expression. Besides that, cells expressing this protein can be selected by an antibiotic resistance 
which is expressed in tandem with the Cre coding sequence due to the presence of an internal 
ribosome entry site (IRES). Deletion was then induced in these cKO cell by lentiviral transduction 
and expression was quantified at days 0, 6 and 12 by RT-qPCR. 
The responses regarding transcriptional changes after induction of deletion were very similar 
between both genotypes (Figure 3.11A). Basically, TE from different ERV classes became 
gradually upregulated over the course of the experiment, with the exception of the ERV class I 
MLV and the class III MERVL. Derepression of IAP was only very mild compared to others. 
Upregulation of imprinted genes were mainly seen following Atf7ip deletion in the first 6 days after 
induction, however, in cells of both genotypes these genes downregulated in the last time point 
(Figure 3.11B). 
 
Figure 3.11 | ATF7IP is involved in SETDB1-dependent TE repression in primary MEF.  
(A) Expression levels of distinct ERV from classes I (MLV and VL30), II (IAP, MusD and ERVK10C) and III (MERVL) 
during the time course after induction of Atf7ip or Setdb1 deletion in the respective cKO pMEF relative to day 0, right 
before deletion. The flox alleles were deleted by expression of lentivirally-delivered Cre recombinase. Transduced 
cells were selected for the antibiotic resistance. Expression was normalized to that of Gapdh and Hprt. The red dotted 
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line indicates the level correspondent to no changes. (B) Same as in A, but for two imprinted genes. (C) Same as in 
A, but for the flox genes targeted for deletion in each cKO line. (D) Same as in A, but for the Cre recombinase and 
the puroR sequence relative to reference genes Gapdh and Hprt. 
When transcription of the genes targeted for deletion was analyzed in both cKO pMEF during 
induction of deletion, a positive feedback between expression of both genes was observed in the 
first 6 days (Figure 3.11C). While transcripts of one gene were reduced due to deletion, the other 
became upregulated. Such a response was expected, as similar results were observed in HeLa 
cells (Timms et al., 2016) and in mESC (Thompson et al., 2015). Of note, the turnover of Atf7ip 
transcripts seem longer than for Setdb1, as 6 days after deletion they still accounted for around 
80 % of the initial expression. Expression of Cre recombinase and the puromycin resistence 
(puroR) were confirmed (Figure 3.11D). 
3.12. Generation of FLAG-ATF7IP knockin mESC 
The interaction between SETDB1 and ATF7IP in mESC is already well defined (Chapter 
1.10 Regulation of SETDB1 catalytic activity by ATF7IP). To confirm that this interaction is not 
impaired by expression of a tagged version of SETDB1 mESC, co-immunoprecipitation (Co-IP) 
was carried out using an Ab against the FLAG epitope and nuclear extracts from a FLAG-SETDB1 
knockin (KI) mESC line previously generated (Fan, PhD Thesis, 2015). As expected, SETDB1-
ATF7IP association could be captured in this cell line (Figure 3.12A). As SETDB1 activity is 
targeted towards histone H3, the functions of this complex SETDB1-ATF7IP on transcriptional 
regulation must happen in concert with its association to chromatin. 
A way to define the genome-wide occupancy of chromatin interactors with high specificity is to 
take advantage of the FLAG tag, for which Ab with strong affinity and great specificity are 
available. As FLAG-SETDB1 KI cells were readily available, the first step to define the genomic 
binding of both proteins was to obtain a FLAG-ATF7IP KI mESC line as well. For that purpose, 
the CRISPR/Cas system was used to target the C-terminus of the Atf7ip (Figure 3.12B). During 
homology-directed repair (HDR) by the intrinsic cellular system, the FLAG-tag could be inserted 
in the target place. Two isogenic clones were isolated and expanded by Zeyang Wang, a PhD 
student from the same laboratory who helped in this specific task. Correct HDR was confirmed 
by PCR (Figure 3.12D) and Sanger sequencing of the products (Figure 3.12E). The translation of 
the tagged protein was confirmed by using nuclear protein extracts for Western blot (WB), probing 
it with a FLAG-Ab (Figure 3.12F). 
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Figure 3.12 | Generation of FLAG-ATF7IP knockin mESC. 
(A) Digital image of the membrane used for blotting the FLAG Co-IP material of FLAG-SETDB1 KI mESC nuclear 
extracts after separation by SDS-PAGE. Membrane was probed with Ab against different epitopes and LAMIN B1 
was used as a control for non-specific binding. (B) Sequence of the C-terminal of Atf7ip locus indicating the stop 
codon (pink). The sgRNA sequence is also shown (purple) together with the PAM sequence (blue). The PAM is 
recognized by the Cas9, which generate double strand breaks at the region indicated with blue arrows. (C) Diagram 
of the HDR template design and of the genotyping scheme. (D) UV-exposed agarose gel to distinguish between wild 
type and knockin clones. As the PCR product are quite similar in size, a restriction enzyme site was added to the 
HDR template. (E) Sanger sequencing of the PCR products of the Atf7ip locus from two independent clones isolated 
after CRISPR knockin. The FLAG-tag (green) was correctly recombined into the locus before the endogenous stop 
codon (pink). The PAM sequence (blue) was mutated (red) to avoid cleavage of the HDR template by the Cas9. (F) 
Digital image of the membrane used for blotting nuclear extracts of the two FLAG-ATF7IP KI mESC clones after 
separation by SDS-PAGE. Membrane was probed with Ab against different epitopes and SUZ12 was used as loading 
control. FLAG-SETDB1 KI cells nuclear extract was used as positive control for the FLAG-Ab. 
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3.13. SETDB1 and ATF7IP co-occupy gene promoters and transposable elements 
With FLAG-tagged mESC lines at SETDB1 and ATF7IP loci in hand, the genomic binding of 
these two proteins was identified by chromatin immunoprecipitation (ChIP). At first, quantitative 
PCR was used to analyze the purified material (ChIP-qPCR) from Flag-Atf7ip KI mESC (Figure 
3.13A) and Flag-Setdb1 KI mESC (Figure 3.13B). As there was clear enrichment over the input 
material when compared to negative regions, chromatin immunoprecipitation followed by high 
throughput sequencing (ChIP-Seq) was carried out. Reads mapping to multiple locations were 
discarded and peaks close to the background noise from input sample were filtered out. Looking 
at all peaks ranked by the strength of their signal, three distinct clusters according to presence of 
either protein can be readily visualized (Figure 3.13C). The majority of the peaks belong to the 
cluster containing SETDB1 only. However, around one third of SETDB1 binding sites are co-
bound by ATF7IP (Figure 3.13D). Interestingly, the strength of SETDB1 occupancy increases with 
that of ATF7IP, especially at sites with the highest occupancy (Figure 3.13E). 
The three clusters were then investigated for the enrichment of biological process GO terms 
(Figure 3.13F). For this analysis, only peaks 2 kb away from an annotated gene TSS were 
included. Co-bound regions showed an enrichment for terms related to meiosis, cell cycle DNAme 
and neuronal-related processes. ATF7IP sole peaks were enriched for rRNA processing and 
transcription initiation. SETDB1 sole peaks, in turn, were associated with several terms related to 
development, especially of neurons. Using GREAT to assign peaks to genes contained in 
regulatory domains which overlap with the peak region (McLean et al., 2010), the majority of the 
sites co-bound by SETDB1 and ATF7IP were associated with two genes (Figure 3.13G). This 
indicates that the complex formed by these proteins may be involved in controlling regulatory 
domains involving multiple genes. 
When the sole and common peaks were assessed for the genomic annotation of the regions 
containing the binding sites, almost half of the co-bound regions occurred at ERV (Figure 3.13H 
- upper panel). SETDB1 sole peaks were very abundant at intra- and intergenic regions, while 
ATF7IP is bound to many promoters without the former. Of note, around half of the SETDB1-
bound promoters were also occupied by ATF7IP (Figure 3.13H - lower panel). Indeed, the closest 
SETDB1 peaks to TSS co-occurred with ATF7IP (Figure 3.13I). However, the majority of the 
peaks around the TSS were represented by ATF7IP sole peaks. Interestingly, common binding 
sites at ERV regions tended to occur closer to TSS, especially for class II elements (Figure 3.13J). 
For this analysis reads with multiple alignment were kept to avoid bias. Thus, the SETDB1-
ATF7IP complex is frequently observed at ERV elements and close by gene promoters. 
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Figure 3.13 | SETDB1 and ATF7IP co-occupy gene promoters and transposable elements. 
(A) Enrichment as percentage of input at positive (IAP and Nnat) and negative (Ptch1 and Tia1) control regions 
obtained by ChIP-qPCR using sheared chromatin of nuclear extracts from Flag-Atf7ip KI mESC. Wild type mESC 
were used as mock sample. Error bars represent standard deviation between technical replicates. (B) Enrichment 
as percentage of input at positive (IAP and H19) and negative (Ptch1 and Tia1) control regions obtained by ChIP-
qPCR using sheared chromatin of nuclear extracts from Flag-Setdb1 KI mESC. Beads not coated with Ab were used 
as mock sample. Error bars represent standard deviation between technical replicates. (C) Heatmap of binding sites 
obtained by ChIP-Seq using KI mESC lines clustered according to presence of SETDB1 or ATF7IP. The peaks were 
ordered decreasingly according to the strength of the signal. (D) Scaled Venn diagram representing the overlap 
between SETDB1 and ATF7IP binding sites. (E) Correlation between the genome coverage of ATF7IP and of 
SETDB1 of all binding sites normalized to input. (F) GO term enrichment analysis for biological processes of sole 
and common SETDB1/ATF7IP peaks. Shown is the probability based on the p-value. The number on top of each 
bar indicates the amount of genes fitting the specific GO term. (G) Number of common ATF7IP/SETDB1 peaks 
associated with putative regulation of 0, 1, 2, or 3 genes according to GREAT analysis. (H) Percentage of genomic 
annotations associated with sole and common SETDB1/ATF7IP peaks (upper panel). The lower panel shows a replot 
of the data from the upper panel to emphasize the percentage of sole or common peaks occurring at each genomic 
annotation. (I) Distribution of peak counts 2 kb around the TSS for sole and common peaks. (J) Same as in I, but for 
peaks occurring at regions containing annotation for different ERV classes in the range of 100 kb around the TSS. 
Reads with multiple alignment were included. 
3.14. Promoters and ERV bound by SETDB1-ATF7IP respond differently to Atf7ip deletion 
To associate the binding of SETDB1-ATF7IP complex to the functional activity of SETDB1 to 
deposit H3K9me3 mark, the enrichment for different H3K9 modifications were investigated in 
control mESC and compared to Atf7ip KO cell lines. SETDB1 binding sites enriched for H3K9me3 
most often co-occurred with ATF7IP (Figure 3.14A). When the co-bound regions were analyzed 
for fluctuations in the enrichment for the distinct H3K9 modifications after Atf7ip deletion almost 
no peaks showed changes in H3K9me3 deposition (Figure 3.14B). However, while H3K9me2 
tended to become increased ERV-associated peaks, promoter associated peaks displayed an 
opposite trend. H3K9ac decreased at ERV instead and increased at a few promoter regions. 
Interestingly, concomitant binding of SETDB1 and ATF7IP nearby TSS was associated with 
presence of H3K9ac and absence of the repressive H3K9me2/3 marks (Figure 3.14C). On the 
other hand, common peaks far away from the TSS were usually devoid of H3K9ac and were 
marked by H3K9me3. In general, no strong differences in behavior were observed between sole 
SETDB1 peaks and the common ones, except for H3K9me2, which became slightly more 
enriched in peaks far from an annotated TSS and H3K9ac, which was already low in control 
samples and became even lower (Figure 3.14D). Intriguingly, investigation of publicly available 
datasets (Karimi et al., 2011) showed that SETDB1 sole peaks did not undergo any changes in 
H3K9me3 levels when Setdb1 was deleted in mESC, whereas the deposition of this mark was 
strongly impaired in mutant cells at common peaks. 
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Figure 3.14 | Promoters and ERV bound by SETDB1-ATF7IP respond differently to Atf7ip deletion. 
(A) Correlation between the genome coverage of SETDB1 and H3K9me3 at all SETDB1 binding sites normalized to 
input. The color indicates whether the peak is a sole peak or co-occurs with ATF7IP. (B) Percentage of common 
SETDB1/ATF7IP binding sites which show differential deposition in H3K9 modifications according to the genomic 
annotations associated with them. (C) Coverage normalized to input material for the distinct H3K9 modifications in 
control mESC at sole and common binding sites according to the distance from the closest annotated TSS. (D) Same 
as in C, but for the fold change in Atf7ip KO cells over control mESC. (E) Fold enrichment of H3K9 modifications in 
Atf7ip KO cells over control mESC for all common binding sites in the vicinity of annotated TSS according to the 
presence or absence of H3K9me3. The colors depict the expression changes in Atf7ip KO (upper panel) or Setdb1 
KO mutants (lower panel). A black line is drawn at the median of all peaks, while the red line represents the median 
of only the peaks nearby an upregulated gene. The red dotted line corresponds to no changes. (F-J) Cumulative plot 
for the coverage of SETDB1, ATF7IP, input material, and H3K9 modifications in control and Atf7ip-deleted cells, for 
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common peaks at different genomic annotations and at peaks containing CTCF motifs. (K) Percentage of genomic 
annotations associated with common SETDB1/ATF7IP peaks according to the presence or not of CTCF motifs. (L) 
Coverage normalized to input material for the SETDB1, ATF7IP and H3K9 modifications in control mESC for 
imprinted genes showing SETDB1 and ATF7IP binding at their promoter region. (M) Fold enrichment of H3K9 
modifications in Atf7ip KO or Setdb1 KO cells over control mESC for the genes in L. Setdb1 KO mESC data is based 
on previously published datasets (Karimi et al., 2011). 
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The common peaks in the vicinity of annotated TSS did not show important changes in H3K9 
modifications after Atf7ip deletion, regardless of the levels of H3K9me3 where they localized 
(Figure 3.14E - upper panel). However, the few upregulated genes in the mutant mESC bearing 
common peaks at their TSS tended to lose H3K9me2 and gain H3K9ac. Interestingly, none of 
those genes were marked by H3K9me3 in control cells. Similar picture is seen for the genes 
upregulated in Setdb1 KO mESC and co-bound by SETDB1 and ATF7IP (Figure 3.14E - lower 
panel). When the coverage of the H3K9 modifications at common binding sites were analyzed in 
both control and Atf7ip KO mESC, distinct trends were observed at the different genomic 
annotations (Figure 3.14F-I). At ERV-associated sites, high levels of H3K9me3 were observed in 
control cells, together with low enrichment for H3K9ac, while Atf7ip deletion led to increase in 
H3K9me2/3 and in the acetylation mark. Similar picture was observed at intra- and intergenic 
binding sites, although to a lower extent. Co-bound promoters, on the other hand, suffered slight 
decrease in H3K9me2/3 after Atf7ip deletion, keeping high levels of H3K9ac. Intriguingly, the first 
nucleosomes downstream of the TSS showed increase in H3K9me3 instead. Besides that, 
Setdb1 deletion led to severe reduction of H3K9me3 at common biding sites, independently of 
the genomic context. 
Considering the recently described role of SETDB1 in impeding CTCF biding to its motif and 
controlling regional genomic insulation (Chapter 1.5.c Neuronal development), changes in 
enrichment for H3K9 modifications at common binding sites containing CTCF motifs were 
assessed (Figure 3.14J). These sites behaved in a similar fashion to what is seen for co-bound 
promoters, even though the majority of them occur at intra- and intergenic regions (Figure 3.14K). 
Regarding the role of SETDB1-ATF7IP complex at imprinted genes (Chapter 1.6.b Endogenous 
genes), several of them displayed strong occupancy of both factors in mESC (Figure 3.14L). 
Besides lacking H3K9me2, these regions were in general enriched for H3K9me3 and H3K9ac in 
control cells. In the absence of ATF7IP imprinted genes co-bound by SETDB1-ATF7IP tended to 
lose H3K9me3, while increasing the deposition of H3K9me2 (Figure 3.14M). Deletion of Setdb1 
also led to impaired deposition of H3K9me3 at their promoters. In summary, common binding 
sites for SETDB1 and ATF7IP at ERV regions show opposing response to Atf7ip deletion 
compared to promoters co-bound by these proteins, whereas both sites lose H3K9me3 following 
Setdb1 deletion. 
3.15. SETDB1-ATF7IP complex binds and silences several ERV from classes I and II 
The binding of both SETDB1 and ATF7IP to regions containing ERV annotations 
(3.14 Promoters and ERV bound by SETDB1-ATF7IP respond differently to Atf7ip deletion) and 
their previously described role in repressing some TE families (Chapter 1.10 Regulation of 
SETDB1 catalytic activity by ATF7IP) strongly suggested the cooperation of these proteins in 
silencing repetitive regions. To investigate this matter, all the reads (including the ones with 
multiple alignments) from occupancy in Flag KI mESC and from ChIP-Seq and RNA-Seq in 
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control and Atf7ip KO mESC were mapped to UCSC annotated repeat clades. In general, the 
clades strongly bound by SETDB1 also displayed strong signal for ATF7IP over the input material 
(Figure 3.15A), suggesting the collaboration between these proteins. Interestingly, these regions 
tended to be enriched for H3K9me3 in control cells, indicating the importance of this mark for their 
repression (Figure 3.15B). Subdividing all the TE into different classes, it becomes clear that 
SETDB1 and ATF7IP forms a complex specifically at ERV, but not at ERV class III (Figure 3.15C). 
To analyze the impact of ATF7IP loss at all TE families individually according to their respective 
class the occupancy data for factors and histone modifications was integrated with the 
transcriptome in control and Atf7ip KO cells. Basically, the data was ordered decreasingly 
according to ATF7IP binding and local regression was performed for all datasets at three ERV 
classes and at LINE as control region. The strength of the signal for SETDB1 and ATF7IP was 
very consistent throughout the different families and practically remained at background levels at 
ERV class III and LINE, as expected (Figure 3.15D). Interestingly, the presence of both factors at 
ERV classes I and II correlated with transcriptional derepression after Atf7ip deletion, even though 
no changes in H3K9me3 deposition could be observed. For ERV class I, ATF7IP loss was 
followed by H3K9me2 increase together with H3K9ac. Unexpectedly, for ERV class II H3K9ac 
levels became lower in the mutant. 
 
Figure 3.15 | SETDB1-ATF7IP complex binds and silences several ERV from classes I and II.  
(A) Correlation between the genome coverage of SETDB1 and ATF7IP at all UCSC annotated TE families normalized 
to input signal. The color indicates whether the peak is a sole peak or co-occurs with ATF7IP. (B) Same as in A, but 
for ATF7IP and H3K9me3. (C) Percentage of families belonging to different TE classes which are bound by either 
ATF7IP or SETDB1 or both together. The total number of families composing each of the classes depicted is shown 
on the top of their respective bar. 
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(D) Local regression of the coverage of each dataset upon all the TE families according to their origin. The data was 
normalized to input signal and, for the KO datasets, also to the control samples. Note that the data was ordered 
according to the strength of ATF7IP binding. Each data point represents one family and the panels are scaled 
according to the number of families. The area around the lines indicates the respective standard error. The number 
on top of each panel represents the number of families of the respective TE class. (E) Same as in D, but for Setdb1 
KO mESC using publicly available datasets (Karimi et al., 2011). (F) Same as in D, but for Dnmt1 KO and Uhrf1 KO 
mESC using published datasets (Sharif et al., 2016). 
Assessing published datasets for the impact at these regions of Setdb1 deletion in mESC 
(Karimi et al., 2011), H3K9me3 levels were strong lost and followed by transcriptional activation 
(Figure 3.15E). Publicly available datasets were also used to investigate the overlap of SETDB1-
ATF7IP complex activity with DNAme machinery (Sharif et al., 2016). The co-binding of SETDB1 
and ATF7IP was also correlated with stronger upregulation of TE when DNAme machinery is 
impaired (Figure 3.15F). Thus SETDB1-dependent H3K9me3 deposition can be independent of 
ATF7IP in a long term after its deletion, but is not enough for keeping their TE targets completely 
repressed. Besides that, DNMT1 plays an important role as a co-repressor of the TE regulated 
by the SETDB1-ATF7IP complex. 
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3.16. DNAme synergizes with SETDB1-ATF7IP repression at IAPEz but not at MusD 
To assess the functions of SETDB1-ATF7IP complex at TE in a more specific manner, the 
analyses were narrowed down to individual elements by counting the number of tags mapping to 
all UCSC annotated copies from IAPEz, ETn and MERVL. Almost all MLV and IAPEz copies and 
several ETn elements were co-bound by both factors (Figure 3.16A). After ordering all copies 
according to the levels of ATF7IP signal and performing local regression, some trends could be 
observed for each clade (Figure 3.16B). Even though IAPEz and ETn belong to the same ERV 
class, they had some discrepancies in the response for ATF7IP loss. For instance, while the 
H3K9ac levels dropped considerably at the former after Atf7ip deletion, they remained the same 
in the latter. Besides that, H3K9me3 levels showed higher increase in IAPEz. On the other hand, 
the enrichment for H3K9me2 increased in the co-occupied copies of both subfamilies. As 
expected, no changes were observed for MERVL copies. Investigating published datasets, loss 
of SETDB1 (Karimi et al., 2011), DNMT1 or UHRF1 (Sharif et al., 2016) led to derepression of 
IAPEz copies (Figure 3.16C). Interestingly, the elements containing intermediate levels of 
SETDB1 and ATF7IP were the ones exhibiting the strongest derepression. Dnmt1 deletion, 
however, did not cause upregulation of ETn elements, indicating that DNAme does not play a role 
in silencing these regions. Thus, DNAme may be related to the strong loss of H3K9ac at IAPEz 
in Atf7ip KO mESC.  
To corroborate these findings, the fluctuation in H3K9 modifications due to Atf7ip deletion in 
mESC was evaluated by ChIP-qPCR in three biological replicates for control and mutant (Figure 
3.16D-G). These observations were in fact replicable. To assess the influence of DNAme on the 
repression of these TE and imprinted genes, control and Atf7ip KO mESC were transferred to 
2i+vitC medium (Chapter 3.9 Loss of DNA methylation further enhances Atf7ip knockout 
phenotype). Strikingly, the higher H3K9me3 levels observed in mutant cells grown in LIF medium 
were reduced again, reaching levels similar to the ones in control samples (Figure 3.16H-I). This 
suggests that presence of ATF7IP may refrain SETDB1 from excessive H3K9me3 deposition at 
regions where DNAme synergizes with ATF7IP for silencing (Figure 3.9B). When the cumulative 
coverage for SETDB1, ATF7IP and H3K9 modifications are analyzed along the consensus 
sequence for IAPEz and MusD, the gag region containing higher signals for those factors show 
stronger increase in H3K9me3 deposition at IAPEz after Atf7ip deletion when compared to MusD 
(Figure 3.16J-K). Besides that, deletion of Dnmt1 only affects IAPEz, whereas Setdb1 loss affects 
both as seen before (Figure 3.16C). Binding of neither SETDB1 nor ATF7IP is seen at MERVL 
and any alterations following Setdb1 or Atf7ip deletion may be due to indirect effects (Figure 
3.16L). 
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Figure 3.16 | DNAme synergizes with SETDB1-ATF7IP repression at IAPEz but not at MusD. 
(A) Percentage of copies belonging to different TE families which are bound by either ATF7IP or SETDB1 or both 
together. The total number of copies composing each of the families depicted is shown on the top of their respective 
bar. (B) Local regression of the coverage of each dataset upon all the TE copies of each family. The data was 
normalized to input signal and, for the KO datasets, also to the control samples. Note that the data was ordered 
according to the strength of ATF7IP binding. Each data point represents one copy of the TE and the panels are 
scaled according to the number of individual elements. The area around the lines indicates the respective standard 
error. The number on top of each panel shows the number of copies of the respective TE family. (C) Same as in B, 
but for Setdb1 KO (Karimi et al., 2011), Dnmt1 KO and Uhrf1 KO mESC (Sharif et al., 2016) using publicly available  
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datasets. (D-G) Enrichment as percentage of input for H3K9 modifications at TE and imprinted genes in control and 
Atf7ip KO mESC. For the mock sample, sheared chromatin was incubated with beads not covered with any specific 
Ab. (H-I) Same as in D, but for control and Atf7ip KO cells grown in 2i+vitC medium. (J) Cumulative coverage for 
factors, H3K9 modifications and transcriptome along the consensus sequence for all IAPEz elements. The colors 
indicate the following regions at the ERV: LTR, gag, pro and pol. The darker region inside the gag represents the 
fragment used for the exogenous TE silencing reporter assay. (K) Same as in J, but for MusD elements. (L) Same 
as in J, but for MERVL elements. Information about subregions is not available for this elements. 
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3.17. Generation of a platform for multifunctional editing of Atf7ip locus in mESC 
Targeted genome editing is a very powerful tool for studying the functions of a gene. A platform 
for quick and versatile engineering of a locus can be created by insertion of the multifunctional 
integrase (MIN) tag containing the phage attachment site (attP) for site-specific recombination 
with the bacterial attachment site (attB) as previously described (Mulholland et al., 2015). The 
serine integrase coded by the bacteriophage Bxb1 catalyzes the recombination generating 
attachment site junctions (attL and attR) as a byproduct of the reaction of integration (Singh et al., 
2013). Thus, a modular system is created, where vectors carrying a desired DNA sequence at 
the right position can be integrated at the target locus by transient co-transfection with the Bxb1 
integrase (Figure 3.17A). 
 
Figure 3.17 | Generation of a platform for multifunctional editing of Atf7ip locus in mESC. 
(A) Diagram of the site-specific recombination mediated by the Bxb1 integrase. Bxb1 recognizes and binds as a 
dimer to the attP and attB sequences to mediate recombination, generating attL and attR scars containing one piece 
of each of the recombination sites. (B) Sequence of the N-terminal region of Atf7ip locus indicating the start codon 
(orange). The sgRNA sequence is also shown (purple) together with the PAM sequence (blue). The PAM is 
recognized by the Cas9, which generate double strand breaks at the region indicated with blue arrows. (C) Diagram 
of the HDR template design and of the genotyping scheme. (D) UV-exposed agarose gel to distinguish between wild 
type and knockin clones. M indicates the lane containing the ladder. (E) Sanger sequencing of the PCR products of 
the Atf7ip locus from four independent clones isolated after CRISPR knockin. The FLAG-tag (green) was correctly 
recombined into the locus after the endogenous start codon (orange). The PAM sequence (blue) and the sgRNA 
target site (purple) were mutated (red) to avoid cleavage of the HDR template by the Cas9. 
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For modifying the Aff7ip locus, the Cas9 was targeted to a region nearby the start codon, with 
the aim to insert the MIN-tag at the 5’-end of the coding sequence (Figure 3.17B). In this way, 
any sequence integrated in the locus later on by recombination would be placed at the beginning 
of the transcript (Figure 3.17C). To favor the HDR the Cas9 was tagged with a peptide which 
signals for nuclear import during mitosis, when DNA damage are more prone to be fixed via HDR. 
Single clones were isolated to obtain isogenic cell lines and insertion of the tag was screened by 
PCR with primers surrounding the tagged region (Figure 3.17D). Correct sequence of the locus 
was verified by sequencing PCR products covering the whole targeted region (Figure 3.17E). 
Hence, a platform for fast integration of sequences of interest in the Atf7ip locus was generated 
and allows the switching of the expression of the endogenous protein by that of mutated 
sequences keeping the physiological conditions and the endogenous expression levels. 
3.18. Domains 1 and 2 are essential for ATF7IP to exert its repressive functions 
The Atf7ip locus encodes for a protein containing several interesting domains and motifs as 
introduced previously (Chapter 1.9.a Structural features). To study the contribution of each of its 
features for the regulation of SETDB1 activity several mutant forms of ATF7IP were cloned in a 
vector containing the attB sequence. In this way, these mutants could be integrated in the Atf7ip 
locus at the beginning of the coding sequence in the mESC line containing the attP sequence 
right after the start codon (Figure 3.18A). Of note, the vectors used for integration contain a late 
polyadenylation (polyA) signal following the mutant coding sequence for efficient transcription 
termination (Schek et al., 1992), making sure transcription does not go further into the locus. This 
means that the endogenous gene is knocked out as a consequence of the recombination. 
Integration of the mutants of interest was done by co-transfecting the MIN-Atf7ip KI mESC line 
with a plasmid coding for the Bxb1 integrase and another plasmid containing the attB followed by 
a cDNA of interest and an antibiotic resistance. As not all the cells show integration in both alleles, 
the strategy adopted was to first integrate an empty vector, for knockout only (Figure 3.18B). 
Afterwards, isogenic clones containing integration in only one allele were screened by PCR 
(Figure 3.18C). This heterozygous clone was then used to express the panel of Atf7ip mutants 
separately by site-specific recombination (Figure 3.18B). Cells containing one knockout allele and 
a second one expressing the mutant of interest were analyzed in rescue experiments. 
The different mutants chosen to be analyzed included: empty vector (to generate knockout 
cells), full-length cDNA (to account for the ability to rescue using the complete coding sequence), 
deletion of Domain 1 keeping the NLS, deletion of the whole Domain 1, deletion of Domain 2, 
mutation at the SIM, deletion of the ABS, mutation at the NLS and a truncation formed only by 
the NLS-Domain 1 (Figure 3.18D). Cloning of all these sequences were performed with the help 
of Büşra Turgu, a master student from the Faculty of Biology - LMU, whom I supervised during a 
two-months internship. 
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Figure 3.18 | Domains 1 and 2 are essential for ATF7IP to exert its repressive functions. 
(A) Graphical representation of the MIN-tagged Atf7ip locus after Bxb1-mediated recombination either with an empty 
vector to knockout the allele or a vector containing a mutant sequence to replace the expression of the endogenous 
one. A cassette for antibiotic resistance is part of the vector and also gets integrated. (B) Experimental design for 
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generation of mESC lines where one Atf7ip allele is knocked out and the other is replaced by different mutant 
sequences via Bxb1-mediated recombination. A first round of co-transfection of Bxb1 expressing vector and an empty 
vector containing only the Flag sequence after the attB together with the hygroR cassette. Isogenic cell lines were 
isolated and expanded after long term selection and used in a second round of co-transfection, this time with a vector 
containing different Atf7ip mutants following the attB and carrying the puroR cassette. Again, isogenic clones were 
isolated and expanded. (C) UV-exposed agarose gel to distinguish between wild type and knockin cell lines. (D) 
Graphical representation of the full-length ATF7IP and the panel of mutants used in rescue experiments of Min-Atf7ip 
KI mESC via Bxb1-mediated recombination. The different domains and motifs are depicted. The asterisks indicate 
the position of the point mutations. The specific aa targeted are specified on the right side of the sequence. (E) 
Expression levels of different TE families, members of ERV classes I (MLV and VL30), II (IAP, MusD and ERVK10C) 
and III (MERVL), and of the imprinted gene Igf2r in Min-Atf7ip KI mESC after Bxb1-mediated recombination. The 
expression levels are relative to the homozygous Min-Atf7ip KI samples. For each replicate, expression was 
normalized by the geometric mean of Gapdh and Hprt expression. The red dotted line indicates the level 
correspondent to no changes. (F) Same as in E, but for Atf7ip and the Flag sequence relative to reference genes 
Gapdh and Hprt. 
To finally investigate the importance of the selected regions for proper function of ATF7IP, cells 
were harvested 6 days after the second round of recombination leading to expression of the 
mutants on the place of the endogenous locus. Expression of endogenous retroviruses were 
assessed by RT-qPCR. The removal of one allele already led to derepression of some TE to 
some extent, especially of MusD elements, and silencing was further impaired by knocking out 
the second allele (Figure 3.18E,F). Expression of full-length Atf7ip, but not of Domain 1 truncation, 
was enough to keep MusD transcription repressed to the same level as observed in the 
heterozygous cell line. However, either constructs were able to keep repression of the other TE 
tested. Interestingly, Atf7ip mutants lacking either Domain 1 or Domain 2 could not prevent 
derepression. Similarly, mutation at the NLS also impaired silencing. However, the ABS and the 
SIM did not seem required by ATF7IP to maintain proper transcriptional silencing. 
3.19. ATF7IP interacts with proteins related to translation, transcription and cell cycle 
The ability of SETDB1-ATF7IP complex to exert functions in multiple contexts may be due to 
other auxiliary proteins which could work along with this complex. The interactors of SETDB1 
have been investigated by high throughput technique previously (Thompson et al., 2015), 
however, the interactome of ATF7IP remains unclear. To address which proteins could be 
associated with the complex via an interaction with ATF7IP, a high throughput approach was 
adopted. Taking advantage of the Flag-Atf7ip KI mESC line generated, co-IP was carried out 
against the FLAG epitope. Considering the importance of SUMOylation for some of the SETDB1 
interactions to take place, activity of SUMO-specific proteases was blocked by addition of the 
cysteine protease inhibitor N-ethylmaleimide (NEM). At first, the immunoprecipitates were 
evaluated by WB (Figure 3.19A) and silver staining (Figure 3.19B) to assess the efficiency of 
capturing the target protein and the level of non-specific binding of the background. These 
experiments were performed with the help of Ren Xie, a master student from the Faculty of 
Biochemistry - LMU, whom I also supervised during a two-months internship. After that, the 
proteins in the immunoprecipitated material were digested into smaller peptides and sequenced 
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by mass spectrometry (co-IP-MS), which was performed with the help of PD. Andreas Schmidt 
through the ZFP Mass Spectrometry Facility of the Biomedical Center - LMU. 
 
Figure 3.19 | ATF7IP interacts with proteins related to translation, transcription and cell cycle. 
(A) Digital image of the membranes used for blotting the FLAG Co-IP material of Flag-Atf7ip KI mESC nuclear 
extracts after separation by SDS-PAGE. Membranes was probed with Ab against different epitopes and LAMIN B1 
was used as a control for non-specific binding. (B) Digital image of the silver stained SDS-PAGE gel used for 
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separating the FLAG Co-IP material of Flag-Atf7ip KI mESC nuclear extracts. The closed arrowhead indicates the 
ATF7IP band and the two open arrowheads indicates the heavy-chain (HC) and light-chain (LC) of the Ab used. (C) 
Volcano plot displaying all identified peptides according to the enrichment over the control and the levels of 
significance. Significant proteins identified (p < 0.05) are highlighted in red. A few proteins of interest are annotated 
in the plot. (D) GO term enrichment analysis for biological processes (upper), molecular function (middle) and cellular 
component (lower panel) of significantly identified proteins in the co-IP-MS of FLAG Ab immunoprecipitates from 
Flag-Atf7ip KI mESC nuclear extracts. Shown is the probability based on the p-value. The number on top of each 
bar indicates the amount of genes fitting the specific GO term. (E) Scaled graphical representation of the Atf7ip locus 
and the position of PTM identified in the co-IP-MS results (open symbols) or only in the PhosphoSitePlus database 
(closed symbols). The number nearby the modification indicates the number of datasets where this specific 
modification was observed and which are available at PhosphoSitePlus database. 
The identified peptides were then aligned to the mouse UNIPROT database. After filtering the 
significantly enriched proteins, a list of around 100 candidate ATF7IP partners were obtained 
(Figure 3.19C). The specific enrichment of SETDB1 was strikingly detected. For the peptide 
counts and the protein coverage of the top 80 candidates, consult the Appendix (Table 9.1). A 
GO term enrichment analyses of all the significantly identified partners identified a series of 
interesting terms, for instance, the ones related to transcription, translation, cell cycle control and 
chromatin modification (Figure 3.19D). Of note, several PTM were identified including 
phosphoserine, methyl-arginine and methyl-lysine (Figure 3.19E). An investigation of other 
possible modifications of ATF7IP was done by inspecting the comprehensive database 
PhosphoSitePlus (Hornbeck et al., 2015) available online (http://www.phosphosite.org). 
Altogether, these data indicate that ATF7IP is heavily modified, what is in agreement with the 
several bands identified in WB (Chapter 3.3 Transposable elements lose repression following 
ATF7IP deletion), and some of these PTM may be involved in promoting the functions of this 
protein. 
3.20. ATF7IP acts in the context of SETDB1 complex and synergizes with other proteins 
A way to investigate the functional relationship between pathways is by assessing the 
occurrence of genetic interaction, a phenomenon which describes the synergistic effects of 
phenotypes arising from the concurrent deletion of two genes (Mani et al., 2008). In this way, 
elements contributing to compensatory effects via independent pathways can be identified. On 
the opposite fashion, genes not showing additive phenotypes could be components of the same 
silencing machinery, in case they are known to act on the context in question. It is clear that 
silencing mechanisms can present overlapping functions, especially those acting upon TE 
(Chapter 1.7 Repression of transposable elements). In order to identify the specific context in 
which ATF7IP acts for the regulation of ERV repression and what are other parallel pathways 
able to compensate for ATF7IP loss, genetic interaction with several other genes was tested by 
taking advantage of the reporter assay for exogenous retrotransposon silencing (Chapter 
3.4 Silencing kinetics of an exogenous IAPEz reporter is impaired by ATF7IP deletion). 
The list of genes to be tested was assembled based on factors which are known to be involved 
in TE repression. Besides that, some of the proteins and ribonucleoproteins (RNP) identified as 
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ATF7IP interactors were added to the list (Chapter 3.19 ATF7IP interacts with proteins related to 
translation, transcription and cell cycle). Firstly, to verify whether any of those genes gathered on 
this list are involved in silencing of the IAPEz-gag reporter, each of the genes were knocked out 
individually in wild type mESC. Six days after deletion by CRISPR/Cas system, the knockout cell 
pools were analyzed in the reporter assay (Figure 3.20A). As expected, deletion of the factors 
known to silence TE led to impaired silencing of the reporter. Besides them, only Uhrf1-deleted 
cells exhibited some disruption of silencing. Unfortunately, the possibility of low efficiency 
knockout induction by each sgRNA cannot be discarded, as most of them were not assessed for 
efficiency prior to this screening. When probed for genetic interaction with Atf7ip, most of those 
genes did not show synergistic effects. The most striking genes leading to a cumulative effect 
were Atrx, Morc3 and Dnmt1 (Figure 3.20B). The role of Atrx in regulating this reporter sequence 
was previously shown (Sadic et al., 2015), whereas the involvement of Morc3 was recently 
identified by Sophia Groh during her Master thesis (Groh, Master Thesis, 2015) and is currently 
under investigation as the focus of her PhD thesis. Regarding Dnmt1, IAPEz regulation by the 
encoded protein was already described (Sharif et al., 2016). Of note, the strong effect of Setdb1 
deletion for the silencing of the reporter in wild type mESC was not observed when it was deleted 
in Atf7ip KO cells. This is an indication that both proteins act in the context of the SETDB1-ATF7IP 
complex and that initiation of exogenous TE repression by SETDB1 cannot take place in the 
absence of its partner protein. 
To validate some of the previous results, the experiments were repeated with more replicates. 
Interestingly, both Atrx and Daxx showed further impairment in silencing of the IAPEz-gag 
fragment reporter (Figure 3.20C). The effects of acute dKO were also tested to prevent any 
possibility of long term adaptation of the cells. For this, cells were co-transfected with a plasmid 
expressing only a sgRNA against Atf7ip and another vector expressing a sgRNA against a second 
target gene, the Cas9 and antibiotics resistance, using a higher molar ratio of the first one. In this 
way, most of the transfected cells would incorporate the former, however, only cells transfected 
also with the latter would survive selection and express Cas9. Firstly, cells were immuno-stained 
for ATF7IP 6 days after KO induction to measure the efficiency of obtaining a dKO cells. The 
amount of cells displaying loss of ATF7IP signal were similar between single KO and dKO 
experiments (Figure 3.20D). Finally, these cells were probed for ability to silence the TE reporter 
and the synergistic effects were again observed in the dKO cells (Figure 3.20E). 
Figure 3.20 | ATF7IP acts in the context of SETDB1 complex and synergizes with other proteins. 
(A) Relative percentage of remaining EGFP+ cells during a time course after the gag fragment reporter assay in wild 
type mESC following acute deletion of a gene of interest. Genes were grouped in different categories, according to 
their functions. Three controls were used: non-transfected cells and cells transfected with either an empty vector or 
with a sgRNA targeting a non-related intergenic region. (B) Same as in A, but for Atf7ip KO mESC after acute co-
deletion of a second gene of interest. (C) Relative percentage of remaining EGFP+ cells during a time course after 
the gag fragment reporter assay in wild type mESC after acute deletion of a gene of interest in either wild type mESC 
or in Atf7ip KO cells. (D) Percentage of cells not stained for ATF7IP after acute deletion of a gene of interest or dKO 
of Atf7ip and a second gene in wild type mESC. (E) Relative percentage of remaining EGFP+ cells during a time 
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course after the gag fragment reporter assay using the cells in D. (F) Expression levels of different TE families, 
members of ERV classes I (MLV and VL30), II (IAP, MusD and ERVK10C) and III (MERVL) in Atf7ip KO mESC after 
co-deletion of a second gene to test for genetic interaction. The expression levels are relative to the sgRNA targeting 
a negative control region. Expression was normalized by the geometric mean of Gapdh and Hprt expression. The 
red dotted line indicates the level correspondent to no changes. 
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When genetic interaction was assessed for its involvement in the regulation of endogenous 
TE, some interesting trends were observed. For instance, IAP elements were strongly impaired 
in Atf7ip KO mESC after depletion of Trim28 or Uhrf1. MusD showed slight upregulation after 
Dnmt3a co-deletion, whereas ERVK10C were mainly affected by co-deletion of Daxx, Setdb1, 
Trim28, Dnmt1 and Morc3 (Figure 3.20F). In summary, the SETDB1-ATF7IP complex have a role 
in silencing newly integrated exogenous TE and is assisted by other pathways which may act to 
ensure silencing maintenance. This suggests a similar role for endogenous TE when they actively 
transpose. Besides that, regulation of endogenous TE, especially IAP and ERVK10C elements, 
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4. DISCUSSION 
4.1. Establishment of tools for the investigation of SETDB1 regulation by ATF7IP 
Several functions of the protein SETDB1 were so far described. The characterization of the 
molecular mechanism utilized by such proteins with a large spectrum of functions is no easy task. 
The requirement for specialized methods to address the most specific biological questions has 
increased exponentially the number of tools available. In this scenario, the CRISPR/Cas9 system 
emerged as a promising means for genome editing allowing for innumerable applications (Shalem 
et al., 2015). Gene knockout, knockin, transcriptional repression and activation are some of them. 
It became an essential technique for this work and by using it three very important tools could be 
generated, which permitted the investigation of SETDB1 regulation by its cofactor ATF7IP. Firstly, 
Atf7ip KO mESC lines could be generated and characterized (Figure 3.1). Using these cells, the 
functions of ATF7IP could be clarified by reverse genetics, where the phenotype was 
characterized applying various techniques, for instance, transcriptomics. Besides that, these cell 
lines could be potentially used for verifying whether SETDB1 depends on ATF7IP to bind non-
methylated gene promoters. SETDB1 recruitment to endogenous retroviruses was shown to be 
dependent on TRIM28 and does not rely on ATF7IP (Thompson et al., 2015), whereas its 
targeting to DNA-methylated gene loci requires ATF7IP binding to MBD1 (Ichimura et al., 2005; 
Matsumura et al., 2015). However, the mechanism of recruitment to non-methylated promoters 
has not yet been investigated. 
Another very important tool which was developed in this work was the Flag-Atf7ip KI mESC 
lines, which were obtained by homologous recombination triggered after Cas9 double-strand 
break (Figure 3.12). The usage of the Flag-tag in cases where a specific Ab against the protein 
of interest is not available or does not work in a specific technique has become very common and 
brings along the advantage of the availability of highly specific Ab (Zhang et al., 2008). The 
presence of this tag can be beneficial for a wide range of techniques involving the immune-
identification of proteins. The use of Flag-tagged proteins in ChIP experiments, for example, has 
been shown to give results comparable to when Ab against the endogenous protein is used 
(Mazzoni et al., 2011). Considering that, the generation of Flag-Atf7ip KI mESC lines helped the 
determination of the genome-wide occupancy of ATF7IP in these cells. Besides, potential proteins 
partners of ATF7IP could be identified by performing mass spectrometry of the material obtained 
in co-IP experiments using FLAG Ab. In addition, localization assays by immunohistochemistry is 
another example of techniques that can be performed with high specificity by using this cell line. 
Lastly, the generation of Min-Atf7ip KI mESC lines opened a wide range of possibilities to 
analyze this locus (Figure 3.17). This short tag can be used for site-specific recombination via 
Bxb1-mediated integration of a provided template. As a result of the integration the endogenous 
sequence of the targeted locus gets knocked out, whereas the integrated sequence gets 
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transcribed using the endogenous promoter. Thus, different constructs can be expressed at 
physiological conditions and endogenous levels (Mulholland et al., 2015). In this work, several 
ATF7IP mutants and one truncation could be evaluated, together with the full-length sequence 
and an empty one. With that, distinct domains or specific aa residues of this protein were 
assessed for their requirement for transcriptional repression in the context of SETDB1. 
Furthermore, this system can be used for further characterization of the mechanism of SETDB1-
ATF7IP complex activity by testing the implications of each of the ATF7IP domains in the 
methyltransferase activity. 
4.2. SETDB1 and ATF7IP can either function in the same context or act independently 
Even though ATF7IP forms a complex with SETDB1 to act as a cofactor and regulate its 
methyltransferase activity (Wang et al., 2003; Basavapathruni et al., 2016), not all functions of 
each of these proteins seem to overlap. The first indication for this is the lethality observed after 
deletion of Setdb1 in mESC (Yuan et al., 2009; Lohmann et al., 2010), which is not recapitulated 
by Atf7ip-depleted mESC (Figure 3.1). Furthermore, transcriptome changes were not as severe 
in the latter in comparison to the former, with few genes being commonly misregulated (Figure 
3.6). Besides that, investigation of the genome-wide occupancy of both proteins reveals an overall 
discrepancy between their binding sites, with nearly one fourth of SETDB1 targets being shared 
with its partner ATF7IP (Figure 3.13C-D). Whereas SETDB1 tends to bind intra- and intergenic 
regions by itself, ATF7IP occupies very often promoter regions independently of the former 
(Figure 3.13H). Unexpectedly, several GO terms related to development and differentiation were 
enriched at SETDB1 sole targets. Evidences for the existence of independent roles for these 
proteins are also available in the literature. For instance, ATF7IP has also been implicated in 
transcriptional activation of promoters containing Sp1 motifs in concert with Sp1 and when 
SETDB1 is absent (Ichimura et al., 2005). In a similar fashion, transactivation of the promoter of 
telomerase-associated genes by both Sp1 and ATF7IP was demonstrated (Liu et al., 2009). In 
contrast to that, establishment of non-nucleosomal H3K9me1 at pericentric heterochromatin by 
SETDB1 in the context of HP1α-CAF1 complex during DNA replication was shown not to be linked 
to ATF7IP (Loyola et al., 2009). 
Despite all the independent functions exhibited by either protein, several evidences for the 
functional overlap between both SETDB1 and ATF7IP were gathered in this work. First of all, the 
majority of ERV classes I and II bound by SETDB1 was also co-occupied by ATF7IP (Figure 
3.15C) and this result was reproduced when individual TE were analyzed (Figure 3.16A). This 
cooperation in TE silencing was also described before (Thompson et al., 2015; Yang et al., 2015). 
The observation that silencing of an exogenous retrovirus reporter is not further impaired by co-
deletion of Setdb1 in Atf7ip KO mESC reveals another context where these proteins act together 
(Figure 3.20A-B) and supports previously published evidences for their cooperation in repressing 
exogenous TE in the context of the HUSH complex (Timms et al., 2016). Although ERV 
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represented the clearest target of the SETDB1-ATF7IP complex in this work, many genes also 
displayed co-binding of these factors at their promoter region (Figure 3.14B) and imprinted genes 
were a good example (Figure 3.14L). In the past, ATF7IP has been implicated in transcriptional 
modulation of promoters containing Sp1 motifs, where co-binding of MBD1 and SETDB1 resulted 
in transcriptional repression (Ichimura et al., 2005). Recently, the repression of an adipocyte 
master regulator was also reported to be dependent on the presence of both ATF7IP and SETDB1 
(Matsumura et al., 2015). The strong interaction between these proteins detected by co-IP-MS 
also supports the importance of the formation of this complex in mESC (Figure 3.19), which was 
previously described (Thompson et al., 2015). Curiously, the same way SETDB1 is essential 
during early embryonic development with knockout leading to peri-implantation lethality (Dodge 
et al., 2004; Keniry et al., 2016), Atf7ip knockout mice also exhibit very strong phenotype and do 
not survive through blastocyst stage (Nuber, Diploma thesis, 2017). This suggests an essential 
role of the SETDB1-ATF7IP complex as early as in the mouse blastocyst stage. 
4.3. Adaptation to Atf7ip deletion allows proper cell differentiation in presence of DNAme 
One way to study the differentiation capacity of mESC is to derive embryoid bodies from an 
agglomerate of cells by removing LIF from the medium. This way, pluripotency is lost and the 
cells can give rise to progenitors from the three germ layers. Setdb1 null mutant mESC, though, 
showed intrinsic signs of pluripotency loss together with impaired potential to differentiate and 
form EB (Bilodeau et al., 2009; Yuan et al., 2009; Lohmann et al., 2010). Unexpectedly, Atf7ip 
null cells had slightly higher levels of pluripotency marker genes (Figure 3.3) and were capable 
of differentiating into EB (Figure 3.5). The fact that these mutants survive and even show potential 
to form differentiated cell types can be explained by a process of adaptation that the cells undergo 
after gene deletion. More specifically, the cells try to compensate the loss of function of a gene 
by changing expression levels of other genes that may act via parallel pathways (El-Brolosy and 
Stainier, 2017), what might explain why Atf7ip KO cell lines exhibit such a low variation from 
control cells and are not clearly grouped in PCA (Figure 3.8A). This is supported by the 
observation that many more genes were found to be dysregulated when the phenotype of ATF7IP 
loss was analyzed few days after depletion, as observed in knockdown cells in comparison to 
stable knockout cells kept in long term culture (compare Figure 3.7A-B and Figure 3.8E-F). In 
addition, acute Atf7ip deletion led to ERV derepression to a higher extent than the observed in 
KO cell lines (Figure 3.8D). 
Global DNA demethylation stimulated by medium switch, where LIF medium is complemented 
with 2i+vitC, completely impaired the dynamics of gene expression during EB formation. Most 
probably this happened due to the fact that the cells took longer to repress the pluripotency 
markers and that the mesoderm-related genes were already expressed in mESC stage. Such 
behavior was reported before, where long exposure to 2i molecules led to irreversible epigenetic 
and genomic changes which negatively impacted male mESC developmental potential (Choi et 
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al., 2017). These changes were represented mainly by karyotypic aberrations and, more 
importantly, by loss of proper DNAme at imprinting control regions. 
Unexpectedly, loss of ATF7IP along with DNAme depletion was somehow enough to allow for 
the proper repression of pluripotency marker genes. With that, differentiation-related genes 
became upregulated during the time course of EB formation. However, the temporal dynamics 
were impaired and late stages marker genes became expressed earlier, while early stage genes 
were activated later. One reason for this could be that the loss of both repressive layers formed 
by DNAme and H3K9me3 deposition at once facilitates expression of poised genes. Besides that, 
it was shown that some poised genes marked by H3K27me3 and H3K4me3 in mESC have a 
different poised state in preadipocytes, where they are composed by H3K4/H3K9me3 bivalent 
chromatin. H3K9me3 deposition at those regions depends on MBD1-SETDB1-ATF7IP complex 
and they only get activated in later stages of adipocyte development, when this repressive 
complex is not present anymore and its absence allows for the binding of transcription factors 
(Matsumura et al., 2015). On the other hand, considering that this mechanism depends on 
lineage-specific gene body DNAme, release from 2i treatment must be enough to permit normal 
Dnmt activity and establishment of DNAme at those poised regions after induction of EB 
formation. Now, with the knowledge that prolonged 2i exposure reduces developmental potential, 
the experimental design could be reformulated to account for that. The cells could be kept in 
2i+vitC medium for only a few passages before induction of differentiation, allowing for loss of 
DNAme without irreversible changes that may alter the outcome of the experiment.  
4.4. SETDB1-ATF7IP complex plays a role in the regulation of gene expression 
The first reports of regulation of gene expression by SETDB1 described the repression of 
artificial promoters in the context of KRAB-ZFP and TRIM28, where their targeting led to 
transcriptional inactivation and chromatin compaction (Schultz et al., 2002; Ayyanathan et al., 
2003; Yang et al., 2003). Evidences for transcriptional repression of endogenous genes started 
arising, for instance at the p53BP2 locus (Sarraf and Stancheva, 2004; Ichimura et al., 2005), and 
soon later SETDB1 was implicated in control of developmental genes (Bilodeau et al., 2009; Yuan 
et al., 2009). Here in this work, some evidences for genome-wide gene regulation by the 
cooperation between SETDB1 and ATF7IP are presented. First of all, deletion of Atf7ip in mESC 
led to consistent dysregulation of a set of genes which overlapped in part with the mysregulated 
genes due to Setdb1 deletion (Figure 3.6). Interestingly, upregulated genes in both phenotypes 
were enriched for GO terms related to meiosis and spermatogenesis, whereas between the 
downregulated genes several terms related to development were enriched. 
Secondly, around 140 promoter regions were co-bound by SETDB1 and ATF7IP and more 
than 600 intra- and intergenic regions, which could be important in gene regulation, also showed 
common peaks (Figure 3.13H). GO term enrichment analysis revealed terms related to meiosis, 
spermatogenesis, gene silencing and neuronal processes (Figure 3.13F). Of note, common 
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binding sites were frequently associated with two distinct genes and suggests that the SETDB1-
ATF7IP complex might be often controlling regulatory domains and not only single genes (Figure 
3.13G). Indeed, it was recently reported that SETDB1 shields chromatin from excessive CTCF 
binding at the boundaries of topologically associated domains, what implicates in multiple gene 
regulation simultaneously (Jiang et al., 2017). CTCF is known to regulate the higher-order 
structure of the chromatin and its accumulation leads to increased domain insulation, what may 
lead to less enhancer-promoter contacts and transcriptional repression (Ong and Corces, 2014). 
The increased insulation might explain why so many developmental-related genes undergo 
downregulation in the absence of either SETDB1 or ATF7IP and implicates the latter in this newly 
described role of SETDB1. Supporting this, the analysis of CTCF motifs co-occupied by SETDB1 
and ATF7IP reveals loss of H3K9me2/3 at these regions after loss of either protein (Figure 3.14J), 
similar to what was observed after Setdb1 deletion in neurons (Jiang et al., 2017). 
This work also presents some evidences for ATF7IP involvement in regulating transcription at 
regions of parental imprinting. Investigation of the H19 locus showed partial loss of transcriptional 
repression after Atf7ip deletion in mESC (Figure 3.5F). Furthermore, the normal upregulation that 
occurs during differentiation was further enhanced in the knockout cells. This phenotype was even 
stronger when DNAme was depleted from mESC (Figure 3.9C) and used in differentiation 
experiments (Figure 3.10F). Besides that, several imprinted genes harbor common SETDB1 and 
ATF7IP peaks around their TSS and are enriched for SETDB1-dependent H3K9me3 mark (Figure 
3.14L). Some of those genes even slightly lose H3K9me3 enrichment following Atf7ip deletion 
(Figure 3.14M). The fact that parental imprinting is often regulated by SETDB1-dependent 
H3K9me3 has been described by others and was shown to take place in the context of TRIM28 
(Yuan et al., 2009; Quenneville et al., 2011) involving DNAme mechanisms (Cruvinel et al., 2014; 
Leung et al., 2014). However, this is the first time that this repressive transcriptional control has 
been associated with ATF7IP activity along with SETDB1. 
4.5. Repression of ERV is largely dependent on SETDB1-ATF7IP complex 
The accumulation of TE throughout the host genomes is responsible to shape the genomic 
architecture and, with that, it drives the constant evolution of eukaryotic gene-regulatory networks 
(Chuong et al., 2017). Due to their ability to transpose and integrate in any genomic region cells 
developed several mechanisms to defend themselves against endogenous retroelements, viral 
infection and mutations and other threats posed by possible insertions. These mechanisms 
depend mainly on trans-acting restriction factors which form many layers of defense either in the 
cytoplasm or in the nucleus. The nuclear factors usually act by epigenetically suppressing 
transcription and may be cell-type specific, of which the H3K9MT are good examples (Goodier, 
2016). The roles of SETDB1 for the transcriptional restriction of ERV has been well studied in the 
past years and this protein is of extreme importance to keep the ERV genome transcriptionally 
silent, especially during early stages of development, when DNAme patterns are reprogrammed 
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(Leung and Lorincz, 2012; Groh and Schotta, 2017). Recently, ATF7IP has also been implicated 
in the negative control of ERV transcription in the context of TRIM28-SETDB1 in mESC, as its 
depletion led to similar TE derepression (Thompson et al., 2015; Yang et al., 2015). By 
investigating stable Atf7ip knockout mESC some ERV families showed transcriptional 
derepression (Figure 3.3A) and often overlapped with the ones derepressed in Setdb1 KO cells 
(Figure 3.7A-C). The effect of compensation previously discussed (Chapter 4.3 Adaptation to 
Atf7ip deletion allows proper cell differentiation in presence of DNAme) is also observed at ERV 
elements, as acute KO cells show stronger upregulation of some ERV or even derepression of 
families which are not dysregulated in stable KO cell lines (Figure 3.8D). Similar results are 
observed in cells where Atf7ip expression was knocked down (Figure 3.8F). The mechanism of 
DNAme must be one of the parallel pathways which functions as a second layer of repression to 
the one established by the SETDB1-ATF7IP complex, considering that the phenotype was even 
more pronounced when the stable mutant cell lines were depleted from DNAme by transferring 
them to medium complemented with 2i+vitC (Figure 3.9B). 
Supporting these findings, ATF7IP co-occurred with SETDB1 at several ERV families from 
classes I and II (Figure 3.15C). Of note, almost half of their common binding sites localized at 
genomic regions containing ERV annotations (Figure 3.13H). Interestingly, even though not all 
ERV families from classes I and II were bound by both SETDB1 and ATF7IP, the presence of 
both proteins correlated with transcriptional derepression in Atf7ip or Setdb1 KO cells (Figure 
3.15D,E). Investigation of ERV regulation at the level of individual TE elements uncovered a bias 
towards the binding to MLV, IAPEz and ETn retrotransposons (Figure 3.16A). When some of 
these elements were assessed for the position where these factors bound along their structure, 
the enrichment was localized mainly at 5’ LTR region and, more strongly, at a subregion of the 
gag portion which was previously described as a signal for recruitment of heterochromatin-
inducing factors and induction of compaction (Sadic et al., 2015). This was the exact region used 
in that work in reporter assays for exogenous retrotransposon silencing and which identified the 
cooperation between SETDB1, DAXX and ATRX for the silencing in mESC. Strikingly, deletion of 
Atf7ip also led to impaired silencing kinetics using this same reporter system (Figure 3.4). Thus, 
repression of proviral genome involves a long list of proteins which act in concert or constitute 
different layers of protection, even completely independent, with the same goal. 
This work also provided some insights into the regulation of ERV in the context of development 
and cell differentiation. It is a fact that the expression of several factors controlling ERV 
inactivation are differentially expressed throughout development and tend to be predominantly 
present in germ cells, mESC and early embryos. In differentiated cells most ERV do not rely 
anymore on H3K9me3 and H4K20me3 for their silencing, probably due to the presence of other 
independent mechanisms (Rowe and Trono, 2011). One speculation is that ERV are also brought 
into the large organized chromatin K9 modifications (LOCKs), which are large regions of G9a-
dependent H3K9me2 involved in gene silencing, highly conserved between mouse and human 
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and that seldom occur in undifferentiated cells, but can cover more than 30 % of the genome in 
differentiated cells (Wen et al., 2009). Cell differentiation experiments using control and Atf7ip KO 
mESC showed the independency of ATF7IP for ERV repression at later stages of EB formation 
(Figure 3.5D). Interestingly, ERV families which lost complete repression in the mutants reached 
the latest time point of differentiation with expression levels similar to the control. On the other 
hand, the elements where no derepression occurred in the mutant cells due to compensation by 
DNAme mechanisms reach the last time point with transcriptional levels lower than the ones in 
control samples. Most probably the mechanisms ensuring repression of these TE in absence of 
ATF7IP lead to a more robust silencing that hinders activation later in differentiated cells. 
Following the same line of reasoning, when DNAme influence was precluded and mESC grown 
in 2i+vitC medium were submitted to differentiate into EB, derepression of some ERV happened 
even at an earlier time point in control cells compared to cells in normal condition without 2i+vitC 
(Figure 3.10D). Besides that, mutant cells devoid of DNAme, which also leads to slightly reduced 
H3K9me3 levels (Figure 3.16D,H), displayed an even stronger reactivation of transcription from 
some of the ERV families after differentiation. This indicates that ATF7IP presence limits 
deposition of H3K9me3 by SETDB1 at ERV in a DNAme-dependent manner, allowing for proper 
reactivation of those regions during differentiation. Such reactivation may be important for ERV 
regions to act as enhancers in different developmental contexts. These results also suggest that 
either DNAme mechanisms or the activity of SETDB1-ATF7IP complex is important to signalize 
for proper transcriptional control of TE at later stages of cellular differentiation. Of note, while 
repression of ERV classes I and II (Matsui et al., 2010) and of exogenous retroviral sequences 
(Sadic et al., 2015) is not dependent on SETDB1 in immortalized MEF, the same is not true for 
primary MEF. Conditional deletion of either Setdb1 or Atf7ip in pMEF by expressing Cre 
recombinase resulted in upregulation of some ERV belonging to classes I and II (Figure 3.11). 
This demonstrates that the SETBD1-ATF7IP complex can still play a role in TE regulation in 
differentiated cells to some extent. 
4.6. ATF7IP conserved domains are essential for its function as co-repressor 
In various studies the structure of ATF7IP and their respective functions have been dissected. 
Apparently, the most relevant regions are the well conserved Domains 1 and 2, which are 
responsible for the interaction with different proteins (Fujita et al., 2003; Ichimura et al., 2005; Liu 
et al., 2009). However, some other interesting regions are present, for instance, a SIM, a NLS 
and an ABS. All these regions were shown to be functional as introduced before (Chapter 
1.9.a Structural features), even though ABS seemed not to be required for ATF7IP repressive 
activity (De Graeve et al., 2000) and the SIM was only associated with ATF7IP accumulation to 
PML-NB so far (Sasai et al., 2013). Here in this work all those regions mentioned were assessed 
for their requirement to repress some of the TE families in mESC by expressing different mutants 
and truncations. First of all, to avoid any biases that could be introduced by the overexpression 
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of those mutants using lentiviral vectors and stable knockout cell lines, a platform for exchanging 
the expression of the endogenous loci by that of target sequences was developed in this work as 
previously discussed (Chapter 4.1 Establishment of tools for the investigation of SETDB1 
regulation by ATF7IP). In summary, the mutant constructs are integrated via Bxb1-dependent 
recombination due to the presence of signal sequences in the vector containing the construct and 
in the Atf7ip locus of the knockin cell line generated. 
The efficiency of recombination after co-transfection of the cells with the recombinase and the 
target sequence when cells are selected for the integration of an antibiotic resistance marker is 
very high for at least one of the alleles (Mulholland et al., 2015). However, this efficiency drops 
drastically when both alleles are expected to be recombined. Thus, cells were selected which 
contained only one allele targeted for recombination using an empty vector and constituted a 
knockout allele. Then, this heterozygous cell line was used for recombination to test the various 
mutant constructs (Figure 3.18B). Of note, the monoallelic knockout already resulted in slight 
derepression of most of the ERV tested (Figure 3.18E). This indicates that a biallelic expression 
of this locus is required for proper function. Interestingly, transcriptional compensation occurs 
(Eckersley-Maslin et al., 2014), considering that Atf7ip expression in heterozygous mutants is 
similar to that in control cells (Figure 3.18F). Besides that, the transcriptional levels of the Flag 
tag are higher in homozygous mutants than in heterozygous cells. Deletion of the second allele 
led to enhanced derepression of some of the ERV, whereas the wild type full-length construct 
was enough to keep ERV transcriptional levels similar to the heterozygous mutants. 
Similar to what was observed in Atf7ip KO mESC lines or after acute deletion of this gene 
(Figure 3.8D), derepression of MusD and ERVK10C elements was more pronounced and the 
effect of the different mutants was clearer. Strikingly, deletion or mutation in the NLS region led 
to impaired repression of these elements. Thus, nuclear localization of this protein is of extreme 
importance for the repressive ability. Unexpectedly, mutation of the SIM region did not disrupt 
silencing, what indicates that binding to SUMO at least by these specific residues is not required 
for TE repression. A very interesting observations was that the expression of a truncated version 
of ATF7IP containing only the Domain 1 preceded by the NLS is enough to keep repression of 
the TE tested, with the exception of the MusD elements. This probably happens because of the 
involvement of the Domain 2 for silencing these ERV families, considering that it was the only one 
affected by its deletion. On the other hand, it is conflicting that the mutant lacking Domain 1 did 
not impair repression of the other ERV. Unfortunately, the effects on the imprinted gene tested 
were not clear enough to extract any meaningful conclusion. 
Overall, the effect caused by acute Atf7ip deletion using this recombination system was not as 
strong as observed before (Figure 3.8D). One reason for this could be the presence of alternative 
transcription start sites along the endogenous locus, which is not a rare event in mammalian cells. 
This could permit the expression of shorter variants capable of compensating for the full-length 
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version of the transcript (Wang et al., 2016). Whether this expression of alternative transcriptional 
variants leads to isoform-specific translation would be an interesting question to be addressed in 
the future, especially if those variants are also detected in normal conditions. 
4.7. Exogenous TE repression in the context of SETDB1 requires ATF7IP 
An interesting fact is observed regarding the silencing kinetics acting over the IAPEz-gag 
fragment after its transduction during the reporter assay. Even though the loss of one of the 
components from the silencing machineries impairs repression, after several days the majority of 
the cells end up repressing the reporter to levels close to what is seen in the control samples. 
This was true for stable knockout cell lines, acute knockdown or knockout cell pools for Setdb1, 
Atrx, Daxx and Trim28 (Sadic et al., 2015) and Morc3 (Groh, Master Thesis, 2015) and was also 
observed for Atf7ip (Figure 3.4E) and those proteins again in this work (Figure 3.20A). This 
happens most probably due to the fact that these and several other proteins act in concert and 
may even be part of independent pathways. 
To address the context in which ATF7IP acts to induce the silencing of the TE reporter in 
question, a list of possible factors was assembled based on proteins previously described to be 
involved in TE transcriptional regulation. In addition, the protein interactors of ATF7IP were 
identified by co-IP-MS in order that some of the candidates could be assessed for their 
contribution to the silencing pathway involving the complex formed by SETDB1 and ATF7IP. In 
this assay, several interesting proteins were identified as strong candidate partners (Figure 3.19C 
and Table 9.1). For instance, KDM1A has been implicated in transcriptional control of MERVL 
(Macfarlan et al., 2011) and is required for maintenance of global methylation by demethylating 
and stabilizing DNMT1 (Wang et al., 2009). This might predict a role for ATF7IP also at the ERV 
class III MERVL and could explain the derepression of this family when DNAme was depleted 
from Atf7ip KO mESC (Figure 3.10D). UHRF1 binding to ATF7IP may be the link in wild type cells 
between SETDB1-dependent H3K9me3 and DNMT1-mediated maintenance of DNAme (Sharif 
et al., 2016) for ERV silencing, whereas binding to DNMT3B may link this histone modification to 
the de novo DNAme machinery. 
ATF7IP interaction with some of the other proteins reinforces the different contexts where the 
SETDB1-ATF7IP complex plays a role. Its interaction with the PcG subunit Eed might associate 
the change from the poised state marked by H3K27me3/H3K4me3 in pluripotent cells to the 
poised state marked by H3K9me3/H3K4me3 in differentiating cells (Matsumura et al., 2015). 
Binding to PCNA most probably happens in the context of DNA replication-coupled maintenance 
of H3K9me3 (Sarraf and Stancheva, 2004). Interaction with PML implicates also ATF7IP in gene 
expression regulation mediated by SETDB1 in PML-NB (Cho et al., 2011). Lastly, SAP18 is a 
component of the histone deacetylase complex and this association suggests ATF7IP to be a 
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component of the multiprotein complex containing mSin3A/B, HDAC1/2, SETDB1 and other 
proteins (Yang et al., 2003). 
The genes gathered in this list were then evaluated for their genetic interaction with Atf7ip in 
the silencing of the reporter IAPEz-gag fragment. Of all the genes tested leading to impaired 
reporter repression, only Setdb1 did not show genetic interaction with Atf7ip (Figure 3.20A,B). 
This result indicates that SETDB1 silences exogenous TE in the context of its complex with 
ATF7IP. Whether H3K9me3 is still deposited by SETDB1 in absence of ATF7IP remains unclear. 
This could be tested by ChIP-qPCR, however, it should be controlled by the activity of other 
H3K9MT. Even though TRIM28 is the anchor for targeting SETDB1 to these regions (Yang et al., 
2015), its knockout enhanced impaired repression. Thus, it must recruit other downstream factors 
leading to SETDB1-independent H3K9me3-mediated repression, for instance, SUV39H1/2, 
which also plays a role in silencing ERV in mESC (Bulut-Karslioglu et al., 2014) and may become 
essential in the absence of SETDB1. As expected, Daxx and Atrx also showed genetic interaction 
with Atf7ip (Figure 3.20C), considering that they also further impair silencing in Setdb1 KO mESC 
(Sadic et al., 2015). Interestingly, Morc3 also showed strong genetic interaction and as it is 
independent of SETDB1 silencing, unraveling the pathway in which this protein acts could be an 
exciting topic. 
4.8. SETDB1-ATF7IP complex regulates promoters and ERV by different means 
In normal conditions, common SETDB1 and ATF7IP binding sites in mESC tend to not be 
marked by H3K9me3 and have rather H3K9ac when they occur in the vicinity of a TSS (Figure 
3.14C). On the other hand, the opposite picture is observed for common peaks occurring more 
than 2 kb away from a TSS. Independently of being promoter regions or ERV, enrichment for 
H3K9me2 is always low. Thus, the epigenetic landscape of these regions is different between 
each another, even though they are both probably under control of SETDB1-ATF7IP complex. 
Consistently, many of those promoter regions lost H3K9me2 to accumulate more H3K9ac when 
mESC were depleted of ATF7IP, whereas the opposite trend was observed at ERV (Figure 
3.14B). Most of the changes in H3K9me3 were not as strong as 2-fold. However, a cumulative 
plot showed that this mark became more enriched at ERV in mutant cells (Figure 3.14F), while it 
was slightly lost at promoters (Figure 3.14G). The most reasonable explanation is that each of 
these regions are regulated by different mechanisms which have SETDB1-ATF7IP complex as a 
common effector. As introduced previously (Chapter 1.6 Silencing of euchromatic genes), there 
are several mechanism governing euchromatic gene silencing which involve SETDB1. The same 
is true for the transcriptional repression of ERV and was also reviewed before (Chapter 
1.7 Repression of transposable elements). 
It was demonstrated that ATF7IP is not required for SETDB1 recruitment to ERV, as 
knockdown of the first does not lead to reduced enrichment of the latter (Thompson et al., 2015). 
In this case, ATF7IP is a downstream effector and could be dispensable for H3K9me3 deposition 
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by SETDB1. Interestingly, a careful inspection of their results reveals that SETDB1 not only still 
binds chromatin in the absence of ATF7IP, but also becomes more enriched at the ERV sites. 
The increased accumulation of SETDB1 in absence of ATF7IP may be the reason why stronger 
H3K9me3 enrichment is observed at ERV in mutant cells. Conversely, ATF7IP could be an 
upstream effector at promoters, which is required for SETDB1 recruitment. In concert with that is 
SETDB1 targeting in the context of MBD1. MBD1 is capable of binding directly to methylated DNA 
and interacts with ATF7IP, which in turn targets SETDB1 to gene promoters (Ichimura et al., 2005; 
Matsumura et al., 2015). In this context, ATF7IP-dependent recruitment of SETDB1 would result 
in loss of H3K9me3 in the absence of the former. This process is an attractive explanation for the 
observed loss of H3K9me2/3 at co-bound promoters in Atf7ip KO mESC. In any case, the 
proposed explanations would mean that ATF7IP does not have the role to stimulate SETDB1 
catalytic activity in the in vivo context. Nevertheless, one could argue that accumulation of 
H3K9me3 at ERV in absence of ATF7IP is exclusively due to activity of other H3K9MT and that 
SETDB1 loses its catalytic ability in the absence of its cofactor. The enhanced accumulation of 
SETDB1 after ATF7IP depletion speaks against it, though. Furthermore, the strong H3K9me3 
loss at ERV in Setdb1 KO mESC makes this alternative hypothesis unlikely. 
Of note, the distribution of SETDB1 and ATF7IP binding around the TSS occurring at genomic 
regions annotated as ERV shows that this combination tends to occur more often in the vicinity 
of TSS (Figure 3.13J). The involvement of TE in establishing regulatory networks for gene 
transcription has been already demonstrated (Rebollo et al., 2011; Rebollo et al., 2012a; Rebollo 
et al., 2012b). Thus, it would be interesting to see the distribution of TE around TSS to verify 
whether they accumulate themselves in the vicinity of TSS or there is a preference for SETDB1-
ATF7IP binding to them. This would implicate SETDB1-ATF7IP complex in regulating either the 
heterochromatin invasion into active genes or the spreading of euchromatic marks into ERV and 
is supported by the chimeric transcripts observed in Setdb1 KO mESC (Karimi et al., 2011). 
4.9. Future directions 
Even though this work could deepen the knowledge regarding the implications of the 
interaction between SETDB1 and ATF7IP to the epigenetic landscape and transcriptional 
regulation in mouse embryonic stem cells, some gaps still persist. For instance, it still remains 
unclear why the phenotype of Atf7ip deletion in mouse blastocysts is much stronger than the one 
in mESC. While these cells survive deletion, embryos do not develop longer than blastocyst stage. 
Thus, characterization of the in vivo phenotype is of ultimate importance. A proposed experiment 
is to investigate the transcription of several targets in knockout and control embryos using the 
digital PCR system Biomark HD (Fluidigm). With this system a large set of targets can be 
measured, the embryos do not need previous genotyping and single embryos can be used, 
excluding the requirement of pooling material. 
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Another question that remains unanswered is the reason for the controversial enrichment of 
H3K9ac at common SETDB1 and ATF7IP binding sites outside repetitive regions. From the 
results obtained within this thesis it was not possible to pinpoint any factor which could block 
SETDB1 activity. However, this may be not the influence of other proteins and may be simply the 
configuration of the epigenetic landscape. For instance, the strong enrichment of this active mark 
may inhibit catalysis of H3K9me3. Or recruitment of KDM1A by ATF7IP to these regions might 
constantly demethylate the H3K9. A last explanation could be that the physical presence alone is 
what determines the regulation of these regions. A way to start addressing this could be by using 
a reporter system where mutant SETDB1 lacking its methyltranferase activity is targeted to these 
regions using a version of this protein which is fused to a catalytically dead Cas9. 
Even with all the efforts from this work it is still not clear whether the de novo establishment of 
the H3K9me3 mark by SETDB1 depends on the presence of ATF7IP. One suggestion of an 
experimental design is to transiently deplete SETDB1 from mESC by using an inducible shRNA 
system. After a few days and before it becomes lethal, enough for reduction of most of the 
SETDB1-dependent H3K9me3, Atf7ip deletion is induced in a conditional knockout cell line and 
the reestablishment of this mark can be evaluated in comparison to Atf7ip-positive cells. 
In summary, this work contributed to the better understanding of the roles of the SETDB1-
ATF7IP complex and the regulation of their functional targets. Some insights in the molecular 
mechanisms of SETDB1 activity regulation by its cofactor ATF7IP were also provided. Besides 
that, several tools for further studying the interaction of these proteins were developed and are 
available for future experiments. 
  




Target ID Weight Host Type Company Catalogue Purpose Dilution 
a-Tubulin 220 50 kDa mouse monoclonal Sigma Aldrich B-5-1-2 Western blot 1000 
Atf7ip 258 240 kDa rabbit polyclonal Sigma Aldrich HPA023505 Western blot 2000 
Flag 132 - mouse monoclonal Sigma Aldrich F1804 
ChIP-qPCR 5 µg 
ChIP-Seq 5 µg 
Western blot 2000 
H3K9ac 275 17 kDa rabbit polyclonal Active Motif 39138 ChIP-qPCR 3 µg 
H3K9me1 - 17 kDa mouse monoclonal Kimura CMA316 Western blot 2000 
H3K9me2 - 17 kDa mouse monoclonal Kimura CMA317 Western blot 2000 
H3K9me2 255 17 kDa mouse monoclonal Abcam ab1220 ChIP-qPCR 3 µg 
H3K9me3 - 17 kDa mouse monoclonal Kimura CMA318 Western blot 2000 
H3K9me3 249 17 kDa rabbit polyclonal Active Motif 39161.39 ChIP-qPCR 3 µg 
Lamin B1 251 70 kDa rabbit polyclonal Active Motif 39095 Western blot 2000 
Setdb1 28 180 kDa mouse monoclonal Elizabeth Kremmer 2D2-111 Western blot 5 
Suz12 253 83 kDa rabbit monoclonal Cell signaling 3737 Western blot 1000 
Trim28 19 110 kDa rabbit polyclonal Abcam ab10484-50 Western blot 2000 
5.2. Data and analyses 
All raw data, processed data and analyses, together with the scripts used for processing and 
analyzing the data are stored in the internal server and are available upon request to Prof. Dr. 
Gunnar Schotta (gunnar.schotta@med.uni-muenchen.de). 
5.3. High-throughput sequencing libraries 
Library Name ID Experiment Antibody Sequencing Index 
RNA_ES_wt26_ct25-1 GS114 RNA-Seq none 50 bp pair-end CGATGT 
RNA_ES_wt26_ct25-2 GS115 RNA-Seq none 50 bp pair-end TTAGGC 
RNA_ES_wt26_ct25-3 GS116 RNA-Seq none 50 bp pair-end TGACCA 
RNA_ES_wt26_ko25-1 GS117 RNA-Seq none 50 bp pair-end ACAGTG 
RNA_ES_wt26_ko25-2 GS118 RNA-Seq none 50 bp pair-end GCCAAT 
RNA_ES_wt26_ko25-3 GS119 RNA-Seq none 50 bp pair-end CAGATC 
ChIP_ES_wt26_input GS133 ChIP-Seq none 50 bp pair-end ATCACG 
ChIP_ES_wt26_ki13-1_Flag-Atf7ip GS134 ChIP-Seq Flag 50 bp pair-end TTAGGC 
ChIP_ES_A9_k9g1_Flag-Setdb1 GS180 ChIP-Seq Flag 50 bp pair-end CTTGTA 
ChIP_ES_ct25-1_input GS232 ChIP-Seq none 50 bp pair-end CGATGT 
ChIP_ES_ko25-1_input GS233 ChIP-Seq none 50 bp pair-end TTAGGC 
ChIP_ES_ct25-1_H3K9me3 GS234 ChIP-Seq H3K9me3 50 bp pair-end TGACCA 
ChIP_ES_ko25-1_H3K9me3 GS235 ChIP-Seq H3K9me3 50 bp pair-end ACAGTG 
ChIP_ES_ct25-1_H3K9me2 GS236 ChIP-Seq H3K9me2 50 bp pair-end GCCAAT 
ChIP_ES_ko25-1_H3K9me2 GS237 ChIP-Seq H3K9me2 50 bp pair-end CAGATC 
ChIP_ES_ct25-1_H3K9ac GS238 ChIP-Seq H3K9ac 50 bp pair-end ACTTGA 
ChIP_ES_ko25-1_H3K9ac GS239 ChIP-Seq H3K9ac 50 bp pair-end GATCAG 
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5.4. Oligonucleotides 
Target Direction ID Sequence Purpose 
Atf7ip ko check 
fw GS2775 ATCGATAAGCTTGATTGGATAGTGTAGAAGAACCTCAGA 
genotyping 
rw GS2776 CTGCAGGAATTCGATGAGTCAGCTCACCAGAAGCC 
attL fw GS4051 CCGGCTTGTCGACGACG genotyping 
Flag-Atf7ip ki check 
fw GS3542 TGGGGAAACAGTACCGGATCGAG 
genotyping 
rw GS3521 GGCTTGCTTTATGGGCTGAATTT 
Min-Atf7ip ki check 
fw GS3999 AATATGAGAACTCCGACCGAG 
genotyping 
rw GS3915 GACTCTGTGCACAGCATCGA 
Min-Atf7ip ki check 2 
fw GS4002 TGGGTTTGTCTGGTCAACCA 
genotyping 
rw GS3797 GCACAATCATCCAAGGCTGAC 
ETn/MusD 
fw GS3752 ATAGAGGCCGCTTCTTTGC 
qPCR 
rw GS3753 TGAGACTCCACCAAATGTCC 
Gapdh 
fw GS3050 CTCTGCTCCTCCCTGTTCC 
qPCR 
rw GS3051 TCCCTAGACCCGTACAGTGC 
H19 
fw GS928 AGCTTTGAGTACCCCAGGTTCA 
qPCR 
rw GS929 GCCTCTGCTTTTATGGCTATGG 
IAP 
fw GS2512 CGGGTCGCGGTAATAAAGGT 
qPCR 
rw GS2513 ACTCTCGTTCCCCAGCTGAA 
Nnat 
fw GS1652 TGCTGCTGCAGGTGAGTATGTA 
qPCR 
rw GS1653 TTGCGGCAATTGGGATAGGA 
Ptch1 
fw GS1689 TGCTGATGCATGTGAGTGTG 
qPCR 
rw GS1690 AAGCCGACAAAGCTTACAAATG 
Tia1 
fw GS477 GCTCGCCGCCATCTTGGAT 
qPCR 
rw GS478 GGCTATGGCTGCGGAAGAGC 
Atf7ip (exon 2) 
fw GS3794 TGATAACCCAGGCTGTGGTAC 
RT-qPCR 
rw GS3795 TGTACTGTAGTGGCCAGCTC 
Atf7ip (exon 3) 
fw GS2975 GCTCACCCTCGAAACAAGAAAG 
RT-qPCR 
rw GS2976 TCAGCTTTGCCGTCCTTCTC 
CD55 
fw GS2152 CAAGTACAGGAACCCCCTCA 
RT-qPCR 
rw GS2153 CCACCTGTGTTAGGCTCTCC 
Cre 
fw GS31.1 CATCGTCGGTCCGGGCTGCC 
RT-qPCR 
rw GS31.2 CCCCCAGGCTAAGTGCCTTC 
Dnmt1 
fw GS1540 GCTTCAACTCCCGCACTTAC 
RT-qPCR 
rw GS1541 CACGAAGTTCCTGACGTTCTC 
ETn/MusD 
fw GS3752 ATAGAGGCCGCTTCTTTGC 
RT-qPCR 
rw GS3753 TGAGACTCCACCAAATGTCC 
Foxa2 
fw GS2757 TGGCTGCAGACACTTCCTAC 
RT-qPCR 
rw GS2758 AAGCTCTCCCAAAGTCTCCA 
Gapdh 
fw GS276.1 TCAAGAAGGTGGTGAAGCAG 
RT-qPCR 
rw GS276.2 GTTGAAGTCGCAGGAGACAA 
H19 
fw GS809 GGAGACTAGGCCAGGTCTC 
RT-qPCR 
rw GS810 GCCCATG GTGTTCAAGAAGGC 
H19 
fw GS3246 AGTCGATTGCACTGGTTTGG 
RT-qPCR 
rw GS3247 GCCAAAGAGGTTTACACACTCG 
Hnf1b 
fw GS3062 AGGGAGGTGGTCGATGTCA 
RT-qPCR 
rw GS3063 TCTGGACTGTCTGGTTGAACT 
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Target Direction ID Sequence Purpose 
Hprt 
fw GS279.1 ATGAGCGCAAGTTGAATCTG 
RT-qPCR 
rw GS279.2 CAGATGGCCACAGGACTAGA 
IAP 
fw GS2512 CGGGTCGCGGTAATAAAGGT 
RT-qPCR 
rw GS2513 ACTCTCGTTCCCCAGCTGAA 
IAPEz 
fw GS3908 CACGCTCCGGTAGAATACTTACAAAT 
RT-qPCR 
rw GS3909 CCTGTCTAACTGCACCAAGGTAAAAT 
Igf2r 
fw GS781 GCTGCCAGCCTTCAGATTCACA 
RT-qPCR 
rw GS782 TTCTTGCAGGCTGCAGTAGTCCTC 
MERVL 
fw GS3455 CTTCCATTCACAGCTGCGACTG 
RT-qPCR 
rw GS3456 CTAGAACCACTCCTGGTACCAAC 
Mixl 
fw GS3040 AACCGACGGGCCAAGTC 
RT-qPCR 
rw GS3041 TCCCCGCCTTGAGGATAAG 
MLV 
fw GS2651 TGGGTCCTCAGGGTCATAAG 
RT-qPCR 
rw GS2652 CAGTTGCTCTTAGCGGGTCT 
MMERVK10C 
fw GS3754 GATTGTCAGCAGCTCTTGCA 
RT-qPCR 
rw GS3755 AAAGCCTCGTCCACAAGGTT 
Nanog 
fw GS534 AACCAAAGGATGAAGTGCAAGCG 
RT-qPCR 
rw GS535 GCTGCAATGGATGCTGGGATACT 
Nodal 
fw GS3060 TTCAAGCCTGTTGGGCTCTAC 
RT-qPCR 
rw GS3061 TCCGGTCACGTCCACATCTT 
Oct4 
fw GS410.1 GCTCACCCTGGGCGTTCTC 
RT-qPCR 
rw GS410.2 GGCCGCAGCTTACACATGTTC 
Reep6 
fw GS2144 ATACCCCGCATATGCTTCAG 
RT-qPCR 
rw GS2145 ACTTGCCCGCGTAGTAGAAA 
Rex2 
fw GS2032 TGTTTGCTCCTCACCAAGAA 
RT-qPCR 
rw GS2033 CCTCCGATGAGAAGTCCAAA 
Setdb1 
fw GS958 AGCAGAACTCCAAAAGACCAGAAGC 
RT-qPCR 
rw GS959 TCTTGCCCAGAATCCGCATG 
T 
fw GS2761 GCTTCAAGGAGCTAACTAACGAG 
RT-qPCR 
rw GS2762 CCAGCAAGAAAGAGTACATGGC 
VL30 
fw GS3457 TTCGCCTCTGCAATCAAGCTCTC 
RT-qPCR 
rw GS3458 TCGCTCRTGCCTGAAGATGTTTC 
WPRE 
fw GS3711 CCGTTGTCAGGCAACGTG 
RT-qPCR 
rw GS3712 AGCTGACAGGTGGTGGCAAT 
 
Target ID fw ID rw Sequence Purpose 
sgAtf7ip GS3822 GS3823 CACCGTCTTCATCCATATATCGC sgRNA 
sgAtf7ip-1 GS2767 GS2768 GTCAGAGGCTGGGTTATCGG sgRNA 
sgAtf7ip-2 GS2769 GS2770 GCCACTACAGTACAGGCTAC sgRNA 
sgAtf7ip-ABS-1 GS3814 GS3815 GTCGTCTTCACTCTTGCC sgRNA 
sgAtf7ip-ABS-2 GS3816 GS3817 GAGTCTTTACTTTGAATT sgRNA 
sgAtf7ip-ATG GS3888 GS3889 GCTCAGAAAAAAGTCTTCA sgRNA 
sgAtf7ip-Domain1-1 GS3820 GS3821 GCCATATATCGCCGGCGTT sgRNA 
sgAtf7ip-Domain1-2 GS3822 GS3823 GTCTTCATCCATATATCGC sgRNA 
sgAtf7ip-Domain1-3 GS3824 GS3825 GCAGTGCTCACCGAGCTGC sgRNA 
sgAtf7ip-Domain2-1 GS3830 GS3831 GTCGTGCTAACTTCAAGTG sgRNA 
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sgAtf7ip-Domain2-2 GS3832 GS3833 GCAGCTTCGGTCCACTTCC sgRNA 
sgAtf7ip-NLS GS3818 GS3819 GTTCTAAGTCAGAAGACA sgRNA 
sgAtf7ip-SIM-1 GS3826 GS3827 GTGTCATTGATCTCACGA sgRNA 
sgAtf7ip-SIM-2 GS3828 GS3829 GATGGACGATGAAGAGAG sgRNA 
sgAtf7ip-Start1 GS2767 GS2768 GTCAGAGGCTGGGTTATCGG sgRNA 
sgAtf7ip-Start2 GS2769 GS2770 GCCACTACAGTACAGGCTAC sgRNA 
sgAtf7ip-stop1 GS3390 GS3392 GTCTAGTGCAGGCACCTGACA sgRNA 
sgAtf7ip-stop2 GS3392 GS3393 GGAGGGTCTTGTCAATCTGGA sgRNA 
sgAtf7ip2-Domain1 GS3836 GS3837 GAAAATGCTTGTGGGGCTC sgRNA 
sgAtf7ip2-Domain2 GS3840 GS3841 GCACAGTTGGGGTTGACCT sgRNA 
sgAtf7ip2-SIM GS3838 GS3839 GCCCGTCCAACTACAGCAT sgRNA 
sgAtf7ip2-Start GS3834 GS3835 GATTCTAGGATATGAAATA sgRNA 
sgAtrx GS2621 GS3106 GCTGTTGCACGCAGTCACCAAGTCCAGTAG sgRNA 
sgAtrx GS3106 GS3107 GACAACTCCTTTCGACCA sgRNA 
sgDaxx GS2659 GS3108 AGTACAATGATGCTGTCATCGG sgRNA 
sgDaxx GS3108 GS3109 GTACAATGATGCTGTCAT sgRNA 
sgDnmt1 GS3526 GS3527 GCTTCGTGAAGTGAGCCGTGA sgRNA 
sgDnmt3a GS3965 GS3966 GACGATGAGCCTGAGTATG sgRNA 
sgDnmt3b GS3967 GS3968 GGAAACAGCTTCCCGGCA sgRNA 
sgDnmt3l GS3969 GS3970 GAAGTCAAAGTGAACCGA sgRNA 
sgEed GS3979 GS3980 GCGTATTTGTGGGCGTGTC sgRNA 
sgEzh2 GS3981 GS3982 GAACTTCATCCCCCATATA sgRNA 
sgHdac1 GS3973 GS3974 GTACCGACAGAGCCTCCCG sgRNA 
sgHdac2 GS3975 GS3976 GGGGCTGTGAAATTAAAC sgRNA 
sgHnrnpk GS3989 GS3990 GACCTACCTCTTCCAAGGT sgRNA 
sgHnrnpl GS3987 GS3988 GCCTGAACTCCGTTCTTC sgRNA 
sgKdm1a GS3971 GS3972 GTGGCTTCAAACGTCAGC sgRNA 
sgMbd1 GS3960 GS3961 GTTGTGCAAAGATTGTCG sgRNA 
sgMcm5 GS3995 GS3996 GAGTGGGCACCGATCGCA sgRNA 
sgMorc3 GS3439 GS3440 GTGAATGCTAAACAGATC sgRNA 
sgNeg GS3126 GS3127 GTTTGGCTCTACAAAGGC sgRNA 
sgPcgf2 GS3985 GS3986 GAGGCGAGGTCCTGGAAC sgRNA 
sgPml GS3977 GS3978 GCAGCGCATCCGCACTAG sgRNA 
sgPspc1 GS3993 GS3994 GCGAAACCTCCTGCACGAA sgRNA 
sgSetdb1 GS3110 GS3111 GCTGAGCTGCAGCAGGCGG sgRNA 
sgSnrnp200 GS3991 GS3992 GTCCGGTCAATGAGAGAG sgRNA 
sgSuz12 GS3983 GS3984 GCTTCGGGGGTTCGGCGG sgRNA 
sgTrim28 GS3112 GS3113 GCCGCGTCGTCCCCTGCG sgRNA 
sgUhrf1 GS3528 GS3529 GTCACAGTGCGAGCACGAGCA sgRNA 
shAtf7ip-1 GS2777 GS2778 CGAGGCCCAATACAGATGAAA shRNA 
shAtf7ip-2 GS2779 GS2780 GACGAACACTTAGACCAAATT shRNA 
shScrambled GS1450 GS1451 CAACAAGATGAAGAGCACCAA shRNA 
5.5. Organisms 
Line Organism Type Source Parent Generation Plasmid 
E126-5 Mus musculus Setdb1 p/p pMEF Gunnar Schotta - - - 
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Line Organism Type Source Parent Generation Plasmid 
E699-1 Mus musculus Atf7ip p/p pMEF this work - - - 
E700-5 Mus musculus Atf7ip p/p pMEF this work - - - 
E701-1 Mus musculus Atf7ip p/p pMEF this work - - - 
wt26 Mus musculus wild type mESC Gunnar Schotta - - - 
k9g1 Mus musculus Flag-Setdb1 KI mESC Gunnar Schotta A9 electroporation p902 
T37 Homo sapiens HeLa mCat Gunnar Schotta HeLa transduction p1055 
min5h-1 Mus musculus Min-Atf7ip/+ KI mESC this work min5 transfection p1584, p1615 
ct25-1 Mus musculus control mESC this work wt26 transfection p963 
ct25-2 Mus musculus control mESC this work wt26 transfection p963 
ct25-3 Mus musculus control mESC this work wt26 transfection p963 
ki13-1 Mus musculus Atf7ip KI mESC this work wt26 transfection p1467, p1516 
ki13-1 Mus musculus Flag-Atf7ip KI mESC this work wt26 transfection p1467, p1516 
ki13-2 Mus musculus Flag-Atf7ip KI mESC this work wt26 transfection p1467, p1516 
ko25-1 Mus musculus Atf7ip KO mESC this work wt26 transfection p963, p1309, p1310 
ko25-2 Mus musculus Atf7ip KO mESC this work wt26 transfection p963, p1309, p1310 
ko25-3 Mus musculus Atf7ip KO mESC this work wt26 transfection p963, p1309, p1310 
min10 Mus musculus Min-Atf7ip KI mESC this work wt26 transfection p1597, p1646 
min2 Mus musculus Min-Atf7ip KI mESC this work wt26 transfection p1597, p1646 
min5 Mus musculus Min-Atf7ip KI mESC this work wt26 transfection p1597, p1646 
min8 Mus musculus Min-Atf7ip KI mESC this work wt26 transfection p1597, p1646 
T89 Mus musculus Cas9+ mESC Gunnar Schotta wt26 transduction p1368 
5.6. Plasmids 
Name ID Marker Resistance Source Purpose 
pCAG/NLS-HA-Bxb1 1584 none ampicilin Addgene (51271) Bxb1 recombination 
pattB/3xFLAG-HA-Atf7ip(dD1)pA-PuroR 1607 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HAAtf7ip(dD2)pA-PuroR 1608 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HA-Atf7ip(dSIM)pA-PuroR 1609 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HA-Atf7ip(dABS)pA-PuroR 1610 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HA-Atf7ip(dNLS)pA-PuroR 1611 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HA-Atf7ip(D1)pA-PuroR 1612 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HA-Atf7ip(dD1+NLS)pA-
PuroR 
1613 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HAPoly(A)-PuroR 1614 puroR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HAPoly(A)-ZeoR 1615 zeoR kanamycin this work Bxb1 recombination 
pattB/3xFLAG-HA-Atf7ippA-PuroR 1649 puroR kanamycin this work Bxb1 recombination 
pBSII-SK+/5'-Atf7ip-Flag-Stop-3'Atf7ip 1467 none ampicilin this work CRISPR knockin 
pX330/sgAtf7ip-stop 1516 none ampicilin this work CRISPR knockin 
pX459/sgAtf7ip-Start 1597 puroR ampicilin this work CRISPR knockin 
pBSII-SK+/5'-Atf7ip-Start-Min-3'-Atf7ip 1646 none ampicilin this work CRISPR knockin 
pX330/U6-Chimeric_BB-CBh-hSpCas9 1238 none ampicilin Addgene (42230) CRISPR knockout 
pX330/sgATRX-2 1244 none ampicilin Gunnar Schotta CRISPR knockout 
pX330/sgDAXX-4 1271 none ampicilin Gunnar Schotta CRISPR knockout 
pX330/sgAtf7ip-1 1309 none ampicilin this work CRISPR knockout 
pX330/sgAtf7ip-2 1310 none ampicilin this work CRISPR knockout 
pX459v2/EF1a-pSpCas9(BB)-2A-Zeo 1650 zeoR ampicilin Heinrich Leonhardt CRISPR knockout 
pX459v2/sgNeg 1652 zeoR ampicilin this work CRISPR knockout 
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pX459v2/sgDaxx 1653 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgSetdb1 1654 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgAtrx 1655 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgAtf7ip 1656 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgDnmt1 1657 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgMbd1 1658 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgMorc3 1659 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgTrim28 1660 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgUhrf1 1661 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgDnmt3a 1662 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgDnmt3b 1663 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgDnmt3l 1664 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgKdm1a 1665 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgHdac1 1666 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgHdac2 1667 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgPml 1668 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgEed 1669 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgEzh2 1670 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgSuz12 1671 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgPcgf2 1672 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgHnrnpl 1673 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgHnrnpk 1674 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgSnrnp200 1675 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgPspc1 1676 zeoR ampicilin this work CRISPR knockout 
pX459v2/sgMcm5 1677 zeoR ampicilin this work CRISPR knockout 
pLenti6/EFEGT-neo-GAG2.22 1074 neoR ampicilin Gunnar Schotta lentiviral expression 
pLenti6/EF1a-CRE-IRES-PURO 1087 puroR ampicilin Gunnar Schotta lentiviral expression 
pLenti6/hPGK-puro-ccdB 1348 puroR ampicilin Gunnar Schotta lentiviral expression 
pLenti6/hPGK-puro-sgNeg 1349 puroR ampicilin Gunnar Schotta lentiviral expression 
pLenti6/hPGK-puro-sgDaxx 1351 puroR ampicilin Gunnar Schotta lentiviral expression 
pLenti6/hPGK-puro-sgSetdb1 1353 puroR ampicilin Gunnar Schotta lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-Start1 1439 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-Start2 1440 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgDnmt1 1449 puroR ampicilin Gunnar Schotta lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-ABS-1 1565 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-ABS-2 1566 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-NLS 1567 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-Domain1-1 1568 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-Domain1-2 1569 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-Domain1-3 1570 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-SIM-1 1571 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-SIM-2 1572 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-Domain2-1 1573 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip-Domain2-2 1574 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip2-Start 1575 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip2-Domain1 1576 puroR ampicilin this work lentiviral expression 
pLenti6/hPGK-puro-sgAtf7ip2-SIM 1577 puroR ampicilin this work lentiviral expression 
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pLenti6/hPGK-puro-sgAtf7ip2-Domain2 1578 puroR ampicilin this work lentiviral expression 
pX459/sgNeg 1618 puroR ampicilin this work lentiviral expression 
pX459/sgDaxx 1620 puroR ampicilin this work lentiviral expression 
pX459/sgAtf7ip 1623 puroR ampicilin this work lentiviral expression 
pX459/sgAtf7ip-2 1624 puroR ampicilin this work lentiviral expression 
pBS/U6-sgAtf7ip 1647 none ampicilin this work lentiviral expression 
pBS/U6-sgAtf7ip-2 1648 none ampicilin this work lentiviral expression 
pLenti6/EFEGT-neo 940 G418 ampicilin Gunnar Schotta lentiviral expression 
pLenti6/EF1a-3xFLAG-IRES-PURO 963 puroR ampicilin Gunnar Schotta lentiviral expression 
pLKO1mod/shAtf7ip-1 1315 puroR ampicilin this work lentiviral knockdown 
pLKO1mod/shAtf7ip-2 1316 puroR ampicilin this work lentiviral knockdown 
pLKO1mod/shScrambled 849 puroR ampicilin Gunnar Schotta lentiviral knockdown 
psPAX2 183 none ampicilin Didier Trono lentivirus packaging 
pLP/eco-env 811 puroR ampicilin Gunnar Schotta lentivirus packaging 
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6. METHODS 
6.1. Cell culture 
Bacteria strains were grown either on LB Agar plates or in LB medium at 37 °C and 160 rpm 
with proper antibiotics. 
Feeder independent mESC were cultured at 37 °C and 5 % CO2 in high glucose DMEM with 
L-glutamine (Sigma Aldrich) supplemented with 15 % v/v FCS (batch tested for mESC), 1x MEM 
non-essential aminoacids, 1x Pen/Strep, 0.175 mM β-mercaptoethanol (Sigma Aldrich) and 
0.4 % v/v LIF (2.103 U/mL). Dishes suitable for tissue culture were coated with 1x PBS (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) 0.2 % w/v gelatin for 20 min before seeding 
cells. mESC were maintained at naïve state by adding 3 µM CHIR and 1 µM PD together with 
50 mg of L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma Aldrich). 
pMEF were cultured in mESC medium without LIF at 37 °C, 5 % CO2, 3 % O2. iMEF, Hela and 
HEK293T were cultured at 37 °C, 5 % CO2 in high glucose DMEM with L-glutamine (Sigma 
Aldrich) supplemented with 10 % v/v FCS, 1x MEM non-essential aminoacids, 1x Pen/Strep, 
0.175 mM β-mercaptoethanol (Sigma Aldrich). HEK293T cell were grown to a maximum of fifteen 
passages and the medium was always complemented with 500 µg/mL of G418 (PAA 
Laboratories). 
For passaging of all adherent mammalian cells, they were first washed with 1x PBS. After that, 
they were trypsinized with 1x Trypsin/EDTA in 1x PBS for 5 min. Trypsin was neutralized with the 
proper fresh medium and cells were pelleted 3 min at 400 g and resuspended in fresh growth 
medium. Cell number was counted using CASY Counter Model TT (Roche Innovatis). Cell stocks 
were frozen in medium specific to each cell line containing 10 % v/v DMSO and 40 % v/v FCS 
using Nalgene Cryo 1 °C freezing containger (Thermo Fischer Scientific). 
6.2. Chromatin immunoprecipitation of histone modifications 
After harvesting, chromatin of 3 million cells was crosslinked under mild agitation for 10 min at 
RT in 1 ml of 1 % v/v methanol-free formaldehyde (Thermo Fischer Scientific) in mESC medium. 
Formaldehyde was quenched under mild agitation for 5 min at RT with 125 mM of 2.5 M glycine 
in 1x PBS. Cells were washed twice with 1x PBS 10 % v/v FCS after pelleting for 3 min at 400 g 
and cell pellets were snap-frozen or freshly processed. Frozen cell pellets were resuspended in 
130 µL of lysis buffer 10 mM Tris/HCl pH 7.5, 140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1 % 
w/v Triton X-100, 0.1 % w/v Na-Deoxycholate, 0.1 % w/v SDS, 1x cOmplete, EDTA-free Protease 
Inhibitor Cocktail (Roche Diagnostics) and incubated for 5 min on ice. Samples were transferred 
to microTUBE AFA Fiber Pre-Slit Snap-Cap 6x16 mm and sonicated for 25 min at 4 °C using 
Covaris S220 series Focused.ultrasonicator (Thermo Fischer Scientific) with the following 
settings: duty factor of 2 %, peak incident power of 105 W, 200 cycles per burst and continuous 
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degassing. SDS of the lysis buffer was diluted in 870 µL of ChIP buffer (50 mM Tris/HCl pH 8.0, 
10 mM EDTA, 1 % w/v SDS, 1x cOmplete, EDTA-free Protease Inhibitor Cocktail). Diluted 
sheared chromatin was centrifuged for 15 min at 4 °C and 17000 g and divided in 6 aliquots of 
150 µL (chromatin of 450 thousand cells) and either snap-frozen or used freshly. 
In a 0.2 mL PCR tube, 11 µL of magnetic Dynabeads Protein G (Thermo Fischer Scientific) 
were washed 2 times with ChIP buffer. A total amount of 3 µg of antibody was bound to the beads 
for 2 h at 4 °C and 35 rpm vertically. Beads-Ab complexes were washed once with ChIP buffer 
and incubated with 150 µL of sheared chromatin for 4 h at 4 °C and 35 rpm vertically. 
Immunoprecipitated chromatin was washed 4 times with ChIP buffer and once with washing buffer 
(10 mM Tris/HCl pH 8.0, 10 mM EDTA) for 10 min at 4 °C and 35 rpm vertically. Chromatin was 
eluted from the beads-Ab complexes with 70 µL of elution buffer (0.5 % SDS, 300 mM NaCl, 
5 mM EDTA, 10 mM Tris HCl pH 8.0) containing 0.3 µg/mL RNase A (Thermo Fischer Scientific) 
for 30 min at 37 °C and 900 rpm horizontally. Proteins were digested with 0.6 µg/µL proteinase K 
(Thermo Fischer Scientific) for 2 h at 55 °C and 900 rpm horizontally. Crosslink was reversed by 
incubating samples for 8 h at 65 °C and 900 rpm horizontally. Supernatant was transferred to a 
new tube and another step of elution was carried out with 30 µl of elution buffer for 1 min. After 
combining eluates, remaining proteins were digested with 0.2 µg/µL proteinase K (Thermo 
Fischer Scientific) for 1 h at 55 °C and 600 rpm horizontally. Purification of DNA was performed 
using Agencourt AMPure XP beads (Beckman Coulter) at a sample-to-beads ratio of 1:2, 
according to the manufacturer’s instructions, eluting in 12 µL of 10 mM Tris/HCl pH 8.5. For ChIP-
qPCR, enrichment on specific regions was analyzed by qPCR using the LightCycler 480 Real 
Time PCR system (Roche Diagnostics). 
6.3. Chromatin immunoprecipitation of transcription factors 
The ChIP protocol for transcription factors is a modification of the one for histone modifications. 
The starting material was 25 million cells and the fixation procedure was scaled up proportionally 
and performed in 1x PBS 10 % v/v FCS (not in medium). The fresh pellets of fixed cells were 
resuspended in 10 mL of lysis buffer 1 (50 mM Hepes-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 
10 % v/v glycerol, 0.5 % v/v NP-40, 0.25 % v/v Triton X-100) and the samples were left rocking 
gently at 4 °C for 10 min. After centrifuging samples for 5 min at 4 °C and 1350 g, nuclei were 
extracted by resuspending cell pellets in 10 mL of lysis buffer 2 (10 mM Tris/HCl pH 7.5, 200 mM 
NaCl, 1 mM EDTA, 0.5 mM EGTA) and rocking gently at RT for 10 min. Nuclei were pelleted and 
resuspended in 1 mL of shearing buffer (10 mM Tris/HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 
0.5 mM EGTA, 0.1 % w/v Na-Deoxycholate, 1 % w/v SDS) and incubated on ice for 5 min. Both 
lysis buffers and the shearing buffer were complemented with 1x cOmplete, EDTA-free Protease 
Inhibitor Cocktail (Roche Diagnostics) right before use. Samples were transferred to tube AFA 
Fiber & Cap 12x12 mm and sonicated for 25 min at 4 °C using the following settings: duty factor 
of 20 %, peak incident power of 140 W, 200 cycles per burst and continuous degassing. After 
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adding 110 µL of 10 % v/v Triton X-100, sheared chromatin was centrifuged for 15 min at 4 °C 
and 17000 g and divided in 110 µL aliquots (chromatin of 2.5 million cells) used freshly. 
A volume of 30 µL of magnetic beads were coated with 5 µg of Ab. Two aliquots of sheared 
chromatin were diluted in 890 µL of ChIP buffer and used for overnight immunoprecipitation. The 
washes were scaled up to 1 mL of buffer and the two samples were pooled together for elution 
from the beads. After removal of RNA and proteins, samples were transferred to a Phase Lock 
Gel Heavy 2 mL tube (5 PRIME) and 400 µL of Phenol/Chloroform/Isoamyl alcohol (Carl Roth) 
was added for DNA purification. Samples were centrifuged for 10 min at 17000 g and aqueous 
phase transferred to a new Eppendorf tube containing 16 µL of 5 M NaCl and 1.5 µL of glycogen 
20 mg/mL. DNA was precipitated with 1 mL of ultrapure EtOH for 1 h at -80 °C. After 
centrifugation for 30 min at 17000 g, DNA pellets were washed with 70 % v/v EtOH. DNA was 
dissolved in 12 µL of 10 mM Tris/HCl pH 8.5. 
6.4. ChIP-Sequencing 
ChIP-Seq libraries were prepared with MicroPlex Library Preparation kit v2 (Diagenode) 
according to manufacturer’s instructions, using at least 1 ng of purified DNA. The purification of 
the libraries was performed with Agencourt AMPure XP beads (Beckman Coulter). Sample 
concentration was measured using the Qubit dsDNA HS Assay kits in a Qubit 3.0 Fluorometer 
(Invitrogen). Library quality was assessed with the Agilent DNA 1000 Kit on an Agilent 2100 
Bioanalyzer (Agilent Technologies). Samples were sequenced with a read length of 50 bp in 
paired-end mode using Illumina’s HiSeq 1500 sequencer at the Laboratory for Functional 
Genome Analysis (LAFUGA) within the Gene Center (LMU Munich). Data demultiplexing was 
done in the Galaxy platform (Afgan et al., 2016). Reads were mapped against the mm10 genome 
using bowtie (Langmead et al., 2009) and bowtie2 (Langmead and Salzberg, 2012), excluding or 
including multimapped reads, respectively. Identification of ChIP-Seq peaks, tag counting, peak 
merging, genomic annotation at peaks and analysis of repetitive regions were performed with 
Homer v4.9 (Heinz et al., 2010). Further downstream analysis was carried out in RStudio 
(RStudio-Team, 2016). 
6.5. Co-immunoprecipitation 
After harvesting 50 million cells by trypsinization, they were resuspended in 2 mL of 1x PBS 
and slowly transferred onto 4 mL of freshly prepared ice cold Ficoll gradient 80 mM Tris/HCl pH 
7.4, 8 mM MgCl2, 8 mM CaCl2, 1.6 % w/v NP40, 1.28 % w/v Triton X-100, 20 % v/v Ficoll (LSM 
1077 Lymphocyte separation medium, PAA Laboratories), 0.1 % v/v DMSO. Nuclei were isolated 
by centrifuging with steps of 30 s at 400rpm, 500 rpm, 600 rpm and 700 rpm and a final step of 
6 min at 800 rpm. This centrifugation was performed in a Heraeus TX 1000 rotor (Thermo Fischer 
Scientific) at 4 °C. 
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Nuclei were resuspended in 500 µL of IP buffer 50 mM Hepes-KOH ph 7.5, 150 mM NaCl, 
0.05 % v/v NP40, 20 % v/v glycerol, 10 mM N-maleimide, 1x phosSTOP (Roche Diagnostics), 
1x cOmplete, EDTA-free Protease Inhibitor Cocktail (Roche Diagnostics). Nucleic acids were 
digested with 250 U of benzonase (Merck Millipore) for 15 min at 37 C. Salt concentration was 
adjusted to 300 mM NaCl and samples were incubated for 30 min on ice. Nuclei were disrupted 
by sonication twice under 10 % amplitude for 10 s using Branson Digital Sonifier S-250D with a 
3 mm tapered microtip (Branson Ultrasonics Corporation). Lysates were cleared by centrifugation 
for 30 min at 4 °C and 17000 g, transferred to a new Eppendorf tube and 25 µL were saved as 
5 % input. To the 5 % input and the pellet containing insoluble proteins, 25 µL of 2x Roti-Load 1 
sample buffer (Carl Roth) were added and samples were boiled for 7 min at 95 °C. 
After washing 50 µL of Anti-Flag M2 affinity gel (Sigma Aldrich) twice with 1 mL of IP buffer, 
nuclear protein extract was transferred to the agarose beads. Immunoprecipitation was carried 
out for for 6 h at 4 °C and 6 rpm vertically. Beads and co-immunoprecipitated complexes were 
washed 4 times with 1 mL of IP buffer with 300 mM NaCl for 5 min at RT and 6 rpm vertically. 
Proteins were eluted in 25 µL of 2x Roti-Load 1 sample buffer (Carl Roth) for 7 min at 95 °C. 
Samples containing the 5 % input, insoluble proteins and immunoprecipitated proteins were 
analyzed by western blot. 
6.6. Embryoid body formation 
After harvest, 0.5 million mESC were resuspended in 10 mL of EB medium (mESC medium 
without LIF), to obtain 500 drops of 20 µL each containing 1000 cells. They were dropped onto 
the inner part of the lid of a 15 cm dish, while the bottom was filled with 15 mL of 1x PBS. The 
dishes were incubated at 37 °C and 5 % CO2. Three days later, the drops were flushed with 20 mL 
of EB medium and split into 2 bacteriological grade dishes. At the fifth and tenth day of 
differentiation, EB of one of the dishes was harvested. After washing once with 1x PBS, EB were 
trypsinized for 5 min and triturated by pipetting 60 times. Trypsin was diluted 10 times in 1x PBS 
and cells were washed once with 1x PBS. Cell pellets were used for RNA extraction. 
6.7. Gene targeting for knockout 
The sgRNA were designed using an online tool (crispr.mit.edu). They were cloned in the 
pX330-U6-Chimeric_BB-CBh-hSpCas9 Addgene plasmid # 42230 (Cong et al., 2013). To 
facilitate the screening process, a pair of sgRNA were used, that were complementary to two sites 
in the second exon of the gene around 100 bp away from each other. This way, deletion of the 
region between the targeted sites would be induced and it was used to easily distinguish mutants 
during genotyping by PCR. One day before transfection, 0.3 million mESC were seeded on a 6-
well dish. The sgRNA-containing plasmids also expressing Cas9 were co-transfected with a 
plasmid expressing EF1α-puromycin (p963) using jetPRIME Transfection Reagent (Polyplus-
transfection) for 16 h. Cells transfected with a high load of plasmids were selected with 1.5 µg/mL 
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of puromycin for 24 h. The described steps were also performed without transfection of Cas9-
containing plasmids to generate control cell lines. For acute knockout experiments, the knockout 
cell pool was analyzed around 6 days after transfection. For generation of stable isogenic cell 
lines, single colonies were picked around 7 days after transfection and expanded to isolate cells 
containing the same type of mutation. The target loci of each clonal cell line were analyzed in 
agarose gel after PCR amplification and by Sanger sequencing (Eurofins Genomics). Knockout 
at protein level was confirmed by western blot. 
6.8. Gene targeting for knockin 
For Flag-Atf7ip KI mESC lines generation, 0.3 million cells were seeded on a 6-well dish one 
day before transfection. The sgRNA were designed with the help of an online tool (crispr.mit.edu). 
The plasmid expressing Cas9 and the sgRNA to target the stop codon region of Atf7ip (p1516) 
was co-transfected with a plasmid containing the Flag sequence surrounded by 800 bp homology 
arms corresponding to the endogenous sequence surrounding the desired insertion site (p1467) 
and another expressing EF1α-puromycin (p963). The PAM sequence of the HDR template was 
mutated to avoid recognition and cleavage by the Cas9. Transfection was performed for 16 h 
using jetPRIME Transfection Reagent (Polyplus-transfection). Cells transfected with a high load 
of plasmids were selected with 1.5 µg/mL of puromycin for 24 h. For generation of stable isogenic 
cell lines, single colonies were picked around 7 days after transfection. The target loci of each 
clonal cell line were analyzed in agarose gel after PCR amplification and by Sanger sequencing 
(Eurofins Genomics). Knockin at protein level was confirmed by western blot. To generate Min-
Atf7ip KI mESC lines, a similar procedure was carried out, with the difference that the plasmid 
expressing Cas9 and the sgRNA targeting the start codon region of Atf7ip also expressed 
puromycin (p1597). In this case the donor plasmid contained the Min-tag sequence surrounded 
by homology arms (p1646) of 800 bp. The target loci of each clonal cell line were analyzed in 
agarose gel after PCR amplification and by Sanger sequencing (Eurofins Genomics). For 
expressing the different mutants, a heterozygous Atf7ip knockout cell line was obtained by co-
transfecting the Min-Atf7ip KI mESC line with an empty pattB vector coding for hygromicin B 
resistence (p1615) and the plasmid coding for the Bxb1 integrase (p1584). After antibiotics 
selection for 6 days to make sure all surviving cells suffered the targeted recombination, single 
clones were isolated and screened for the heterozygous genotype by PCR. For the rescue 
experiments, a heterozygous clone was again co-transfected to integrate the different mutants of 
interest separately, which also expressed zeocin resistance. 
6.9. Immunofluorescence microscopy 
Coverslips were placed each in one well of a 24-well tissue culture grade dish. They were 
washed once with 100 % ethanol and once with sterile ddH2O. After drying at RT for 5 min 10 % 
Poly-L-Lysine (Sigma Aldrich) in water was added to each well and incubated for 15 min at RT. 
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The coverslips were washed three times with sterile ddH2O and air-dried for 5 min. After that, they 
were incubated 30 min at 37 °C. Around 200 thousand cells in suspension were seeded on each 
well and incubated 60 min, to let them adhere. The medium was aspirated and cells were carefully 
washed once in 1 mL of 1x PBS. Fixation was carried out with 500 µL of 3.7 % formaldehyde 
(Carl Roth) in 1x PBS for 10 min at RT: Fixed cells were washed twice in 1 mL of 1x PBS for 5 min 
and permeabilized with 500 µL of 3 mM sodium citrate tribasic dehydrate (Merck), 0.1 % v/v Triton 
X-100. Permeabilized cells were washed twice in 1 mL of washing solution 1x PBS and twice in 
1x PBS, 0.1 % v/v Tween 20, 0.2 % w/v BSA for 5 min. Cells were blocked with 300 µL of blocking 
solution 1x PBS, 0.1 % v/v Tween 20, 2.5 % w/v BSA for 30 min and incubated overnight at 4 °C 
with 200 µL of blocking solution containing the desired primary Ab. The dish was warmed to RT 
for 30 min and stained cells were washed three times in 1 mL of washing solution for 10 min. 
They were incubated with proper secondary Ab diluted 1:1000 in blocking solution, 10 % normal 
goat serum (Dianova-Jackson Immuno Research) at RT for 1 h. After washing three times in 
1x PBS, 0.1 % Tween 20 for 10 min, cells were imbedded in Vectashield Antifade Mounting 
Medium with DAPI (Vector Laboratories) on standard microscope slides (Carl Roth) and sealed 
with nail polish. The immunofluorescent staining was examined with Axiovert 200 M inverted 
microscope for transmitted light and epifluorescence (Carl Zeiss Microscopy) with the help of the 
AxioVision Special Edition Software (Carl Zeiss Microscopy). 
6.10. Mass spectrometry 
In the last step of co-IP, instead of eluting the proteins from agarose beads, the excess of NP-
40 detergent and protease inhibitors was removed by washing beads and co-immunoprecipitated 
complexes 3 times with 300 µL of 100 mM Tris/HCl pH 7.5. To avoid contamination with Ab 
peptides, proteins were eluted from the agarose beads by digesting with 1 µg of endoproteinase 
LysC in 50 µl of 100 mM Tris/HCl buffer, 3.7 M Urea. Samples were incubated for 50 min at 28 °C 
and 1200 rpm horizontally. After spinning down the samples, supernatants were transferred to 
fresh low binding eppendorf tubes. Beads were washed 3 times with 75 µL of 100 mM ammonium 
bicarbonate and the supernatants were combined with the first one of that sample. DDT was 
added to a final concentration of 10 mM and proteins were digested overnight with 1.5 µg of 
trypsin at 28 °C and 1200 rpm horizontally. Digestion was blocked with 30 mM of iodoacetamide 
for 40 min at RT and 550 rpm in the dark. 
Samples were acidified with 1 µl of 100 % v/v trifluoroacetic acid and 2 µl of 100 % v/v formic 
acid. Formic acid was added until pH of samples reached between 2 and 3. Purification of 
peptides was carried out using C18 stage tips. Tips were first activated by washing twice with 
50 µl of methanol, once with 50 µl of elution solution and three times with 65 µl of 0.1 % v/v 
trifluoroacetic acid in. Samples were loaded into the activated tips by centrifugation for 20 min at 
55 g. The stage tips were washed twice with 70 µL of 0.2 % v/v formic acid in ultra-pure H2O and 
dried completely by centrifuging for 2 min at 170 g. Peptides were eluted twice by adding 65 µl of 
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elution buffer and centrifuging for 4 minutes at 70 g. The flow through was vacuum-dried and re-
suspended in 10 µl 2% v/v formic acid in ultra-pure H2O. High-performance liquid 
chromatography-tandem mass spectrometry (HPLC-MS/MS) was performed by injecting purified 
peptides in an Ultimate 3000 nanoLC system coupled to a QExactive HF hybrid quadrupole-
Orbitrap mass spectrometer (Thermo Fischer Scientific). Measurements were done with a 90 min 
program of data-dependent acquisition. 
The raw data files were analyzed by MaxQuant Software Suit v.1.5.5.1 (Cox and Mann, 2008). 
Peptides were searched against the Swiss-Prot mouse database (October 2016) using the 
Andromeda search algorithm allowing for a maximum of three missed cleavage sites. 
Carbamidomethylation (C) was set as fixed modification and oxidation (M) and acetylation at the 
protein N-terminus as variable modifications for peptide identification. Mass deviation for 
precursor ions used was 20 ppm for the first search and 5 ppm for the main search. MS/MS mass 
deviation was set to 25 ppm. Peptide spectrum matches were filtered for 1% FDR rate and 
proteins filtered for 5%. Log-fitted iBAQ values were calculated for protein quantitation. For 
quantitative analysis of IP experiments, reversed protein hits were removed prior to further 
analysis. Protein hits with log 2 transformed iBAQ values lower than 3 quantitation values were 
removed. All samples were normalized by the median from the sample with the highest median. 
Subsequently, normalized IP-MS data were analyzed in Perseus (Tyanova et al., 2016) to 
determine proteins specifically enriched in the FLAG-ATF7IP pulldown experiment. A modified t-
test was performed employing a permutation-based FDR rate. For analysis of PTM of ATF7IP, 
lysine acetylation, lysine ubiquitination (GG), lysine and arginine monomehtylation, as well as 
phosphorylation of serine, threonine, and tyrosine were enabled as variable modifications. 
6.11. Molecular cloning 
Bacteria were transformed using heat shock method. Plasmid preparation was performed 
using NucleoBond Xtra Midi kit and NucleSpin Plasmid (noLid) kit (Macherey-Nagel), according 
to manufacturer’s instructions. For restriction digestion-based cloning, restriction endonuclease 
products, T4 DNA ligase and Antarctic Phosphatase from New England BioLabs were used. For 
PCR-based cloning, Gibson Assembly Master Mix (New England BioLabs) was used. DNA 
fragments of interest were amplified with Q5 High Fidelity DNA Polymerase (New England 
BioLabs). Sequence of the constructs was verified by Sanger sequencing (Eurofins Genomics). 
6.12. Protein extracts 
Nuclear protein extracts were obtained using the Nuclear Extract Kit (Active Motif). Whole cell 
proteins extracts were prepared by resuspending cell pellets in freshly prepared lysis buffer 
50 mM Tris/HCl pH 7.5, 2 % w/v SDS, 1 % v/v Triton X-100, 1 mM PMSF, 0.5x cOmplete, EDTA-
free Protease Inhibitor Cocktail (Roche Diagnostics). Samples were vortexed for 10 s at max 
speed and boiled for 10 min at 95 °C. They were sonicated twice under 10 % amplitude for 10 s 
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using Branson Digital Sonifier S-250D with a 3 mm tapered microtip (Branson Ultrasonics 
Corporation). After a 15 min centrifugation at RT and 17000 g, supernatant containing soluble 
protein extracts were mixed with 1x Roti-Load 1 sample buffer (Carl Roth) and stored at -20 °C. 
Protein concentration was quantified with the Pierce BCA Protein Assay kit (Thermo Fischer 
Scientific). For acid extraction of histones, nuclei of 20 million cells were isolated as described for 
the co-immunoprecipitation protocol. After that, they were resuspended in 100 µL of ice cold 0.4 N 
HCl and incubated overnight at 4 °C and 20 rpm vertically. Samples were centrifuged for 20 min 
at 17000 g and transferred to a fresh eppendorf tube on ice. They were dialyzed 3 times in 1 L of 
100 mM acetic acid for 1 h each. After adding 1x Roti-Load 1 sample buffer (Carl Roth) samples 
were stored at -20 °C. 
6.13. Quantification of RNA levels 
The RNA levels were quantified by two-step RT-qPCR. For that, harvested cells were washed 
once with 1x PBS and cell pellet was snap-frozen in RLT buffer (Qiagen), 1% v/v β-
mercaptoethanol (Sigma Aldrich). Total RNA was extracted using RNeasy Mini Kit (Qiagen) 
coupled to DNA on-column digestion using RNase-free DNase I (Qiagen). Synthesis of cDNA 
was carried out using SuperScript III Reverse Transcriptase (Invitrogen), Random Primer 6 (New 
England BioLabs) and RNasin Ribonuclease Inhibitor (Promega). Quantification of cDNA was 
performed with Fast SYBR Green Master Mix (Applied Biosystems) in a LightCycler 480 (Roche 
Diagnostics), according to the MIQE Guidelines (Bustin et al., 2009). Reactions were performed 
in a volume of 10 µL in a 384-well LightCycler plate PP (Sarstedt). Cq values were calculated by 
the LightCycler 480 Software (Roche Diagnostics) using the Fit Points method of absolute 
quantification. Gapdh and Hprt were used as reference genes and data normalization was 
performed as described elsewhere (Vandesompele et al., 2002). 
6.14. RNA-Sequencing 
The integrity of the purified total RNA was verified using the Agilent RNA 6000 Pico Kit on an 
Agilent 2100 Bioanalyzer (Agilent Technologies). Ribosomal RNA was removed from 4 µg of 
purified total RNA with Ribo-Zero Magnetic Kit (Human/Mouse/Rat, Epicentre) using RiboGuard 
RNase Inhibitor. rRNA-depleted samples were purified using the RNA Clean & Concentrator-5 
columns (Zymo Research). Depletion was checked on the Bioanalyzer. RNA-Seq libraries were 
prepared following the NEBNext Ultra Directional RNA Library Prep Kit for Illumina (New England 
BioLabs). Library quality was assessed with the Agilent DNA 1000 Kit (Agilent Technologies) on 
the Bioanalyzer. Before every Bioanalyzer run, sample concentration was measured using either 
the Qubit RNA HS Assay or the Qubit dsDNA HS Assay kits in a Qubit 3.0 Fluorometer 
(Invitrogen). Libraries were sequenced with a read length of 50 bp in paired-end mode using 
Illumina’s HiSeq 1500 sequencer at the Laboratory for Functional Genome Analysis (LAFUGA) 
within the Gene Center (LMU Munich). Data demultiplexing was done in the Galaxy platform 
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(Afgan et al., 2016). Reads were mapped to mm10 mouse genome using Tophat (Trapnell et al., 
2009). Tags were counted with Homer v4.9 (Heinz et al., 2010). Differential expression was 
calculated using Cufflinks v2.2.1 (Trapnell et al., 2012). Further downstream analysis was carried 
out in RStudio (RStudio-Team, 2016). 
6.15. RNA interference 
One day before transfection for virus packaging, around 4 million HEK293T cells were seeded 
in a 10 cm cell culture dish. Transfection was carried out using the calcium phosphate method 
1 h after changing the medium to a fresh one without G418. For that, a total of 24 µg of plasmid 
DNA consisting of equimolar ratios of the lentiviral transfer vector, psPax2 (p183) and pLP-eco-
env (p811) were mixed with 120 µL of 2.5 M CaCl2 and diluted to 1.2 mL of sterile ddH2O. While 
gently vortexing the solution, 1,2 mL of 50 mM HEPES, 280 mM NaCl, 1.5 mM Na2HPO4, 
adjusted to pH 7.05 with NaOH was added dropwise. The 2.4 mL transfection mix was quickly 
added to the medium, to ensure no changes in pH. After 5-6 h, cells were washed once in 1x PBS 
and 10 mL of fresh medium was added. The supernatant containing viruses were harvested 30 h 
and 60 h after transfection, centrifuged for 5 min at RT and 3000 g to pellet debris, snap frozen 
in liquid nitrogen and stored at -80 °C. For transduction of mESC, 0.3 million cells were seeded 
per well on a 6-well dish. The next day, the medium was removed and 1 ml of a fresh one was 
added to the cells. Viruses were quickly thawed and 2 ml of viral supernatant were added to the 
cells containing 6 µl of 4 mg/ml of polybrene (final concentration of 8 mg/ml). Plates were spun 
down in the Thermo Multifuge 4KR, for 1 h, at 1000 g and 34° C. Polybrene was diluted by adding 
3 ml of fresh medium. Then, the cells were incubated overnight at 37° C + 5% CO2. One day after 
transduction medium was removed and the cells were washed in 1xPBS, trypsinized and 
transferred to a 10 cm dish for antibiotic selection with 1.5 µg/ml of puromycin. 
6.16. Exogenous TE silencing reporter assay 
Viral production for control (p940) and test viruses (p1074) was carried out as described in the 
previous section (Chapter 6.15 RNA interference). Virus titer was calculated by transducing HeLa 
T37 cells. For that, 30 thousand cells were seeded into wells of a 12-well dish. The day after, a 
serial dilution of the viruses was added to the cells (containing 1 µl to 64 µl of viruses) together 
with 8 µg/ml of polybrene. Transduction and data acquiring was performed as described below 
for mESC.  For the reporter assay in mESC, 0.1 million cells were seeded per well in two wells of 
a 12-well dish for each genotype tested and volume of medium was completed to 700 µl. The 
cells were incubated for around 3 h to let them attach to the bottom of the well. Control and test 
viruses were quickly thawed and added to the cells containing enough polybrene 4 mg/ml to a 
final concentration of 8 mg/ml in the well. Usually between 300 and 500 µl of viral supernatant 
were used, depending on the titer, to obtain a multiplicity of infection of only 15 %. Of note, mESC 
are normally 60-fold harder to transduce than HeLa T37 cells. One well should contain the control 
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virus used for normalization and the second well should contain the test virus for evaluating the 
silencing efficiency. Plates were spun down in the Thermo Multifuge 4KR, for 1 h, at 1000 g and 
34° C. Polybrene was diluted by adding 1 volume of fresh medium and the cells were incubated 
at 37° C + 5% CO2. Two days after transduction, cells were washed in 1x PBS and 100 µl of 
trypsin was added. After 3 min of incubation at 37° C, 100 µl of 1x PBS was added to each well 
and the plates were placed on ice. After pipetting up and down several times, the cells were 
filtered and EGFP-positive cells were counted by flow cytometry using BD FACSCanto flow 
cytometer (BD Biosciences) with the help of the BD FACSDiva Software. Data were further 
processed using the FlowJo Software (TreeStar). Percentage of remaining EGFP-positive cells 
were calculated by dividing the values obtained for the test virus by the values from the control 
after correcting by the virus titer. This protocol was based on a previously published method 
(Sadic et al., 2015). 
6.17. Silver staining 
Polyacrylamide gels were fixed at RT in 10 % v/v acetic acid, 30 % v/v isopropanol for at least 
2 h. Gels were washed 3 times for 20 min in 30 % v/v ethanol and incubated in 0.02% sodium 
thiosulfate at RT for 1 min. They were washed with ddH2O 3 times for 20 s. Staining was 
performed at RT in 0.1 % w/v silver nitrate for 1 h with mild agitation in the dark. Stained gels 
were washed 3 times for 30 s with ddH2O and developed in 3 % w/v Na2CO3, 0.05 % v/v 
formaldehyde, 0.0004 % Na2S2O3 for 5 to 10 min, until the bands were clear. Reduction was 
quenched by incubating the gels in 5 % w/v glycine for 10 min. Developed gels were stored in 
ddH2O at 4°C until scanning. 
6.18. Western blot 
Protein extracts were denatured by adding 2x Roti-Load 1 sample buffer (Carl Roth) and 
boiling at 95 °C for 5 min. Samples were separated through SERVAGel TG PRiME 4-12 % 
precast SDS Page (SERVA Electrophoresis) in running buffer 25 mM Tris, 200 mM glycine, 1 % 
(m/v) SDS at RT for 1 h and 25 mA per gel. They were blotted onto methanol activated-PVDF 
membranes in a wet-blotting chamber (Bio-Rad Laboratories) containing blotting buffer 50 mM 
Tris, 40 mM glycine, 10 % v/v methanol, 5 µM SDS for 1.5 h at 4 °C and 400 mA. The blotting 
was performed at 400 mA under 4°C for 1.5 hours. Membranes were incubated in blocking buffer 
1x PBS, 2.5 % w/v BSA and 2.5 % w/v skim milk at RT for 1 h under mild agitation. Blocked 
membranes were incubated with primary Ab in blocking buffer at 4°C for 16 hours. After that, they 
were washed 3 times with PBST buffer 1x PBS, 0.1 % v/v Tween 20 for 20 min. Incubation with 
secondary Ab was done in a dilution of 1:3000 in blocking buffer at RT for 1.5 h. The probed 
membranes were washed 3 times in PBST for 20 min. Chemioluminescence was detected in X-
ray films (Fujifilm) using ECL Western blot detection reagent (Amersham Biosciences) or 
Immobilon Western Chemiluminescent HRP Substrate (Merck Millipore).  
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7. ABBREVIATIONS 
2i+vitC two inhibitors medium complemented with vitamin C 
aa amino acid(s) 
Ab antibody(ies) 
Atf7ip Activating transcription factor 7-interacting protein 1 (also mAM, Mcaf1) 
bp base pair(s) 
Cas9  CRISPR-associated endonuclease 9 
cDNA complementary DNA 
ChIP chromatin immunoprecipitation 
ChIP-qPCR chromatin immunoprecipitation followed by quantitative PCR 
ChIP-Seq chromatin immunoprecipitation followed by high throughput sequencing 
cKO conditional knockout 
co-IP co-immunoprecipitation 
CpG cytosine nucleotide followed by a guanine in the 5’ to 3’ direction 
CRISPR clustered regularly interspaced short palindromic repeats 
ddH2O Double-distilled water 
dGene-ID Drosphila gene 
dKO double knockout 
DNAme deoxyribonucleic acid methylation 
dPROTEIN-ID Drosphila protein 
EB embryoid body(ies) 
EGFP enhanced green fluorescent protein 
EGFP+ EGFP-positive 
GO gene ontology 
H3K9ac Histone 3 Lysine 9 acetylation 
H3K9me/1/2/3 Histone 3 Lysine 9 -, mono-, di- or tri- methylation 
H3K9MT Histone 3 Lysine 9 methyltransferase(s) 
HDR homology-directed repair 
HKMT Histone lysine methyltransferase(s) 
HEK293T 
human embryonic kidney cell line 293 transformed with the large-T-
antigen of SV40 virus 
HeLa human cervix carcinoma cell line 
HP1 Heterochromatic protein 1 
hPROTEIN-ID human protein 
hygroR hygromycin B resistance 
IAP Internal A-type Particle 
ICM inner cell mass 




LIF leukemia inhibitor factor 
MBD methyl-CpG binding domain 
MEF mouse embryonic fibroblast(s) 
mESC mouse embryonic stem cell(s) 
MIN multifunctional integrase 
mRNA messenger ribonucleic acid 
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NHEJ non-homologous end-joining 
p flox allele 
PCA principal component analysis 
attB bacterial attachment site 
attP phage attachment site 
Pol-II RNA polymerase II 
PcG Polycomb group 
PML-NB promyelocytic leukemia nuclear bodies 
PTM post-translational modification/s 
puroR puromycin resistance 
qPCR quantitative polymerase chain reaction 
rpm rotations per minute 
RNA-Seq RNA high throughput sequencing 
rRNA ribosomal RNA 
RNP Ribonucleoprotein(s) 
RT room temperature 
RT-qPCR reverse transcription quantitative polymerase chain reaction 
sgRNA single guide ribonucleic acid(s) 
shRNA short hairpin ribonucleic acid(s) 
RNA-Seq ribonucleic acid-sequencing 
SAM S-adenosyl-L-methyonine 
Setdb1 SET domain bifurcated 1 (also ESET) 
SIM Sumo-interaction motif 
TE transposable element(s) 
TKO triple knockout 
TRD transcriptional repression domain 
TSS transcription start site(s) 
WB Western blot 
XCI X chromosome inactivation 
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9. APPENDIX 
Table 9.1 | Mass spectrometric analysis of anti-FLAG co-IP of Flag-Atf7ip mESC versus wild type cells. 
The top 80 hits are displayed, together with their peptide counts and the protein coverage obtained in all replicates. 
Gene Description ct1 ct2 ct3 ip1 ip2 ip3 ip4 % Coverage p 
Atf7ip 
Activating transcription factor 7-interacting 
protein 1 
4 0 4 28 53 38 30 50 0.033 
Setdb1 Histone-lysine N-methyltransferase SETDB1 1 2 2 26 38 27 25 31 0.001 
Flnb Filamin-B 1 3 4 7 37 17 28 21 0.018 
Nup214 Nuclear pore complex protein Nup214 2 7 9 12 35 18 16 24 0.028 
Ddx39a ATP-dependent RNA helicase DDX39A 2 6 8 14 19 14 15 54 0.017 
Nono 
Non-POU domain-containing octamer-binding 
protein 
2 6 7 14 22 9 11 57 0.021 
Uhrf1 E3 ubiquitin-protein ligase UHRF1 2 4 3 8 24 14 9 43 0.009 
Nup93 Nuclear pore complex protein Nup93 0 1 3 4 17 13 12 29 0.020 
Hcfc1 Host cell factor 1 0 1 1 4 21 9 11 15 0.002 
Ruvbl1 RuvB-like 1 2 4 4 7 15 11 10 48 0.002 
Smc3 
Structural maintenance of chromosomes 
protein 3 
0 0 3 2 23 5 5 21 0.026 
Nop56 Nucleolar protein 56 1 4 6 10 19 15 15 38 0.009 
Kpnb1 Importin subunit beta-1 2 5 8 12 18 14 14 28 0.028 
Nop2 
Probable 28S rRNA (cytosine-C(5))-
methyltransferase 
0 1 2 5 12 10 9 24 0.007 
Eif4a3 Eukaryotic initiation factor 4A-III 1 3 10 7 13 14 15 42 0.024 
Ccar2 Cell cycle and apoptosis regulator protein 2 0 1 1 3 10 6 8 13 0.009 
Skiv2l2 Superkiller viralicidic activity 2-like 2 0 2 5 6 17 14 15 25 0.012 
Mcm5 DNA replication licensing factor MCM5 0 0 4 4 7 8 8 19 0.007 
Polr1c 
DNA-directed RNA polymerases I and III 
subunit RPAC1 
0 0 1 1 3 1 1 10 0.028 
Ppp1ca 
Serine/threonine-protein phosphatase PP1-
alpha catalytic subunit 
1 2 4 3 8 4 5 28 0.007 
Wdr18 WD repeat-containing protein 18 0 0 1 4 8 5 5 31 0.007 
Sap18 Histone deacetylase complex subunit SAP18 0 0 1 0 3 1 2 23 0.028 
Pcna Proliferating cell nuclear antigen 0 3 3 4 12 6 6 63 0.010 
Rbbp4 Histone-binding protein RBBP4 2 2 6 1 9 7 8 39 0.024 
Dkc1 H/ACA ribonucleoprotein complex subunit 4 0 1 0 1 7 3 5 27 0.029 
Rae1 mRNA export factor 0 1 0 1 5 2 3 22 0.011 
Cpsf1 
Cleavage and polyadenylation specificity factor 
subunit 1 
0 0 1 1 5 5 5 9 0.019 
Eed Polycomb protein EED 0 0 1 1 5 3 4 13 0.028 
Gatad2a Transcriptional repressor p66 alpha 0 0 2 3 12 8 9 26 0.011 
Pno1 RNA-binding protein PNO1 0 0 0 2 4 2 2 24 0.000 
Eif2s3x/y 
Eukaryotic translation initiation factor 2 subunit 
3 
0 1 1 1 7 6 6 24 0.014 
Usp39 U4/U6.U5 tri-snRNP-associated protein 2 0 1 0 1 6 2 4 16 0.009 
Rpl30 60S ribosomal protein L30 0 1 0 2 4 2 2 47 0.001 
Cstf2 Cleavage stimulation factor subunit 2 0 0 1 2 6 3 4 16 0.007 
Rpl10a 60S ribosomal protein L10a 1 3 2 7 8 4 4 33 0.001 
Ppp1cc 
Serine/threonine-protein phosphatase PP1-
gamma catalytic subunit 
0 1 6 4 6 3 5 21 0.017 
Smarcb1 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily B 
member 1 
0 0 1 1 4 3 4 16 0.010 
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Gene Description ct1 ct2 ct3 ip1 ip2 ip3 ip4 % Coverage p 
Zfr Zinc finger RNA-binding protein 0 0 0 0 4 2 1 4 0.016 
Uqcrc1 
Cytochrome b-c1 complex subunit 1, 
mitochondrial 
0 0 0 1 2 2 3 10 0.001 
Fscn1 Fascin 1 0 2 3 7 12 12 23 0.014 
Rps5 
40S ribosomal protein S5;40S ribosomal 
protein S5, N-terminally processed 
0 0 0 0 2 2 2 23 0.034 
Pml Protein PML 0 0 1 1 5 5 6 14 0.022 
Polr1a DNA-directed RNA polymerase I subunit RPA1 0 0 1 0 5 3 2 4 0.003 
Pabpn1 Polyadenylate-binding protein 2 0 0 1 2 4 3 4 15 0.016 
Ppp2r1a 
Serine/threonine-protein phosphatase 2A 65 
kDa regulatory subunit A alpha isoform 
0 1 0 1 6 3 1 14 0.015 
Sympk Symplekin 0 0 1 2 8 4 4 10 0.002 
Kdm1a Lysine-specific histone demethylase 1A 0 0 1 1 4 2 3 9 0.001 
Wdr43 WD repeat-containing protein 43 0 0 0 2 7 3 6 15 0.003 
Lin28a Protein lin-28 homolog A 0 2 0 1 3 1 1 23 0.017 
Ddx39b Spliceosome RNA helicase Ddx39b 1 5 4 13 15 13 13 44 0.025 
Bub3 Mitotic checkpoint protein BUB3 0 0 0 2 4 2 2 17 0.000 
Exosc10 Exosome component 10 0 0 0 0 2 2 2 4 0.009 
Nup37 Nucleoporin Nup37 0 0 0 0 6 4 3 26 0.018 
Rps11 40S ribosomal protein S11 1 1 1 5 5 3 3 33 0.002 
Eif3f 
Eukaryotic translation initiation factor 3 subunit 
F 
0 0 0 0 5 2 3 13 0.020 
Rpl3 60S ribosomal protein L3 0 1 2 3 6 2 4 18 0.031 
Polr2e 
DNA-directed RNA polymerases I, II, and III 
subunit RPABC1 
0 0 0 0 4 2 3 30 0.025 
Emg1 
Ribosomal RNA small subunit 
methyltransferase NEP1 
0 0 2 2 5 3 4 23 0.013 
Eif3l 
Eukaryotic translation initiation factor 3 subunit 
L 
1 0 0 1 4 1 1 8 0.029 
Mtco2 Cytochrome c oxidase subunit 2 0 0 0 3 2 2 3 19 0.000 
Polr2h 
DNA-directed RNA polymerases I, II, and III 
subunit RPABC3 
0 0 0 3 3 2 2 34 0.000 
Dnmt3b DNA (cytosine-5)-methyltransferase 3B 0 0 1 1 5 3 4 8 0.019 
Znf518a Zinc finger protein 518A 0 0 0 0 4 3 3 3 0.002 
Cct8 T-complex protein 1 subunit theta 0 0 0 1 3 1 0 9 0.024 
Rps14 40S ribosomal protein S14 0 0 3 4 4 3 4 38 0.022 
Ddx42 ATP-dependent RNA helicase DDX42 0 0 0 0 4 2 3 6 0.023 
Gnb1 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
0 1 2 3 4 3 3 17 0.023 
Pes1 Pescadillo homolog 0 0 0 0 3 2 1 10 0.027 
Ddx6 Probable ATP-dependent RNA helicase DDX6 0 0 0 1 4 2 3 16 0.007 
Rpl8 60S ribosomal protein L8 0 0 2 2 2 2 2 11 0.032 
Thoc5 THO complex subunit 5 homolog 0 0 0 0 3 2 3 8 0.016 
Ddx1 ATP-dependent RNA helicase DDX1 0 0 1 0 3 1 2 8 0.027 
Noc4l Nucleolar complex protein 4 homolog 0 0 1 1 1 2 3 9 0.030 
Exosc9 Exosome complex component RRP45 0 0 2 1 2 2 2 5 0.029 
Cstf3 Cleavage stimulation factor subunit 3 0 0 0 1 2 1 1 5 0.002 
Exosc5 Exosome complex component RRP46 0 0 0 2 3 2 1 15 0.000 
Rpl38 60S ribosomal protein L38 0 1 0 1 3 3 3 46 0.032 
Nol6 Nucleolar protein 6 0 0 0 1 3 2 2 4 0.017 
Prmt1 Protein arginine N-methyltransferase 1 0 0 0 0 3 1 2 12 0.033 
Cdc40 Pre-mRNA-processing factor 17 0 0 0 0 3 1 1 7 0.003 
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